Vital Healthcare Property Trust logo

Full year results release

Full Year Results10 August 2022VHPReal Estate

VITAL HEALTHCARE PROPERTY TRUST
Managed by NorthWest Healthcare

Properties Management Limited



vhpt.co.nz


MARKET RELEASE

Managed by NorthWest Healthcare

Pr operties Management Ltd

11 August 2022


Strong earnings growth driven by high-quality property portfolio


Despite increasing volatility in stock markets around the world, healthcare property

remains a strong defensive asset class offering stable and transparent rental income

cashflows to investors with potential for further growth, says Australasia’s leading specialist

owner of healthcare real estate.

NorthWest Healthcare Properties Management Limited (NorthWest), the manager of Vital

Healthcare Property Trust (Vital), released its results for the 12 months ended 30 June 2022

(FY22) today. The result included confirmation of 9.625 cents per unit (cpu) distributions for

the year; 8.5% above FY21.

NorthWest said the increase in distributions was underpinned by strong growth in earnings

and recent asset acquisitions and development activity.

Fund Manager Aaron Hockly said Vital's Board and Management expect to deliver

further growth in earnings and distributions and has today provided FY23 distribution

guidance of 9.75cpu.

“Over FY22 Vital committed to undertake an additional $146 million of new

developments including the expansion of Ormiston Hospital in Auckland, Grace Hospital

in Tauranga and further additions to Wakefield Hospital in Wellington and Playford Health

Hub in Adelaide. Newly committed developments replenish Vital's development pipeline

following the recent completion of a A$97 million development and expansion of

Epworth Eastern Hospital in Melbourne and a new day surgery adjoining Royston Hospital

in Hastings which was officially opened earlier this month. Vital currently has 10

developments underway across Australia and New Zealand for a total projected cost of

$293.2m providing a forecast blended yield of 5.8%

1

.,” said Mr Hockly.

As part of its $1.8 billion pipeline of potential developments across Australia and New

Zealand, Vital is planning further development at its healthcare precinct in Remuera

where it owns Ascot Hospital and Ascot Central.

In addition to the above, Vital has $169 million of ambulatory care fund-through

2


developments underway in Australia comprising a A$54.4 million development for

Genesis Care (stage 1 of Campbelltown, Sydney) and a newly announced A$98.6m

fund-through development for Nexus in Hobart.


1

Forecast assumes developments are fully let on current expectations of future market terms.

2

These are developments where Vital is funding a development rather than acting as developer.


VITAL HEALTHCARE PROPERTY TRUST

Managed by NorthWest Healthcare Properties Management L

vhpt.co.nz

Page 2 of 3

Vital undertook $382

3

million of property acquisitions in FY22 including its first South Island

assets, purchasing sites in central Christchurch and Queenstown. Both sites housed

existing healthcare operators and offered future development potential, Mr Hockly said.

Mr Hockly noted NorthWest's focus on maintaining a consistently low average building

age within Vital as a means to minimise maintenance capital expenditure and to ensure

Vital’s properties meet current and future needs of healthcare operators and patients.

“Vital’s $3.3 billion property portfolio is high quality and high acuity, with a current

weighted average lease expiry of 17.6 years – the longest of any property group on the

NZX,” said Mr Hockly.

Net property income increased by 12.2% over FY22 reflecting the contributions from

rental growth, acquisitions and developments. Like-for-like, same property rental growth

using a constant currency was 2.8% for FY22. With ~80% of Vital's leases linked to CPI in

some way, Vital also retained high occupancy at 98.8% (30 June 2021: 99.2%).

During the past year, Vital and NorthWest both issued their first Sustainability Reports.

NorthWest has subsequently appointed three "Sustainability Champions" to its Australasian

business, part of its commitment to achieving net zero emissions across all its operations

and platforms, including Vital, by 2050.

FY22 Results at a glance

FY22 FY21 Change

Property Portfolio $3.3 billion $2.6 billion 26.7%

Occupancy (by income) 98.8% 99.2% -

AFFO $67.8 million $57.5 million 18.0%

AFFO per unit (cpu) 11.92 11.54 3.3%

NTA per unit ($pu) 3.34 2.89 15.3%

Balance sheet gearing 30.0% 35.0% -

Weighted average cost of debt 3.73% 3.32% -

Weighted average debt maturity 3.9 years 2.5 years -

Distributions (cpu) 9.625 8.88 8.5%


Over the 10 years ended 30 June 2022, Vital has delivered a total return

4

of 13.2% per

annum outperforming the NZX REIT index by 4.2% per annum and the NZX50 by 0.9% per

annum

5

.

Over the five years ending 30 June 2023, Vital expects to record a compound annual

growth rate for distributions of 2.3% per annum.

Vital's balance sheet gearing was reduced to a conservative 30.0% at 30 June 2022 (30

June 2021: 35.0%) and has no debt expiring until October 2023.

– ENDS –


3

Excludes transaction costs and includes Kawarau Park Health Precinct, Queenstown which settled in

July 2022.


4

Unit price change plus distributions.

5

Source: Forsyth Barr


VITAL HEALTHCARE PROPERTY TRUST

Managed by NorthWest Healthcare Properties Management L

vhpt.co.nz

Page 3 of 3

ENQUIRIES

Aaron Hockly

Fund Manager, Vital Healthcare Property Trust


Tel 09 973 7301, Email aaron.hockly@nwhreit.com

Michael Groth

Chief Financial Officer, NorthWest Healthcare Properties Management Limited

Tel +61 409 936 104, Email michael.groth@nwhreit.com



About Vital (NZX code VHP):


Vital Healthcare Property Trust is an NZX-listed fund that invests in high-quality healthcare

properties in New Zealand and Australia including private hospitals (~80% of portfolio

value), out-patient facilities (~16% of portfolio value) and aged care (~4% of portfolio

value)

6

.


Vital is the only specialist listed landlord of healthcare property in Australasia and

currently has a portfolio valued at over $3.3 billion

3

.


Vital is managed by NorthWest Healthcare Properties Management Limited, a subsidiary

of Toronto Stock Exchange listed NorthWest Healthcare Properties REIT, a global owner

and manager of healthcare property.


For more information, visit our website: www.vhpt.co.nz


Disclaimer:


This announcement has been prepared by NorthWest Healthcare Properties Management

Limited (the "Manager") as manager of the Vital Healthcare Property Trust (the "Trust"). The

details in this announcement provide general information only. It is not intended as

investment, legal, tax or financial advice or recommendation to any person and must not

be relied on as such. You should obtain independent professional advice prior to making

any decision relating to your investment or financial needs.


All references to $ are to New Zealand dollars unless otherwise indicated.


This announcement may contain forward-looking statements. Forward-looking statements

can include words such as “expect”, “intend”, “plan”, “believe”, “continue” or similar

words in connection with discussions of future operating or financial performance or

conditions. The forward-looking statements are based on management's and directors’

current expectations and assumptions regarding the Trust’s business, assets and

performance and other future conditions, circumstances and results. As with any

projection or forecast, forward-looking statements are inherently susceptible to uncertainty

and to any changes in circumstances. The Trust’s actual results may vary materially from

those expressed or implied in the forward-looking statements. The Manager, the Trust, and

its or their directors, employees and/or shareholders have no liability whatsoever to any

person for any loss arising from this announcement or any information supplied in

connection with it. The Manager and the Trust are under no obligation to update this

announcement or the information contained in it after it has been released. Past

performance is no indication of future performance.


6

All figures as at 30 June 2022.

---

Annual Report
2022

HEALTHY PROPERTIES

DELIVER HEALTHY RETURNS

Kawarau Park Health Precinct,

Queenstown

Investing in healthcare
infrastructure in New

Zealand and Australia

2

|

VITAL HEALTHCARE PROPERTY TRUST

FY22 HIGHLIGHTS
Contents

About Vital and NorthWest 4

Overview of Vital


6

Key events over FY22 10

Short, medium and longer term

progression 12

Manager’s report 14

Asset allocation 20

Australian portfolio overview 22

New Zealand portfolio overview


24

5 largest assets and asset groupings 26

Developments 32

Acquisitions 36

Sustainability 44

Our Board 76

Our executive team 78

Corporate governance 80

Financial statements 88

Independent auditor’s report 132

Unit Holder statistics 135

Vital’s structure 136

Directory 139

9. 625cpu11 . 9 2cpu

8.5% ABOVE FY21

3.3% ABOVE FY21

$287m

1

DISTRIBUTIONSAFFOACQUISITIONS TO SUPPORT

FUTURE GROWTH

1

Excluding transaction costs

ANNUAL REPORT

|

3

To be Australia and
New Zealand’s leading listed

healthcare property fund.

Deliver stable and growing total Unit

Holder returns, including an attractive

risk-adjusted income distribution, majority

sourced from healthcare real estate.

VisionMission

NZX listed property trust which owns ~$3.3 billion of

healthcare property in New Zealand and Australia.

4

|

VITAL HEALTHCARE PROPERTY TRUST

NorthWest Healthcare
Properties REIT

TSX listed owner and manager of NZ$12.4 billion

of healthcare property across four continents.

Hard work, integrity, collaboration, drive,

flexibility, team work, fun and results.

Be the leading global diversified

healthcare real estate company.

Provide best in-class real estate

solutions to the healthcare

industry and deliver exceptional

shareholder value to investors.

EXCELLENCE

Delivering exceptional

outcomes

INTEGRITY

Doing what’s

right

PARTNERSHIP

Succeeding

together

We value

VisionMission

Values

NorthWest (Australia and New Zealand)

is the manager of Vital, with over 60

professionals in the region. We have

offices in Auckland, Melbourne, Sydney

and the Gold Coast.

ANNUAL REPORT

|

5

1
Number of properties include Kawarau Park Health Precinct, Queenstown, but excludes strategic assets. All other figures exclude Kawarau Park Health Precinct, Queenstown.

As at 30 June 2022

Overview of Vital

1

Vital is the only specialist healthcare landlord on the NZX.

~$3.3bn

47 PROPERTIES

(AUS & NZ)

~$2.4bn

31 PROPERTIES

(AUS)

~$0.9bn

1 6 PROPERTIES

(NZ)

6

|

VITAL HEALTHCARE PROPERTY TRUST

Vital Portfolio by Geography
AUSTRALIA

72%

NEW ZEALAND

28%

WESTERN

AUSTRALIA

NORTHERN


TERRITORY

SOUTH

AUSTRALIA

NEW SOUTH

WALES

TASMANIA

VICTORIA

QUEENSLAND

4

3

6

6

12

14

2

ANNUAL REPORT

|

7

Acute Hospitals 53%
Ambulatory Care 16%

Specialty Hospitals

(mental health & rehabilitation) 27%

Aged Care 4%

53%

27%

16 %

4%

H

O

S

P

I

T

A

L


8

0

%

O

T

H

E

R


2

0

%

19 %

16 %

22%

15 %9%

4%

3%

3%

3%

2%

4%

Healthe Care Surgical 16%

Norfolk Southern Cross Limited 4%

Evolution Healthcare 9%

Epworth 15%

Hall & Prior 4%

Bolton Clarke 3%

Sportsmed 3%

Mercy Ascot 3%

Ramsay 2%

Other 22%

Aurora Healthcare 19%

TENANT DIVERSIFICATION

% of Rent

SUB-SECTOR DIVERSIFICATION

% of Value

8

|

VITAL HEALTHCARE PROPERTY TRUST

1
Income producing properties only

2

Average building age = the later of the date of construction or last significant capital works

$123m

11.1

years

AVERAGE BUILDING AGE

2

98.8%

PORTFOLIO OCCUPANCY

FY22 PROPERTY INCOME

17.6 years

WEIGHTED AVERAGE

LEASE EXPIRY (WALE)

4.58%

WEIGHTED AVERAGE CAP RATE

1

(AUS 4.54%, NZ 4.70%)

ANNUAL REPORT

|

9

Key events over FY22
• FY22 AFFO and distribution

guidance announced 11.8cpu

and 9.5cpu respectively

• Acquisition of Hutt Valley

Health Hub, Wellington

for $46.5m announced

AUGUST 2021

• 2.375cpu distribution paid

• 2.375cpu distribution paid

• Practical completion of

Stage 1 of Wakefield

Hospital, Wellington for a

total cost of ~$50.8m

SEPTEMBER 2021

DECEMBER 2021

JULY 2021

2021

• $27.8m raised via a Unit Purchase Plan

from existing retail holders at $2.85 per unit

• Completion of Stage 1 of Playford

Health Hub, Adelaide for ~A$20m

• Commencement of $6.3m Royston

Stage 2, $31.7m Grace Hospital and

$6.3m Bowen Hospital developments

• MoU signed with Calvary Health

Care to operate a ~A$93m hospital

(Stage 3 of Playford Health Hub)

NOVEMBER 2021

• A$315m debt refinance to

extend debt capacity by A$65m

and extend debt tenor

• Acquisition of Tennyson Centre,

Adelaide for A$92.75m

• $115m placement primarily to existing

institutional holders at $2.90 per unit

• Commencement of $91.5m Wakefield

Stage 2 with demolition of existing building

• Terms agreed for $74m of new and

extended brownfield developments

across five of Evolution Healthcare’s

facilities in New Zealand

OCTOBER 2021

10

|

VITAL HEALTHCARE PROPERTY TRUST

• Appointment of Angela Bull as an additional Independent Director
• Acquisition of 68 Saint Asaph St, Christchurch for $50.7m

• Acquisition of Kawarau Park Health Precinct, Queenstown for

~$95m (settled July 2022)

• Acquisition and expansion of Endoscopy Auckland announced

for $43.8m (acquisition cost plus estimated development spend)

• Announcement of expansion of Ormiston Hospital, Auckland

for ~$40m (includes land already owned by Vital)

APRIL 2022

• 2.4375cpu distribution paid

• Practical completion of

A$97m Epworth Eastern

East Wing Tower

• A$39.3m Playford Health

Hub Stage 2 commenced with

demolition of existing building

• A$350 debt refinance

completed, increasing facility

limits by A$150m and weighted

average term to maturity by

1.1 years to 4.4 years

• $200m in new equity raised

through an entitlement

offer at $2.95 per unit

• Acquisition of a vacant aged

care facility in Mt Eliza, Victoria

for ~$A12m to be re-purposed

as a private hospital

• Ormiston Hospital ~$40m

expansion commenced

• 2.4375cpu distribution paid

• Retirement of Andrew Evans

as an Independent Director

after 15 years on the board

• Acquisition of 80 Ascot

Ave, Remuera for $16m

• Agreement to undertake a

~A$98m development of a new

private hospital and ambulatory

care facility in Hobart, Tasmania

MARCH 2022

2022

MAY 2022JUNE 2022

• Acquisition of land for expansion of The Hills

Clinic in Sydney for ~A$50.0m (includes

land cost and estimated construction costs)

• Announcement of acquisition of multi-stage

development site in south-west Sydney for

A$76.6m (includes acquisition costs, Stage

1 construction costs and tenant incentive)

• Upgrade to annualised AFFO and distribution

guidance to at least 11.9cpu and 9.75cpu

FEBRUARY 2022

ANNUAL REPORT

|

11

Short, medium and
longer term progression

1

Portfolio enhanced through acquisitions, development and disposals to:

(1) increase diversity of assets and tenants, (2) reduce age of building and

(3) maintain long WALE. This helps to reduce income risk for Vital’s Unit Holders.

Portfolio enhancements support target of growing

AFFO and distributions by 2–3% per unit per annum.

1

All figures are as 30 June at the end of the financial year listed other than Net Property Income, AFFO and Distributions which are for the financial year.

2

Average building age = the later of the date of construction or the last significant capital works

3

Includes $214.9m of committed development spend remaining and ~$1.8bn of developments being considered. Development timing and therefore spend expected to be over

a staged and lengthy period (at least 10 years)

489%

growth (FY12-FY22)

Maintenance of

market leading WALE

Younger buildings

reduce maintenance

capex requirements

156%

increase (FY12 - FY22)

Enhance earnings

and valuation growth

and support portfolio

development

Concentration

risk reduced

Diversity of assets reduces

risk and enhances earnings

F Y 12F Y 19FY22

Total property

value

~$0.57bn

(AUS: 71%, NZ: 29%)

~$1.93bn

(AUS: 76%, NZ: 24%)

$3.34bn

(AUS: 72%, NZ: 28%)

WALE11.9 years18.1 years17.6 years

Average

Building Age

2

Data not availabile13.5 years11.1 years

Net Property

Income (annual)

$48m$98m$123m

Development

pipeline

~$60m$279m$2.1bn

3

Largest single

tenant exposure

40%49%19 %

Sector split

Hospital: 88%

Ambulatory care: 12%

Aged care 0%

Hospital: 83%

Ambulatory care: 14%

Aged care 3%

Hospital: 80%

Ambulatory care: 16%

Aged care 4%

Weighted average

cap rate

9.30%5.61%4.58%

Reduction demonstrates: (1)

quality of assets and tenants;

and (2) value added by leasing

and development undertaken

12

|

VITAL HEALTHCARE PROPERTY TRUST

Balance sheet strengthened during FY22 through raising $379m
of new equity and extending debt whilst supporting portfolio

growth as a means to grow AFFO and distributions.

4

Net Distributable Income per unit (AFFO not reported)

Significantly

expanded

No debt expiring until

October 2023

49%

growth (FY12-FY22)

25%

growth (FY12-FY22)

241%

growth (FY12-FY22)

F Y 12F Y 19FY22

Balance sheet

gearing

42.3%35.3%30.0%

Average debt

maturity

3.8 years2.2 years3.9 years

NTA per unit

$0.98$2.31$3.34

AFFO per unit (cpu)

8.0c

4

9.9c11 . 9 2 c

Distributions

per unit (cpu)

7.7c8.75c9.625c

ANNUAL REPORT

|

13

Manager’s report
Vital recorded growth in earnings, distributions

to Unit Holders and assets during FY22 as

NorthWest’s management continued to

demonstrably benefit Unit Holders.

14

|

VITAL HEALTHCARE PROPERTY TRUST

Tēnā koutou,
NorthWest Healthcare Properties Management

Limited (NorthWest), the Manager of Vital Healthcare

Property Trust (Vital), is pleased to report Vital’s

results for the year ended 30 June 2022 (FY22).

Despite a more uncertain economic

environment and rising debt costs, NorthWest

has continued to deliver earnings and

distribution growth for Vital's Unit Holders

whilst also continuing to enhance the property

portfolio and embed sustainability into all

parts of NorthWest and Vital.

FY22 highlights included:

• 3.3% increase in AFFO per unit from 11.54

cents per unit (cpu) to 11.92 cpu.

• 8.5% increase in distributions per unit from 8.88 cpu to

9.625 cpu on a prudent 81% AFFO pay-out ratio.

• 15.3% increase in net tangible assets (NTA)

per unit from $2.89 to $3.34.

• $287m of property acquisitions (before costs)

and $15m of disposals undertaken.

• $100m of capital expenditure undertaken comprising $86m

for developments, ~$12m for value-add works and ~$2m

for maintenance and tenant incentive related works.

• Commencement of $240m of new developments

including Ormiston Hospital expansion in Auckland

and Stage 2 of both Wakefield Hospital in Wellington

and Playford Health Hub in Adelaide.

• Replenishment of potential development pipeline to provide

future earnings and valuation upside for Unit Holders.

• Release of inaugural Sustainability Reports for both

Vital and NorthWest as well as participation in both

the Carbon Disclosure Project (CDP) and the Global

Real Estate Sustainability Benchmark (GRESB). Results

are due to be publicly released later in 2022.

• $379m (before costs) of equity raised primarily via a

$143m placement and UPP in late 2021 and a $200m

entitlement offer in early 2022. Equity was raised to

support the acquisitions and developments referred to

above and to keep balance sheet gearing below 35%.

• Appointment of Angela Bull as an Independent

Director, replacing long-term director Andrew Evans,

completing a two-year process of Board renewal.

ANNUAL REPORT

|

15

Our commitment to sustainability
During FY22, Vital released its first Sustainability Report

(part of its Annual Report released in August 2021) and

NorthWest released its first Sustainability Report (available

here). These reports, which include measurable targets,

demonstrate our commitment to sustainability and are

considered the first key steps in our sustainability journey.

FY22 sustainability highlights include:

• Establishment of global and regional sustainability teams

and governance structures in NorthWest including

the appointment of three dedicated sustainability

resources in Australia and New Zealand to champion

sustainability initiatives in this region including for Vital:

• Clare Solomon – Vice President

Sustainability and Development.

• Tony Gill – National Engineering and Operations Manager.

•Liz Ingram – Sustainability Associate.

• Commitment by NorthWest covering all of its

operations and platforms including Vital to achieve

net zero emissions by 2050. We are now focused on

establishing baseline emissions with a view to establishing

science-based interim 2030 reduction targets.

• Materiality workshops and stakeholder engagement

meetings held with key Vital Unit Holders,

employees, debt providers and tenants.

• Alignment of NorthWest and Vital’s commitments and

targets with United Nations Sustainability Goals and the

Global Real Estate Sustainability Benchmark (GRESB).

• Establishment of ESG working groups with key

tenants including Epworth Healthcare in Australia

and Evolution Healthcare in New Zealand.

• Participation in both GRESB and the Carbon Disclosure

Project (CDP) with results released later in 2022.

Please refer to pages 44-75 of this Annual Report

for Vital’s detailed Sustainability Report.

We will build on these achievements as well

as our targets and goals over time.

Portfolio overview

Vital’s ~$3.3 billion property portfolio remains high

quality, high acuity with a long WALE and limited

upcoming expiries (on average 1.7% of the portfolio's

rent expires per annum over the next 10 years).

Vital’s weighted average lease expiry (WALE) was 17.6 years

at 30 June 2022 compared to 18.7 years at 30 June 2021.

The average building age has been maintained at a

young 11.1 years consistent with the Manager's strategy to

maintain or lower this key metric as a means of maintaining

relatively low capital expenditure and ensure Vital's

assets continue to meet tenant / patient demand.

Net property income

Net property income increased by 12.8% from FY21 (excluding

foreign exchange impacts), reflecting contributions from the

structured rent reviews within the portfolio, developments and

acquisitions. After adjusting for foreign exchange, net property

income increased by12.2%.

~80% of Vital's rent is linked to CPI. 77% of this having a weighted

average annual limit of ~3.7% with the balance being uncapped.

This structure provides Vital's Unit Holders with some protection in

periods of elevated inflation.

Like-for-like net property income increased by 2.8% over FY22

on a same currency basis.

Acquisitions

Further details of the $287m

1

of acquisitions during FY22 plus

other acquisitions to the date of this report are included on

pages 36-43 of this report.

Divestments

$15m of divestments undertaken at a premium to previous

book value due to the disposal of surplus development land.

Developments

In addition to asset enhancing and maintenance capital

expenditure, Vital had ~$293m of development projects underway

in New Zealand and Australia with ~$215m remaining to spend.

In addition, $169m of fund-through

2

developments have been

committed to.

Further details of specific developments are

available on pages 32-35 of this report.

Financial results

Cash from operations available to Unit Holders, measured by

AFFO, increased 18.0% to $67.8m. AFFO per unit was 11.92c;

a 3.3% increase from FY21.

Expenses were $66.2m, 13.0% higher than FY21

notwithstanding a 27.7% increase in assets.

Vital’s NTA per unit increased by 15.3% to $3.34 primarily due to

$244.2m of property revaluation gains. These revaluation gains

included ~$10m in development margins and ~$100m due to

rental increases and leasing.

Capital management

During the year Vital’s debt facilities were increased by ~A$215m

along with a renegotiation of facilities expiring early in FY23.

The next debt facility expiries now occur late 2023. Vital has a

weighted average debt maturity at 30 June 2022 of 3.9 years,

and management continues to investigate measures to extend

Vital's debt tenor. Vital’s all-in weighted average cost of debt

at 30 June 2022 was 3.73% (30 June 2020: 3.32%) now

beginning to reflect a challenging cost of debt environment.

$379m (before costs) of equity was raised primarily

via a $142.8m placement and UPP in late 2021 and a

$200m entitlement offer in early 2022. Equity was raised

to support the acquisitions and developments referred to

above and to keep balance sheet gearing below 35%.

The debt to total assets ratio was 30.0% at 30 June 2022

2

Developments where Vital is funding through the development

rather than acting as developer.

1

Excluding acquisition costs

16

|

VITAL HEALTHCARE PROPERTY TRUST

18.0%
INCREASE IN AFFO

(CASH IN EARNINGS)

15.3%

INCREASE IN NTA

PER UNIT

12.8%

INCREASE IN NET

PROPERTY INCOME

3.3%

INCREASE IN AFFO

PER UNIT

ANNUAL REPORT

|

17

support and non-discretionary spending. As noted
above, we have added to Vital's development

capacity through strategic acquisitions.

Our plan for the short

to medium term is:

• Renew Vital’s 5-year portfolio strategy noting

that we have achieved many of the targets

of the previous strategy ahead of time and

to reflect changed market conditions.

• The above strategy will help us continue to grow

earnings and distributions for Unit Holders whilst

maintaining a prudent pay-out ratio of ~80%.

• Focus on the current and potential development

pipeline in New Zealand and Australia to

provide new and upgraded health facilities

for communities across our region.

• Maintain Vital’s debt maturity profile and

consider further diversifying sources of debt

to support returns for Vital's Unit Holders.

• Continue to enhance and upgrade our

sustainability programme, as part of

NorthWest’s wider programme, to play

our part in protecting and enhancing the

environment, the communities in which we

operate and the stakeholders we serve.

Nā māua noa, nā

(30 June 2021: 35.0%). Vital currently has

approximately A$302m of headroom under its

debt facilities and considers that enough headroom

is available to facilitate the development

pipeline reported in this Annual Report.

Board renewal

In April 2022, Angela Bull was appointed as

an Independent Director and member of the

Audit Committee to replace Andrew Evans who

retired from these roles on 30 June 2022.

Angela is currently Chief Executive of Tramco Group,

a New Zealand owned property investment company

which specialises in large scale land holdings,

notably the Viaduct Harbour precinct in Auckland and

Wairakei Estate in the Waikato. She holds a Bachelor

of Laws and a Bachelor of Arts (Political Science)

and practised property and environmental law prior

to her executive career. Angela held a number of

senior positions over a 10-year period with Foodstuffs,

most recently being General Manager Property

Development for Foodstuffs North Island. Angela is an

independent director of the Real Estate Institute of New

Zealand, realestate.co.nz, Foodstuffs South Island Ltd

and Foodstuffs NZ Ltd. She is located in Auckland,

New Zealand.

Andrew had been on the Board of

Vital’s manager since 2007.

The replacement of Andrew with Angela maintains

key existing attributes of the Board including majority

independent directors, geographic balance (two

directors in each of New Zealand and Australia and

one director in Canada) and an appropriate skills mix.

FY23 guidance

1


TThe Board and management are pleased to

provide FY23 distribution guidance of 9.75 cpu

(payable quarterly); 1.3% above FY22 whilst

maintaining a prudent ~80% payout ratio.

Outlook

Despite recent heightened market volatility,

healthcare property remains a defensive asset

class, underpinned by a high level of government

Graham Stuart

Independent Chair

11 August 2022

NorthWest Healthcare Properties Management Limited, the Manager of Vital Healthcare Property Trust

Aaron Hockly

Fund Manager

As Australasia’s leading listed

owner of high quality, high acuity

healthcare real estate, supported

by NorthWest’s unmatched

development and management

expertise, Vital remains well

positioned to take advantage

of opportunities in this sector.

1

Refer to disclaimer on back page of this report for limitations to this guidance.

18

|

VITAL HEALTHCARE PROPERTY TRUST

Financial summary
Portfolio metrics

All figures are in New Zealand dollars (NZD) unless otherwise stated

All figures are in New Zealand dollars (NZD) unless otherwise stated

1

AFFO for FY18 has been restated to include the notional impact of the 1 July 2018 introduction of attributed FIF tax rule changes

1

Excludes properties held for development

2

Additions include Tennyson Centre, Playford Health Hub - Retail and Carpark, 120 Thames Street, Hutt Valley Health

Hub, 68 Saint Asaph St, Endoscopy Auckland, and disposal of Gold Coast Surgery Centre. Excludes post 30 June 2022

acquisition of Kawarua Park Health Precinct, Queenstown

2 018

$000s

2 019

$000s

2020

$000s

2021

$000s

2022

$000s

Financial Performance

Net property income90,65997,683100,147109,66312 3 , 018

Revaluation gain/(loss) on investment properties85,461103,55645,703235,383244,239

AFFO and distributions

Adjusted Funds From Operations (AFFO)

1

47,07443,89747,21157,457 6 7, 8 2 4

AFFO (cpu)10.84 9.90 10.4511 . 5 411 . 9 2

Cash distribution to Unit Holders (cpu)8.508 . 758 . 758.889.63

Financial Position

Total assets1,786,8281,9 31, 5432,105,2182,662,5603,399,834

Borrowings6 7 0 ,12 4734,211813 , 515929,3001,018,777

Total equity9 8 7, 9 7 61,029,7451, 078 ,9791,503,4512,165,876

Debt to total assets ratio (%)38.735.338.735.030.0

Net tangible assets ($ per unit)2.262.312.382.893.34

2 0182 019202020212022

Investment properties ($m)1, 7311,8362,086 2,6343,339

Number of investment properties

1

4242444146

2

Occupancy (%)99.399.499.499.298.8

Weighted average lease term to expiry (years)18.218 .118 .118 . 717. 6

12 month lease expiry (% of income)1.81. 71.41. 71. 7

ANNUAL REPORT

|

19

Asset allocation
Vital invests in health ecosystems in New Zealand and Australia. Our

precinct strategy will help create new opportunities for Vital to build out

assets in health-related precincts where public, private, education, aged

care and research uses are closely agglomerated and interrelated.

TARGET PORTFOLIO WEIGHTINGS

1

Healthcare precinct = area or hub for healthcare delivery typically including at least two of a public hospital, major private hospital, health teaching facility or health research facility

2

The initial focus for this sub-sector will be New Zealand. Hospitals and aged care are the priority for Vital's growth in Australia at least in the near-term

Comprises

Public, private, speciality, rehabilitation

and mental health hospitals

Comprises

Administration, diagnostic services and specialist

consulting, primary care out-patient facilities

Targeting

Government supported or high private health

insurance catchments with growing populations

Targeting

Facilities located in a healthcare precinct

1

and/

or from where healthcare is delivered

HOSPITALSOUT-PATIENT/AMBULATORY CARE

Target portfolio weighting

50 - 70%

(30 June 2022: 80%)

Target portfolio weighting

10 - 20%

(30 June 2022: 16%)

20

|

VITAL HEALTHCARE PROPERTY TRUST

Comprises
Residential aged care facilities

(excluding retirement facilities)

Comprises

Biotechnology, pharmaceutical, biomedical, university,

health education and other research facilities

Targeting

High quality operators with substantial balance sheets

and <45% rent/EBITDAR and high-quality infrastructure

Targeting

Specialised facilities and/or facilities

located in a healthcare precinct

1

AGED CARELIFE SCIENCES/RESEARCH

Target portfolio weighting

10 - 20%

(30 June 2022: 4%)

Target portfolio weighting

5 - 15%

(30 June 2022: 0%)

2

Investments are targeted to provide earnings growth

from a diversified and defensive asset base.

ANNUAL REPORT

|

21

Australian portfolio
overview

• Abbotsford Private Hospital

• Hamersley Aged Care

• Marian Centre

• Rockingham Aged Care

• Sportsmed Hospital, Clinic

and Consulting

• Tennyson Centre

• Playford Health Hub

• 120 Thames Street

• Ekera Medical Centre

• Epworth Camberwell

• Epworth Eastern Hospital

• Epworth Rehabilitation

• South Eastern Private Hospital

WESTERN

AUSTRALIA

SOUTH

AUSTRALIA

NEW SOUTH

WALES

VICTORIA

QUEENSLAND

WESTERN AUSTRALIASOUTH AUSTRALIAVICTORIA

4

3

6

6

12

~$2.4bn

31

1

PROPERTIES (AUS)

1

Income Producing Property (excludes strategic assets)

22

|

VITAL HEALTHCARE PROPERTY TRUST

PRIVATE HOSPITALS
AMBULATORY CARE

AGED CARE

• 17 hospitals (acute and specialty –

mental health, rehabilitation)

• 4 hospital operators

• 80% of AUS portfolio value; 79% of AUS rent

• WALE: 19.1 years

• Baycrest Aged Care

• Belmont Private Hospital

• Eden Rehabilitation

• Palm Beach Currumbin Clinic

• Tantula Rise Aged Care

• The Southport Private Hospital

• Clover Lea Aged Care

• Darlington Aged Care

• Fairfield Aged Care

• Grafton Aged Care

• Hirondelle Private Hospital

• Hurstville Private Hospital

• Lingard Day Centre

• Lingard Private Hospital

• Maitland Private Hospital

• Mons Road Medical Centre

• The Hills Clinic

• Toronto Private Hospital

• 6 assets, multiple tenants

• 14% of AUS portfolio value; 12% of AUS rent

• WALE: 7.0 years

•8 facilities

•2 operators

• 6% of AUS portfolio value; 9% of AUS rent

•WALE: 14.0 years

QUEENSLAND

NEW SOUTH WALES

ANNUAL REPORT

|

23

New Zealand portfolio
overview

1

• Apollo Health and Wellness Centre

• Ascot Carpark (Right of Use)

• Ascot Central

• Ascot Hospital

• Boulott Hospital

• Bowen Hospital

• Endoscopy Auckland

• Grace Hospital

• Hutt Valley Health Hub

• Kensington Hospital

• Napier Health Centre

• Ormiston Hospital

• Royston Hospital

• Wakefield Hospital

NORTH ISLAND

14

2

1

Number of properties include Kawarau Park Health Precinct, Queenstown, but excludes strategic assets. All other figures exclude Kawarau Park Health Precinct, Queenstown.

~$0.9bn

16 PROPERTIES (NZ)

24

|

VITAL HEALTHCARE PROPERTY TRUST

PRIVATE HOSPITALS
AMBULATORY CARE

•9 hospitals (all acute)

•6 hospital operators

• 75% of NZ portfolio value; 75% of NZ rent

•WALE: 21.6 years

• 6 assets, multiple tenants

• 25% of NZ portfolio value; 25% of NZ rent

• WALE: 9.9 years

• Kawarau Park Health Precinct

• 68 Saint Asaph St

SOUTH ISLAND

ANNUAL REPORT

|

25

5 largest assets and
asset groupings

Valued at $1.32bn and representing 40% of Vital’s total portfolio, the

five largest assets or asset groupings (i.e. adjoining assets or assets which

form part of the same healthcare precinct) span Melbourne, Newcastle,

Auckland, Brisbane and Wellington and a diverse range of tenants.

They represent a core part of Vital’s value and earnings. Development

has recently occurred or is planned to occur at each of these sites.

It is anticipated that this list will evolve over time primarily through

developments. Notably Vital’s recent acquisition in Campbelltown,

Sydney is expected to end up being one of Vital’s largest assets through

the delivery of a multi-staged development over several years.

26

|

VITAL HEALTHCARE PROPERTY TRUST

Comprising three income producing assets plus 5,500 square
metres of development land, this is Vital’s largest asset concentration

and forms part of the Box Hill Health and Education Precinct which

includes Box Hill Public Hospital and Box Hill (tertiary training)

Institute approximately 14 kilometres from Melbourne’s CBD.

These assets have been acquired, developed and improved

over time reflecting Vital’s two decade relationship

with Epworth (Victoria’s largest private healthcare

operator and Vital’s third largest tenant by income).

The largest of the three income producing assets, Epworth

Eastern Hospital, is valued at A$406m comprising 286

inpatient beds, 14 operating theatres, three endoscopy

suites and six floors of specialist medical consulting including

radiotherapy, medical imaging and pathology. A 14 storey

redevelopment of this hospital was completed in early 2022.

The development land at 17-23 Nelson Road is expected

to have a value if fully developed in excess of A$350m.

Epworth Eastern Precinct, Melbourne, VIC

A$482m

VALUE

ASSETS

Epworth Eastern Hospital, 17-23

Nelson Rd (development land), Ekera

Medical Centre & 120 Thames St

PATIENT BEDSLAND AREA

NLA

270~15,000sqm

~35,000sqm

PROXIMITY TO

PUBLIC HOSPITAL

% OF VITAL'S

PORTFOLIO

YEAR ACQUIRED

BY VITAL

150m

16.0%1999

ANNUAL REPORT

|

27

Comprising two income producing assets, this is Vital’s second
largest asset concentration and is fully leased to Healthe Care

Surgical (Vital’s second largest tenant by income). The assets are

~4 kilometres from Newcastle’s CBD.

Lingard Private Hospital is a 123-bed

acute medical and surgical hospital

which has recently been expanded and

redeveloped and is valued at A$203m.

Due to demand at the hospital, a new

day surgery unit was completed in mid-

2020 including four day theatres and two

endoscopy suites which is valued at A$43m.

Lingard Private Hospital Precinct, Newcastle, NSW

A$256m

VALUE

ASSETS

Lingard Private Hospital, Lingard

Day Centre and 27 Hopkins

Street (development land)

LAND AREANLA

~15,000sqm14 0

11,500sqm

PROXIMITY TO

PUBLIC HOSPITAL

% OF VITAL'S

PORTFOLIO

YEAR ACQUIRED

BY VITAL

3.6km

8.5%

2 010

PATIENT BEDS

28

|

VITAL HEALTHCARE PROPERTY TRUST

Ascot Hospital was developed in 1999 and was Vital’s first significant
hospital development. Over the last 23 years, Vital has developed

the adjoining Ascot Central (specialist centre) and recently acquired

3,415 square metres of land with a view to further expanding one

of New Zealand’s leading health precincts.

Ascot Hospital has 12 operating theatres,

88 inpatient beds and is valued at $140.5m.

It is operated by Mercy Ascot, New Zealand’s

second largest private hospital operator.

Ascot Central is valued at $44.8m and has

a range of medical and ancillary tenants

including Fertility Associates, New Zealand’s

leading provider of fertility services.

Ascot Hospital Precinct, Auckland, NZ

$209m

VALUE

ASSETS

Ascot Hospital, Ascot Central,

80 Ascot Ave (development

land) & Ascot Carpark

LAND AREANLA

~40,000sqm

88

~16,000sqm

PROXIMITY TO

PUBLIC HOSPITAL

% OF VITAL'S

PORTFOLIO

YEAR ACQUIRED

BY VITAL

5.6km

6.3%

1999

PATIENT BEDS

ANNUAL REPORT

|

29

Belmont Private Hospital is a 150-bed general mental health hospital
approximately 12 kilometres from Brisbane’s CBD. It is the largest mental

health hospital in Queensland and offers a range of specialist acute

mental health services catering for both inpatient and day patients.

The facility is currently under development to add an additional

35 beds, 13 consulting suites and 70 car parks. This $23m

development is expected to be complete in late-2022.

Belmont Private Hospital, Brisbane, QLD

A$146m

VALUEASSETS

Belmont Private

Hospital

LAND AREANLA

~43,000sqm

~8,700sqm

PROXIMITY TO

PUBLIC HOSPITAL

% OF VITAL'S

PORTFOLIO

YEAR ACQUIRED

BY VITAL

11.0km4.8%2 010

15 0

PATIENT BEDS

30

|

VITAL HEALTHCARE PROPERTY TRUST

Wakefield Hospital is the largest private hospital in the Wellington
region, located on a 2.2 hectare site, 5 kilometres south of

Wellington’s CBD and 850 metres from Wellington Regional Hospital.

Vital has committed to a full redevelopment of this

facility to provide a seismically resilient, modern

and functional facility including eight operating

theatres, 47 beds, a 3,000sqm medical consulting

building and over 260 carparks. The combined

value of the development works is approximately

$134m with Vital’s commitment at $112.8m and

the balance funded by Evolution Healthcare, New

Zealand’s third largest private hospital operator.

The first stage of this project involving the construction

of a new building housing medical specialist consulting

space, a full radiology unit, and new administration

and front of house area was completed in mid-2021.

Stage 2 is underway and is expected

to be completed in late 2024.

Wakefield Hospital, Wellington, NZ

$130m

VALUEASSETS

Wakefield

Hospital

LAND AREA

NLA

~20,000sqm

14,500sqm

PROXIMITY TO

PUBLIC HOSPITAL

% OF VITAL'S

PORTFOLIO

YEAR ACQUIRED

BY VITAL

850m

3.9%2 017

68

PATIENT BEDS

ANNUAL REPORT

|

31

Developments
Vital has 10 committed developments underway

at a total projected cost of $293m with $215m

remaining to spend. In addition, Vital has $169m

of fund-through developments underway and a

potential development pipeline of $1.8bn.

~ $2.1bn

COMMITTED AND POTENTIAL

DEVELOPMENT PIPELINE

1

During FY22 $86m was spent on developments including completion of Vital’s

largest single development Epworth Eastern. $148m was also converted from

potential developments into committed developments.

All values shown in $m

ABBOTSFORD PRIVATE HOSPITAL

PERTH

PLAYFORD HEALTH HUB STAGE 2

ADELAIDE

BELMONT PRIVATE HOSPITAL

BRISBANE

Development cost

A$18.6

Spend to date

A$14.0

Cost to complete

A$4.6

Forecast Net Return

6.1%

Forecast completion date

Late-22

Development cost

A$39.3

Spend to date

A$5.3

Cost to complete

A$34.0

Forecast Net Return

7.3%

Forecast completion date

Early-24

Development cost

A$22.6

Spend to date

A$10.4

Cost to complete

A$12.2

Forecast Net Return

5.8%

Forecast completion date

Late-22

2

Stabilised yield based on Genesis Care rent in Yr3

1

Excluding fund-through developments

Committed and fund-through developments

32

|

VITAL HEALTHCARE PROPERTY TRUST

In addition, $169m of the fund-through developments have been committed to
4

BOWEN HOSPITAL OT5

WELLINGTON

ORMISTON HOSPITAL STAGE 1

AUCKLAND

CAMPBELLTOWN STAGE 1

SYDNEY

TASMAN MEDICAL CENTRE

HOBART

ENDOSCOPY AUCKLAND

AUCKLAND

GRACE HOSPITAL STAGE 1

TAURANGA

BOULCOTT HOSPITAL

WELLINGTON

ROYSTON HOSPITAL STAGE 2

HASTINGS

Development cost

NZ$6.3

Spend to date

NZ$3.0

Cost to complete

NZ$3.3

Forecast Net Return

5.3%

Forecast completion date

Late-22

Development cost

NZ$37.9

Spend to date

NZ$5.1

Cost to complete

NZ$32.8

Forecast Net Return

5 .1 %

Forecast completion date

Mid-24

Development cost

A$54.4

Spend to date

A$6.1

Cost to complete

A$48.3

Forecast Net Return

4.3%

2

Forecast completion date

Early-24

Development cost

A$98.6

Spend to date

A$9.5

Cost to complete

A$89.1

Forecast Net Return

~4.5%

Forecast completion date

Late-24

WAKEFIELD HOSPITAL STAGE 2

WELLINGTON

Development cost

NZ$91.5

Spend to date

NZ$29.1

Cost to complete

NZ$62.4

Forecast Net Return

5.6%

Forecast completion date

Late-24

Development cost

NZ$22.6

Spend to date

NZ$0.3

Cost to complete

NZ$22.3

Forecast Net Return

5 .1 %

Forecast completion date

Late-23

Development cost

NZ$31.7

Spend to date

NZ$5.5

Cost to complete

NZ$26.2

Forecast Net Return

5.3%

Forecast completion date

Late-23

Development cost

NZ$7.7

Spend to date

NZ$0.0

Cost to complete

NZ$7.7

Forecast Net Return

6.2%

Forecast completion date

TBC

3

Development cost

NZ$6.3

Spend to date

NZ$2.4

Cost to complete

NZ$3.9

Forecast Net Return

5.3%

Forecast completion date

Late-22

3

Subject to receipt of final business case

4

Developments where Vital is funding through the development rather than acting as developer

ANNUAL REPORT

|

33

New and proposed developments
1

Stage 1 Medical Office Building Development Application

lodged in April 2022 and Stage 2 Mental Health

Development Application lodged in June 2022.

Early works have commenced on site at Ormiston

Hospital with Savory Construction to form on

grade carpark and associated infrastructure.

Trade pricing for main contract underway

with Savory engaged on an ECI basis.

The Ormiston Hospital

development's main contractor,

Savoury Construction has

registered the site with the

MATES in Construction

programme which aims to shape

and strengthen connections

on building sites and across

the construction industry to

raise awareness and support

those at risk of suicide.

By encouraging positive wellbeing

and supportive conversations

through on-site training, MATES field

officers who are trained in suicide

intervention, facilitate connections

for those at risk of suicide with the

appropriate professional support.

Development Application lodged in July 2022.

Detailed design phase commenced with procurement

strategy to be determined in late-2022.

Coomera

BRISBANE, QLD

Woolloongabba

SOUTH BRISBANE, QLD

Ormiston

AUCKLAND, NZ

Work is underway to convert ~$196m of strategic land holdings into

income producing properties (including the below).

1

All photos are artist's impressions

34

|

VITAL HEALTHCARE PROPERTY TRUST

Epworth Eastern
MELBOURNE, VIC

Having identified the opportunity within

the Box Hill Health and Education

Precinct to co-locate a public and

private hospital, Epworth Eastern Private

Hospital was constructed in 2005,

consisting of 208 beds, eight operating

theatres, associated radiology,

pathology and consulting suites.

Subsequent expansion of the Epworth Eastern

tower was announced in 2018 responding

to the precinct’s growth requirements.

The Epworth Eastern tower project consists of

14-storey building including five operating

theatres and 63 beds. Construction

was successfully completed throughout

COVID-19 lockdowns with practical

completion reached in March 2022.

The project had a total cost of A$97 million

bringing the total value of the Epworth

Eastern campus to over A$400 million.

Epworth have taken a head lease over all floors

to level 10 with the remaining levels 11-14 to be

leased to individual consulting surgeons.

Further investment and growth opportunities

have been recognised and provisioned

for via the acquisition of an adjacent land

total cost

A$97m

WALE

20.5 years

fully let blended yield

~5.8%

Grace Hospital

TAURANGA, NZ

In late 2020 Vital announced that

it had acquired Grace Hospital.

As part of the acquisition Vital and the

hospital operator (a joint venture between

Evolution Healthcare and Southern Cross

Healthcare) have been undertaking design

and planning to extend the existing facility.

Vital committed to funding masterplanned

works at Grace Hospital over five years from

settlement of the transaction. Stage 1 of the

masterplan works was to complete the fit

out of two cold shell theatres, taking the total

number of operational theatres to 11 and to

improve admission areas and patient flows.

This initial stage has been completed and

will officially open in mid July 2022.

Detailed planning and design for further stages

of Grace Hospital's expansion continue.

The project is forecast to increase the

value of the site by over 25%.

expected completion

Late 2023

project value

$31.7m

yield

5.3%

spend to date

$5.5m

Development case studies

parcel with potential for a 40,000sqm

mixed use development. Master

planning for this site has commenced.

completion

March 2022

ANNUAL REPORT

|

35

Acquisitions
During FY22, Vital acquired five income

producing healthcare properties in

Adelaide, Auckland, Christchurch,

Queenstown and Wellington; all with

significant development potential.

Vital has also acquired development sites in

Melbourne, Auckland, Hobart , and two in Sydney.

1

Includes post 30 June 2022 acquisition of Kawarau Park Health Precinct, Queenstown and excludes transaction costs

~$382m

1

OF ACQUISITIONS

UNDERTAKEN

36

|

VITAL HEALTHCARE PROPERTY TRUST

Kawarau Park Health Precinct
QUEENSTOWN, NZ

WALE underpinned by

hospital lease of 12 years

8.7 years

of leases (by income)

increase by the greater of

market and CPI (uncapped)

~40%

fully let blended yield

~4.5%

1

purchase price

$95m

Arvida Retirement and

Aged Care Facility

(under construction)

Queenstown

Airport

Childcare

Retail 2

Retail 1

Medical Centre


/ Pharmacy

Southern Cross

Hospital

Radiology

Centre of Medical

Excellence

Arvida Group

Country Club

Buildings to be on separate

titles which supports a higher

valuation than if combined

Kawarau Park Health Precinct

Tenants

A newly developed health precinct comprising six tenanted buildings

including Queenstown's only private hospital operated in a joint

venture between Southern Cross Healthcare and Central Lakes Trust.

The hospital includes three operating theatres and 13 inpatient rooms.

Other tenants include nationwide providers such as NZX-listed

Green Cross Health and Pacific Radiology (subsidiary of NZX-listed

Infratil), along with several surgical consulting rooms, childcare

and supporting retail and commercial uses.

Favourable demographics

The hospital is the only private hospital in Queenstown

and Central Otago and the precinct benefits from

Queenstown's favourable demographics.

Development potential

The precinct is situated on over 2.3ha of land and has additional

development potential of at least 2,000sqm of land.

1

Excludes development land of ~$4m

ANNUAL REPORT

|

37

Vital has acquired a 27.6 hectare
site in Campbelltown. The site is

well positioned within the rapidly

growing south-west Sydney

growth corridor and down the

road from the newly redeveloped

Campbelltown Public Hospital.

Campbelltown Health Precinct

will be delivered in stages.

Stage 1

A fund-through development with

GenesisCare to construct a state-

of-the-art Comprehensive Cancer

Centre (CCC) and wellness centre.

Construction for Stage 1 will

commence next week with

completion forecast for Q2 2024.

Stage 2 and 3

The remaining ~2-3 hectares offers a

valuable long term staged precinct

opportunity. Masterplanning for

the precinct is underway and

commercial discussions to anchor

Stage 2 are progressing.

The precinct will deliver a range of

services including mental health, day

surgery and other services such as

specialist consult suites, pharmacy,

psychology and allied services. It is

anticipated that a State Significant

Development Application (SSDA) will

be lodged for Stage 2 in 2023.

New healthcare precinct to be developed

CAMPBELLTOWN, NSW

Camden Rd

Hurley St

Cancer Cancer

CentreCentre

Mental Mental

HealthHealth

Health Health

FacilityFacility

Last large land holding

available in Campbelltown for

healthcare precinct development

38

|

VITAL HEALTHCARE PROPERTY TRUST

Artist’s Impression
Central

Health precinct

Located in the heart of Campbelltown,

~20kms south-west of Liverpool

Close to or in the broader health

precinct that includes Campbelltown

Hospital and Western Sydney

University Medical School

40,000sqm

of potential gross floor area

Up to

ANNUAL REPORT

|

39

Logan Hospital is undergoing a
$540 million expansion to deliver

688 beds by late 2022.

Vital have acquired 17 residential lots in

Meadowbrook co-located with Logan Hospital.

A DA was lodged in March 2022 for 18,347 square

meters of GFA for both public and private health

services to support the growing catchment.

In late June, Vital acquired 3,415 square

metres of vacant land adjoining Ascot

Hospital in Remuera, Auckland for $16m.

Work is underway to expand Vital’s footprint

comprising two existing buildings plus a car

park in this leading healthcare precinct.

Meadowbrook

80 Ascot Ave

QUEENSLAND

AUCKLAND, NZ

The public health services offered include general medical

and a broad range of surgical services including obstetrics,

paediatrics and psychiatry. The hospital is located in

South Brisbane and services a population of >340,000

within one of Queensland’s fastest growing areas.

40

|

VITAL HEALTHCARE PROPERTY TRUST

In July 2022, Vital agreed terms with Nexus
Hospitals to fund-through the development of a new,

purpose-built 8,747 square metre day hospital and

ambulatory care facility in Hobart, Tasmania.

The facility will be known as “Tasman Medical Centre”. Total

costs are expected to be ~A$98m including A$9.5m of land

which Vital acquired in early July 2022. Construction is expected

to complete by the end of 2024. Vital will receive a ~4.5 yield

both during construction and from practical completion.

New development fund-through planned;

Vital’s first asset in Hobart and its only exposure

to Tasmania. The WALE is expected to be 13.3

years from practical completion with annual

rent reviews a mixture of CPI (collar of 2.5%

and cap of 5%) and fixed rent reviews.

In May 2022, Vital acquired a former 60-bed aged

care facility ~7 kilometres from Frankston for ~A$12m.

A process is underway to redevelop this facility.

Tasman Medical Centre

Mt Eliza

HOBART, TAS

MORNINGTON PENINSULA, VIC

Tasman Medical Centre is 100% pre-leased from practical

completion to a mixture of Nexus (60% of rent) and a mix

of healthcare and ancillary tenants. The WALE is expected

to be 13.3 years from practical completion with annual rent

reviews a mixture of CPI (collar of 2.5% and a cap of 5%)

and fixed rent reviews (typically 2.5%). This fund-through is

Vital’s sole investment in Tasmania after previously selling a

small facility in Burnie, Northwest Tasmania in late 2020.

ANNUAL REPORT

|

41

In the second half of FY22, Vital settled its acquisition of the
Hutt Valley Health Hub, a purpose-built seismically resilient

medical office building and out-patient facility for $46.5m.

The existing Hutt Valley Health Hub was completed in late

2019 consistent with the Manager’s focus on developing

and acquiring new and recently constructed buildings.

The property adjoins Vital’s existing asset, Boulcott Hospital,

as well as the main public hospital for the region, Hutt

Hospital. The acquisition has increased Vital’s future expansion

land holding to ~3,200 square metres in the precinct to

meet both public and private healthcare demand.

In February 2022, Vital acquired 4,340

square metres of land in north-west Sydney,

approximately 28 kilometres from the CBD

and adjacent to an existing Vital asset, The

Hills Clinic. The Hills Clinic a specialist mental

health hospital 100% leased to Aurora

Healthcare Australia, Australia’s largest

specialty private mental health provider

with 1,000 beds across 16 facilities.

The acquired land is subject to a leasing pre-

commitment from Aurora enabling expansion

of the existing hospital with additional beds,

group rooms and other facilities. Total

development costs, inclusive of the land, are

expected to be ~$50m and will be rentalised

at an initial yield of ~5%. The expansion lease

is expected to have the same term as the

existing lease which has 25 years remaining

with rent growing annually in line with CPI

and market reviews every 10 years.

Hutt Valley Health Hub

The Hills Clinic

WELLINGTON, NZ

SYDNEY, NSW

42

|

VITAL HEALTHCARE PROPERTY TRUST

In late 2021, Vital acquired the
Tennyson Centre in Adelaide for

~A$93m providing an initial yield of

4.7%. The Tennyson Centre is one of

Adelaide’s leading “Cancer Centres

of Excellence”, comprising high

quality tenants who operate within

the identification, assessment and

treatment of cancer through oncology,

radiotherapy, imaging and consulting

services. Tenants include Nexus, Icon,

Sonic, GenesisCare and Dr Jones &

Partners. Since acquisition, the WALE has

been extended from 2.7 years to 4.5

years with further leasing anticipated.

The transaction included 1,920

square metres of adjoining land

for future development.

This large, modern ambulatory care (maternity) and life

sciences site is located 300 metres from Christchurch Hospital,

New Zealand’s second largest hospital. It was acquired

by Vital for $50.7 million in April 2022 on an initial yield

of ~5.1%. Existing tenants include the Canterbury District

Health Board and life sciences corporate Syft Technologies.

~30% of net lettable area is available for lease and subject

to a 24-month vendor rental underwrite. The building has

a WALE of 8.5 years (including the vendor underwrite).

The acquisition includes 1,600 square metres of

expansion land.

In June, Vital settled the acquisition of the majority of the

land and buildings at 148 Gillies Avenue and 22-24 Kipling

Avenue, Epsom

1

for $22.2 million providing an initial yield

of ~4.75%. Currently, the properties comprise an existing

endoscopy facility and residential units on ~4,000 square

metres of land. The hospital business is jointly owned

by Healthcare Holdings and Evolution Healthcare.

Terms have been agreed to utilise the vacant land at 22 Kipling

Ave and develop a new day surgery and endoscopy facility,

with the existing facility expanding surgery capacity for a total

development cost of ~$21.6 million increasing the property yield

to ~5.1%. The existing buildings have a 20 year WALE and the

new hospital will be pre-leased for 20 years from completion.

68 Saint Asaph StEndoscopy Auckland

The Tennyson

Centre

CHRISTCHURCH, NZAUCKLAND, NZ

ADELAIDE, SA

Gillies Property

Kipling Property

(site now predominantly

cleared for development)

The Tennyson

Centre

Development

Land

1

The balance of the development land remains subject to Overseas Investment Office approval

Skilled asset management has resulted in a

significant WALE extension and progression of

planned development.

ANNUAL REPORT

|

43

Sustainability
NorthWest is on a journey to connect more people

and places with enduring possibilities, rooted in a deep

commitment to a sustainable future. This journey includes

all of the investment platforms it manages including Vital.

NorthWest remains steadfast in our dedication

to drive value for every stakeholder, leading

with our focus on partnering with our tenants as

we work with them to achieve better outcomes

for their patients as sustainably as possible.

By formalising our sustainability commitment, we

will amplify our collective impact - empowering

the growing ambitions of our partners, enabling the

next generation of the workforce, and engaging

in the sustainable evolution of healthcare.

Vital’s sustainability

achievements

In August 2021, Vital released its first sustainability

report. Vital’s achievements against set

targets are on page 46 of this report.

44

|

VITAL HEALTHCARE PROPERTY TRUST

Ehara tāku toa I te toa takitahi,
engari he toa takitini.

My strength is not as an individual,

but as a collective.

Whakataukī

Māori proverb

ANNUAL REPORT

|

45

Vital’s FY22 sustainability targets
and achievements

Continue to improve diversity on

the Board and in Management

1


Women in management 48%.

Angela Bull appointed as Independent

Director to the Vital Board

Focus on mentoring and

career progression


20% of our staff have moved to

new roles or been promoted to the

next level role this year so far

Encourage greater

community involvement

Volunteering policy formalised

providing employees with

two days of paid time off

designated for volunteering

Continue existing

professional development

through the launch of LinkedIn

Learning 2022, in addition to

targeted and general employee

personal development, diversity

equity and inclusion training

provided to all employees,

and personal and professional

coaching through Careerbase

Participate in third-party

assessments through GRESB

and CDP

Vital has submitted to GRESB and CDP

with results expected in Q2 FY23

Improve our CDP score

Vital was one of 5 NZ participants

to improve their scores in 2021.

We are seeking to further improve

this in 2022 capturing initiatives

implemented over FY22

Deploy sustainability initiatives

with key stakeholders

including tenants

• Continued to foster the Strategic

ESG Alliance with Epworth

Healthcare facilitating active

collaboration, information-

sharing, and improved sustainable

outcomes at both the property

and operating levels

• Vital is a member of both the

Green Building Council of Australia

and the New Zealand Green

Building Council. We have pursued

registration of four active and pipeline

development projects including Stage

2 of Playford Health Hub in Adelaide

Continue to progress investigation

of additional solar installations

Vital has undertaken desktop

sustainability audits of all Vital assets

to better understand environmental

impacts and opportunities and has

now commenced level 2 audits for all

landlord-controlled assets. Sustainable

tenant fit-out and tenant sustainability

guides launched and currently

being piloted at nominated assets


Establish baseline

environmental reporting

Underway across energy,

water and waste


Meet distribution guidance

and AFFO target

Upgraded guidance met

Maintain prudent payout ratio

Maintained at ~80%

Continue charitable and

community support programmes

Vital has pledged to a three-year

scholarship programme for the Keystone

Trust in conjunction with the University

of Auckland, with applications

open as at the date of this report

Extend and diversify debt

Debt extended and debt

funders increased

PeoplePracticePlaces

1

As part of wider renewal/recruitment processes.

46

|

VITAL HEALTHCARE PROPERTY TRUST

Sustainability framework
In December 2021, NorthWest released its

first sustainability report covering all of its

operations including Vital which it manages.

As a result, Vital's sustainability framework

has now been updated to align with the

NorthWest framework as outlined below.

NORTHWEST'S

SUSTAINABILITY

FRAMEWORK

Healthy

planet

Deepening our

contribution to a

healthy planet

Inclusive

company

Building for our current

team members as well as

our future employees

• Sustainability governance and team • Sustainability integration into investment processes

• Sustainable financing • Green leases • Reporting and disclosures

Thriving

partners

Preparing lasting tenant spaces

for health and healing

Enablers

Strong

communities

Investing in the

communities we serve

ANNUAL REPORT

|

47

Vitals material matters and
stakeholder engagement

During FY22, management undertook material

matters workshops for key stakeholders.

These workshops were facilitated by an external

consultant, Proxima, and were designed to identify

the key risks for Vital as an entity across all areas of

sustainability. The workshops identified the following:

Low

Medium

Low

High

Critical

MediumCriticalHigh

Community

Health, Safety,

and Wellbeing

Carbon

Disclosures

and Energy

Management

Enabling

Quality Care at

Our Properties

Healthy Building

Certifications

and

Performance

Materials,

Design, & Processes

Fit for Healthcare

Tenancies &

Sustainability

Sustainability

Integration

into Corporate

Processes

Diversity, Equity,

and Inclusion

Employee

Experience

Tenant

Partnership

Experience

Corporate

Governance on

Sustainability

MATERIALITY TO VITAL

MATERIALITY TO STAKEHOLDERS

The above matrix was provided to Vital’s key internal

and external stakeholders to ensure there was

alignment and to elicit any additional discussion points

or focus areas. These stakeholders included:

• Key NorthWest executives notably NorthWest’s

President and Chief Administrative Officer

• Vital’s six largest institutional Unit Holders

• Representatives of retail Unit Holders notably the

CEO of the NZSA and brokers from Forsyth Barr

• Key tenants (New Zealand and Australia)

• Largest debt providers in New Zealand

48

|

VITAL HEALTHCARE PROPERTY TRUST

Tenant engagement and interaction
Tenant engagement survey

Formalising our commitment to provide consistent

interactions and partner to improve our facilities we will

be undertaking a tenant engagement survey with an

ambition to achieve top quartile performance on tenant

Net Promoter Score (NPS) relative to our peers.

Tenant engagement programme

We continue to support and educate our partners about the

benefits of sustainable practices, including during our new

development phases and retrofit activities and are working

with a number of our tenants to formalise ESG strategic

alliances to further enhance our facilities for quality care.

As a region we are supporting the global approach in establishing

working groups locally with our stakeholders. While this will be

driven by the broader business, we will be engaging directly

with our tenants for the sharing of our experiences in the

sustainability space and our journey and ambition to reduce

our carbon emissions in line with our net-zero commitments.

Towards the end of 2022, we aim to host a workshop

with our key tenants with guest speakers and activities

encouraging active engagement in our sustainability efforts.

Strategic tenant alliances and

tenant advisory boards

Vital have established strategic tenant alliances that allow for

the sharing of information and collaboration with our healthcare

partners to identify some of the key opportunities and challenges at

the intersection of healthcare and sustainability. In the Australia and

New Zealand region, NorthWest have entered an ESG alliance

agreement with Epworth Healthcare and Evolution Healthcare to

facilitate active collaboration, information-sharing, and improved

sustainable outcomes at both the property and operating levels.

The alliance’s steering committee’s roles are to identify

opportunities, establish and deliver against shared goals and

targets that are aligned with each organisation’s vision.

We recognise the challenge of establishing a baseline,

tracking and transparently reporting against Scope 3 GHG

emissions in the healthcare sector. Vital will prioritise our

efforts through these strategic alliances to tackle this challenge

in partnership with our healthcare tenant operators.

Vital will seek to further expand these strategic alliances moving

forward with an ambition to identify and address key sector

challenges in the future in partnership with our healthcare tenants.

We are looking to further prioritise and develop our ESG alliance

with Epworth Healthcare and Evolution Healthcare and explore

opportunities to scale up and implement similar ESG alliances

with other key operators such as Healthscope and HealtheCare.

Inaugural tenant forum

Fostering a network of healthcare experts to further deliver

differentiated value to our tenants, we will launch a series of

initiatives to connect our tenants and promote knowledge sharing

across the industry, leveraging our unique position at the intersection

of healthcare and sustainability. Through a multi-pronged

engagement approach, our tenants and other stakeholders can

participate and engage in ways that could offer mutual benefit

and positively impact the healthcare real estate sector as a whole.

Once pandemic complications clear, we plan to convene

select tenant partners on relevant topics in an inaugural forum,

establishing and formalising a network of healthcare experts.

This will further promote idea generation, best practices sharing,

and innovation across the healthcare industry. We will also

expand and formalise our global communication strategy

in order to activate and engage with the network experts.

Topics might include GHG emissions and renewable energy

procurement, energy, water and waste efficiency, community

development, and health and wellbeing initiatives.

Thriving partners

Vital recognises the importance of fostering and strengthening our

relationships with our healthcare tenant partners. Through providing

consistent interactions and prioritising improvements to our facilities

we seek to improve the user experience and provide infrastructure

that allows for our tenants to deliver improved patient outcomes.

ANNUAL REPORT

|

49

Optimising spaces for patient wellness
As the largest NZX-listed landlord of healthcare real estate in

Australia and New Zealand and with a development pipeline of

~NZ$2.1bn, our spaces are designed with our tenants and their

patients needs at the centre. Through intentional design we create

spaces for patient wellness by enhancing the indoor environment

and facilitating connections to the outdoors where possible.

All our properties undergo region-specific indoor air quality

assessments to ensure the facilities meet industry standards and

adopted guidelines (ie Green Star, WELL health and safety ratings).

This ensures that our spaces support quality environments for

patients and other building visitors; maintaining comfort through key

areas such as noise, temperature, humidity and most importantly

protecting against any potential indoor environmental hazards.

In 2022/23, Vital will continue to undertake air quality

testing with 100% of our managed and controlled

properties to be assessed against wellness dimensions,

including air quality and accessibility, with one-third of

these assessments to occur within the reporting year.

50

|

VITAL HEALTHCARE PROPERTY TRUST

During FY22, Vital and NorthWest joined the
New Zealand Green Building Council and

the Green Building Council of Australia.

Membership of these green building councils has provided a

range of benefits including sustainability training for all asset

managers, development managers, facilities managers and

the sustainability team across Australia and New Zealand

in June 2022 (Foundations in Greenstar Performance).

Also during FY22, Vital and NorthWest joined the Property Council

of Australia in addition to its long-standing membership as an

industry leader of the Property Council of New Zealand. NorthWest

employees are regular attendees at property council events in

Australia and New Zealand including the annual conference,

ESG training, market updates and women in property events.

Memberships and

industry leaderships

Women In Property Annual Lunch, NSW

ANNUAL REPORT

|

51

Intentional culture
NorthWest must attract, retain, and

support our talent to ensure sustainable

success in an equitable culture.

NorthWest aspires to create a workforce that reflects the

diverse communities in which it operates. This includes

Australia and New Zealand where Vital is managed.

Inclusive company

FY22 highlights include:

• Regional staff conference held in northern New South Wales.

• Appointment of Angela Bull as an additional Independent

Director on Vital's Board. Angela is a highly experienced

property executive and has served on several boards.

• Diversity Policy established in April to support our focus

on diversity and inclusion including gender equity.

• Parental Leave Policy which grants paid leave to a primary

carer following the birth or adoption of a child.

• Volunteerism Policy established offering all full-time and

part-time employees paid time off to further assist the

communities in which we operate with community and

charitable efforts.

• Regular team social activities for each regional office as well

as Property Council training sessions, sporting activities.

• A range of health and wellbeing benefits being provided for

staff including flu vaccines, executive level health check-ups,

fruit provided in all offices and flexible working arrangements.

Preparing lasting tenant spaces for health and healing.

As a global business, NorthWest creates an inclusive

environment that encourages all people to bring their unique

self and passion to work, allowing them to feel safe in doing so.

52

|

VITAL HEALTHCARE PROPERTY TRUST

Learning and development
Globally, NorthWest has launched access for all permanent

employees to LinkedIn Learning – an online learning experience

platform that offers engaging video content, typically instructional

in nature driving personalised suggestions based on topics of

interest across business, technology-related and professional

development delivered through experts in the field.

Following a successful pilot of Careerbase in 2021, NorthWest

rolled out the personalised learning and development platform

to all permanent and contract staff, including new staff once they

have completed probation. This offer to staff in A/NZ which

gave points to source vendors and activities to build knowledge

and skills aligned to identified personal development needs,

with uptake in courses with the Australian Property Council

to personality diagnostics and 1:1 coaching sessions.

Angela Bull was

appointed as replacement

Independent Director

ANNUAL REPORT

|

53

Cyber security
and upgrades

During the past 12 months,

NorthWest IT has undertaken

five significant initiatives to

harden our cyber security and

protect our digital assets.

The upgrades were in response to new

requirements from our cyber security

insurer and the general increase

in cyber threats from the global

pandemic and the war in Russia.

Firewall fleet upgrade

The upgrade gives us better visibility into

security threats across our offices, and

a more automated tool for ensuring that

all firewalls are up to date and correctly

configured to block cyber threats.

Upgrade to Veeam

We moved our primary backup

infrastructure to the highest-rated

platform in the industry to provide

more recovery options along with

easier and faster recovery options.

54

|

VITAL HEALTHCARE PROPERTY TRUST

Ransomware protection
To ensure a layer of impermeable

data protection against ransomware,

we added WASABI backup solution.

This solution is an immutable backup

store that would be incorruptible by

ransomware. It is a cloud solution and

a third layer of backup replication.

KnowBe4

Knowbe4 is a cyber security training and

testing platform. We use the software to

send out email phishing simulations to

help us identify which of our staff requires

cyber security training. We provide

onboarding cyber security training for

new employees and use Knowbe4 for

testing and quarterly training updates.

Our goal is to ensure that our employees

have the skills to help protect our

organisation against a cyber attack.

Duo MFA

We now use a best-in-class Multi-

Factor Authentication (MFA) platform

called DUO from Cisco for externally

facing services. MFA double checks

each user’s identity so cyber attackers

cannot use lost or compromised

passwords to access our network.

ANNUAL REPORT

|

55

56
|

VITAL HEALTHCARE PROPERTY TRUST

All-staff conference
Our team of healthcare real estate professionals

attended an A/NZ staff conference in Kingscliff,

NSW for three days of learning opportunities,

future-focused workshops and brainstorming,

beach walks and adrenalin pumping exercise,

plus thought-provoking addresses from

both internal and external speakers.

Innovation, ESG and a strong network of personal

relationships will continue to define how NorthWest

does business, underpinned by a dedicated and

capable team leading us into the future.

ANNUAL REPORT

|

57

Career progression
JOEL SMART

SENIOR ANALYST, INVESTMENT AND ASSET

MANAGEMENT, UK REAL ESTATE

LIZ INGRAM

SUSTAINABILITY ASSOCIATE

How many years have you been with NorthWest?

2.5 years. I joined the Auckland office in January 2020,

and transferred to the UK office in April this year.

What attracted you to NorthWest? The opportunity

to learn from great people within a global

company and work on an NZX listed fund.

Where are you located? London, UK.

What has the transition been like to a new country?

There’s been a bit more rain than the ‘summer’ I’m used to.

What has been the greatest aha moment? A small

clause in an agreement can have a big impact.

What has surprised you? That the fundamentals of real

estate are still similar across very different regions.

What has been the greatest challenge? Learning to

connect with people and build relationships remotely.

What are you thankful for? I’m thankful for the

opportunities I’ve been given to learn and to have job

security when moving to the other side of the world.

What would your advice be for someone looking

for a new opportunity or challenge? Speak up

and let others know what you’re looking for. People

are often willing to help if you reach out to them.

How many years have you been with

NorthWest? 2 years in October.

What attracted you to NorthWest? The team! Team culture

is really important to me because I am with my colleagues for

more hours in a day that I am with my own family. It doesn't

feel like work when you are with your friends all day.

Where are you located? Auckland, New Zealand.

What has the transition been like to your new role?

Eyeopening! I didn't realise how passionate I was or how

invigorated I am by the sustainability space until I made

the leap. Having encouragement from great mentors

within the team has also made the change easier.

What has been the greatest aha moment? Realising

how intertwined ESG is across every area of our

business. Also realising the privilege of being part a

team that can help facilitate initiatives that will have a

positive impact on our planet and future generations.

What has surprised you? The amount

of acronyms in the ESG space!!

What has been the greatest challenge?

Relinquishing the parts of my old role that I loved.

What are you thankful for? The opportunity to transition

to a completely different role with a global reach,

while maintaining relationships with the local team.

What would your advice be for someone looking

for a new opportunity or challenge? Take the leap

and do it! I have no regrets and love what I do.

There has been significant growth within the team,

with an increase in headcount from 45 in January to

61 in July 2022 across all areas; finance, corporate

support, development and asset management teams.

A focus of 2022 has been to identify and further support

enhanced development and growth opportunities including

promotions and new roles for those at NorthWest with further

potential. This included identifying talent for new roles, extending

the scope of roles or identifying opportunities for talent to work

in other global offices. 20% of our staff have moved to new

roles or been promoted to the next level role this year so far.

58

|

VITAL HEALTHCARE PROPERTY TRUST

GEORGIE HUXLEY
VICE PRESIDENT, LEASING

CLARE SOLOMON

VICE PRESIDENT, SUSTAINABILITY AND

DEVELOPMENT

How many years have you been with

NorthWest? 5 years at the end of this year.

What attracted you to NorthWest? The people! Even though

it was only a team of four at the time. I could tell it was a

great work environment, with people who genuinely cared,

both about their work but also about each other. We all still

work here today! I also felt huge alignment with the social

infrastructure nature of our properties and the sense that we are

giving back to the community through our product delivery.

Where are you located? Melbourne, Australia.

What has the transition been like leading a new function?

Change is always an adjustment. I was lucky in that I was

already doing quite a bit of strategic leasing as part of my

previous role – a quasi trial run of the new job! The most

challenging part is probably having to navigate priorities

as we have so many large scale projects on the go.

What has been the greatest aha moment? I’d be lying if

I didn’t acknowledge that each day brings a new learning.

With healthcare real estate, you are naturally entwined

with the success of your partner operators’ businesses. It’s

important to keep on top of pressures and challenges that

your operators may be facing, whether that be at a workforce

level, competition, technological or economic factors.

What has surprised you? Not exactly work related

but the standout of the last 2 years to me has been

the resilience of the healthcare sector, in particular

the front line workers. Just outstanding.

What has been the greatest challenge? Starting in a new

role and not being able to travel was quite difficult. I always

prefer to meet in person if possible as it’s a great way to get

to know people and understand them both professionally

and personally which is so important. Delivering Stage 1

of Playford Health Hub completely remotely and hitting

practical completion without having stepped foot onsite

during construction was a huge effort from the team.

What are you thankful for? The team. The leasing environment

can be very fast paced and a rollercoaster of emotions sometimes.

It’s the team that sits behind and alongside me that helps ride

the wave, support the vision and ultimately deliver the projects.

What would your advice be for someone looking

for a new opportunity or challenge? Say yes to the

challenges. Push yourself out of your comfort zone.

You never know how much you might enjoy it.

How many years have you been with

NorthWest? Just over 8 years.

What attracted you to NorthWest? Since commencing

my career in development I have been fortunate enough

to work in the health and aged care sector. It is an

incredibly rewarding sector to be in with opportunity

to deliver infrastructure that can directly impact and

improve patient outcomes and the health of the broader

community. NorthWest commitment, vision and ambition

in this sector is what attracted me initially to NorthWest.

Where are you located? Melbourne, Australia.

What has the transition been like to your new role? My

transition indirectly commenced prior to formalisation of

the appointment of my new role through my involvement

with the global team in the development of the NorthWest

Sustainability framework, strategy and commitments

released at the end of 2021. My involvement in this, under

the guidance of Boston Consulting Group has allowed me

to make a smooth transition into my new role, grounded

with enthusiasm to deliver against our ESG strategy.

What has been the greatest aha moment? To be

successful and drive change ESG must be integrated

into our core business strategy – every member of

every part of our business has a role to play!

What has been the greatest challenge? I don’t think I

have faced my greatest challenge in my new role – but

it is coming! Realising the opportunities where healthcare

and sustainability meet is both exciting and challenging

with a portfolio that is heavily reliant of combatting scope

three emissions in a challenged sector! This is an exciting

challenge that I look forward to partnering with our

tenant operators and industry experts moving forward!

What are you thankful for? The commitment NorthWest and

particularly the Global Leadership Team have to realising

the vision and ambition for the business and the critical role

ESG has to play in achieving this vision moving forward.

ANNUAL REPORT

|

59

Indigenous workgroup
and RAP initiative

New spaces for our growing team

Sydney office

We are proud to announce the opening of our Sydney

office at 285 George Street, Brookfield Place.

Designed by award-winning Hammond Studio, the interior of the Peapes

Building offers a contemporary and highly functional transformation

of a heritage building. The Sydney team selected the artwork together

from Artbank, including a highly notable Ginger Riley painting. Through

the partnership with Artbank, the office is providing direct support

to Australian contemporary artists and are promoting the value of

Australian contemporary art to our visitors as they join our space.

Together we create value though

people, place and community and this

extends to our first placemakers – the

First National people of Australia,

and Māori in New Zealand.

With this in mind an indigenous workgroup has

been created to lift our focus and commit our

good intention to improved actions in 2022.

We have committed to two priorities; deliver

online training for all our staff in A/NZ to

ensure a baseline understanding of indigenous

matters across Māori, Aboriginal and Torres

Strait Islander cultures and the development

of a Reconciliation Action Plan (RAP).

These two priorities, together with sponsorship

of our indigenous workgroup by our leadership

team help us to focus and start our journey

of reconciliation with the intention in the

medium term we will go deeper and focus

on improved outcomes in the health industry

as well as partners with other like minded

organisations to continue to advance and learn.

In April, the Auckland team joined Ngarimu

Blair of Ngati Whatua ki Tāmaki for an

insightful Walking Wānanga (guided walk)

to gain a deeper understanding of Tāmaki

Makaurau (Auckland) and Māori history.

Just as we engage our tenants, we engage our people to

ensure their needs are met and their voices are heard.

Our employees’ positive experiences as part of the NorthWest team

strengthen who we are as an organisation and the values that drive

us forward. With a need now more than ever to attract and retain top

talent, as well as creating space for the growing team across the A/NZ

region, Sydney and Auckland offices have moved into new offices.

60

|

VITAL HEALTHCARE PROPERTY TRUST

Auckland office
NorthWest opened a new Auckland office

in the Commercial Bay precinct at the

start of 2022 with the goal of creating

a collaborative space conducive to the

approach we bring to our stakeholders.

Chosen for its alignment with NorthWest’s ESG

strategy, the building boasts initiatives such as

worm farms, low energy fittings and group wellness

classes for tenant use. Designed with a focus on

sustainability, people and place the new office

appoints art curated purposefully with local New

Zealand artists, including works by Bill Hammond

to its both functional breakout spaces and open

plan areas used for celebrating NorthWest’s

successes. The office incorporates considered

design such as recycling the existing concrete slab,

grinding and polishing as needed and locally

sourced products and suppliers where possible.

ANNUAL REPORT

|

61

Strong communities
We are committed to enhancing the communities where we

operate by sharing our time, research and resources and

amplifying the healthcare objectives of our partners. Giving

back to our communities is ingrained in who we are and we

align our community investment efforts to those of our tenants.

62

|

VITAL HEALTHCARE PROPERTY TRUST

Building on our existing support
and sponsorship of the Keystone

New Zealand Property Education

Trust, Vital has committed to

a three year Key Scholarship

Partner programme through an

annual scholarship, mentoring

and support to a student from

the University of Auckland.

The Keystone Trust provides education

and career support for students with

financial and circumstantial needs who

are working towards a qualification in

the property and construction sectors.

Keystone Trust

NorthWest supports

five key international

days including

• International Womens Day

• World Health Day

• Earth Day

• World Mental Health Day

• Human Rights Day

ANNUAL REPORT

|

63

To strengthen the places where we operate, Vital and NorthWest partners
with our tenants and local communities through charitable giving, working

with organisations to improve the social determinants of health in our

communities and supporting our communities during times of crisis.

Charitable giving

and community

involvement

Contributed to form the NorthWest

REIT International Policy Network

Investing in healthcare research

At the NorthWest group level, one of our 2022

sustainability initiatives is to support research into

the response of healthcare systems in pandemics.

NorthWest has pledged a contribution of C$5m over five

years to form the NorthWest REIT International Policy Network.

As part of this initiative, the University of Toronto, will work

with its first partners, the University of Melbourne School of

Population and Global Health and the University of Sydney

School of Public Health, to examine pressing issues in health

policy and health systems in Canada and Australia.

“This gift will provide a strong foundation for

better healthcare systems here and around

the world. The NorthWest International Policy

Network will provide invaluable opportunities

to learn what works best to create sustainable

and high-performing healthcare systems.”

Adalsteinn Brown

Dean and Professor

at the University of Toronto

Dalla Lana School of Public Health

C$5m

64

|

VITAL HEALTHCARE PROPERTY TRUST

Donations totaling in excess of ~$60,000
1


were made to various charities and

community organisations over the course

of the year. Some of these include:

A$10,000 +

A$5,000 +

Donated to

St Vincent de Paul Society

Donated to Baby Give Back

A$7,230

Beyond Blue

A$8,900

Epworth Medical Foundation

NZ$15,000

Mercy Hospice Auckland

NZ$3,840

Mental Health Foundation of NZ

NZ$3,000

Starship Foundation

NZ$2,600

Te Kura Kaupapa

Māori o Hoani Waititi

QLD and NSW flood donations

Many individuals and communities were

affected by the devastating floods in New

South Wales and Queensland this year.

The damage and destruction that they faced

is unprecedented and recovery efforts will

take years of support and hard work.

NorthWest committed to supporting the flood-affected

communities and donated A$5,000 over and above

any by NorthWest staff donations which it also matched

dollar for dollar. We partnered with St. Vincent’s

Health Australia and Vinnies Australia to maximise

donations. St Vincent’s Health pledged to dollar match

any contributions made by their staff or the public via

the St. Vincent’s Health Australia Flood Appeal.

Baby Give Back

CEO and founder of Queensland charity

Baby Give Back, Carly Fradgley, addressed

the team at the A/NZ staff conference,

on the important work they do in the local

communities of south-east Queensland to

support vulnerable babies, children and

families by recycling essential children’s items.

The work Carly and her team do is a timely reminder of

the value in sustainable re-use, alongside the immense

impact sustainable re-use can have for people in need.

1

Figure does not include the C$5m donated to research in healthcare

ANNUAL REPORT

|

65

Asset management and
standing assets

As a leader in healthcare real estate, NorthWest

supports our tenants by collaborating with them on ways

to reduce the environmental impact of their operations

and continues to pilot and test innovative ideas at the

intersection of healthcare and sustainability.

Green Star training

All asset managers, property managers and development

managers have undertaken Green Star - Foundations

training demonstrating our commitment to improve our

capabilities and our approach to reducing the environmental

impact of our properties and development projects.

Green Star Performance

We have undertaken Green Star - Performance v1.2 (Energy

and water) ratings on across the Vital portfolio and are

exploring opportunities for Green Star certification on a

number of the landlord-controlled assets within the portfolio.

Healthy planet

Vital recognises the importance of minimising our impact on

the planet and are committed to further bringing sustainability

into the core of our business including our approach to asset

management, development and precincts.

Commitment to building audits

Following desktop audits for all assets, we have now

commenced level 1 and level 2 analysis providing detailed

energy calculations with the added financial analysis of

proposed energy measures for each site which will assist in

determining a targeted roadmap for delivering on sustainable

business initiatives at an individual property level.

Sustainable fitout guide

As a trusted partner to healthcare operators, we are working

with industry experts and collaborating with our tenants to

create a sector appropriate sustainability guideline. This

will provide a reference for our healthcare operators to

reduce and manage resources through sustainable materials,

processes, and design. This is currently being piloted

and will be extended to all tenants moving forward.

The tenant sustainability guide includes topics such as:

• connectivity to communities and public transportation

• fit-out/renovations recommendation as appropriate

• best practices for the management and reduction of energy

and water consumption as well as waste production

• additional building processes promoting

a healthy indoor environment

66

|

VITAL HEALTHCARE PROPERTY TRUST

Development
In line with this goal and our sustainability strategy, these

Ecologically Sustainable Development (ESD) guidelines have

been developed to ensure that all new developments and major

redevelopments have a consistent reference for embedding ESD

principles and initiatives into projects. The guidelines support

various scales of developments and provide a framework that

facilitates improved outcomes and opportunities for us to pursue

certified sustainability ratings aligned with industry leadership.

The following key ESD priorities are prioritised across all projects:

• Net-zero emissions: In line with international and national

commitments, net-zero emissions are a priority to mitigate the

impacts of climate change. All new projects must be net-zero

emissions ready and enable a transition to 100% renewable

energy powered buildings, with zero onsite fossil fuels.

• Embodied emissions and life cycle assessments:

Embodied carbon emissions are a significant driver

of increasing greenhouse gas (GHG) emissions and

reducing upfront carbon emissions is a key requirement

for all new building projects and redevelopments.

• Health and wellbeing: To improve health and wellbeing,

prioritise wellness factors and reduce environmental

impacts, sustainable and healthy designs and sustainably

procured building materials will be incorporated on all

projects where possible, including increased daylight,

improved fresh air provisions and sustainable materials.

• Climate resilience: All projects must be climate resilient

with climate change risks identified and design responses

incorporated that mitigate and adapt to a changing climate.

• Certified outcomes: To demonstrate leadership, ensure

transparency, and celebrate sustainability initiatives, all

major projects will achieve a certified rating. This includes

building and community certifications for major developments

and performance ratings for existing assets. The guidelines

incorporate a range of ESD requirements and best practice

provisions to embed ESD into developments and enable

a holistic approach for projects to improve environmental,

social and economic performance. The guidelines have

been structured to provide minimum ESD requirements

that all projects must incorporate and a number of flexible

pathways for projects to achieve a certified rating.

Renewable energy

We are currently exploring sustainability opportunities

within the Vital portfolio by undertaking detailed energy

audits to explore opportunities for installation of solar,

thermal storage, electrification, current equipment

efficiency calculations and other sustainable outcomes.

Stage 1 of this process includes assets within the portfolio

that are landlord-controlled, enabling us to formulate a

sustainability roadmap to carbon neutrality at an individual

asset level. Stage 2 expands this out to the remainder of the

portfolio, to assist providing our parnters with sustainable

opportunities, working together to become carbon neutral.

Vital have further partnered with Veolia to create an energy

dashboard for the purpose of automating the collection of data into

a centralised database. The system has been created to collect,

track, compare and report Vital’s emissions usage in real time.

In line with this approach, the following sites are currently

undergoing energy audits, and are part of our pilot

programme with the new hubgrade dashboard system:

• Tennyson Centre

• 120 Thames St

• Playford Health Hub

• Ormiston Hospital

• Mons Road Medical Centre

• Epworth Eastern Medical Centre

• Ekera Medical Centre

• Ascot Hospital

• Ascot Central

• Apollo Health and Wellness Centre

• Hutt Valley Health Hub

The hubgrade system is designed to capture utility data including

already installed solar energy, giving us the ability to accurately

report on our green energy production. We are currently in the

process of installing solar on a number of our assets to expand to

the production of green energy across our portfolio. Sites with solar

PV include the South Eastern Private Hospital, Maitland Private

Hospital, Tennyson Centre, Epworth Eastern Hospital, Lingard Day

Centre and Lingard Private Hospital, The Hills Clinic, Abbotsford

Private Hospital, Hurstville Private Hospital, Ekera Medical Centre,

Sportsmed (hospital, clinic and consulting suites), Palm Beach

Currumbin Clinics, Eden Rehabilitation and Belmont Private Hospital.

ANNUAL REPORT

|

67

Net-zero carbon
Understanding our climate risks

Certifications for

sustainable excellence

We recognise the growing need to do more for our planet and

are committed to achieving net-zero carbon emissions by 2050,

with a focus over the next 18 months on establishing a roadmap

for for a science-based interim 2030 reduction target.

Through the comprehensive energy audits currently underway, we can establish

a prioritisation roadmap to identify a variety of energy efficiency programmes

which will inform our strategy to reach our net-zero ambition by 2050.

Our efforts over the next 18 months include setting a short-term

emissions and 100% renewable energy target, and exploring

opportunities to phase out fossil fuels from our existing portfolio.

We understand that emissions from our partners and tenants (Scope

3 emissions) are a significant portion of our carbon footprint and and

we will continue to work with our tenants to improve energy and water

efficiencies and increase renewable energy procurement where possible.

ESD guidelines set out stringent requirements for all new

developments to permit net-zero carbon operation and minimise

upfront emissions from the design construction process.

Physical climate risks such as drought, wildfires, flooding, earthquakes

and rising sea levels have the potential to pose major threat to our

portfolio. By understanding and pre-empting these physical climate risks

across all our assets, we can ensure we have a resilient portfolio.

Through Measurabl, we have undertaken risk assessments of each

asset and are analysing the results to identify which buildings are

facing the greatest risk to help us recognise the impact climate change

will have across the portfolio. Following this analysis, we will establish

a framework of measures to take preventative action to ensure the

portfolio is resilient to climate change and our healthcare providers are

not impacted during a time of crisis when they are needed most.

Vital and NorthWest continue to pursue opportunities that enhance the

experience for our tenants and their patients, through the integration of

sustainability practices into our existing facilities and new developments.

In an explicit effort to demonstrate our commitment to sustainability as well as

ensure long-term value creation for our stakeholders, we will have undertaken

Green Star – Performance certifications across the Vital portfolio and will

review and identify opportunities for enhancements and retrofits to improve

certification levels. We are also exploring other certifications such as NABERS,

Energy Star and WELL, among others relevant to each property and location.

For our new developments, we integrate certification considerations into our

processes where applicable and have registered the below development

projects for Green Star – Design & As Built certifications: Coomera Health

Precinct, Logan Private Hospital and Playford Health Hub Medical Precinct.

68

|

VITAL HEALTHCARE PROPERTY TRUST

Seismic resilience
As part of the recent lease extension to the Hawkes Bay DHB, management

agreed to upgrade the seismic resilience of the Napier Health Centre

to >67%NBS in line with the government’s strategy to house their

workers in well performing buildings. In coordination with the DHB,

the build methodology proposed excludes excessive odour and noise

producing activities and ensures full and continual care is provided to

Hawkes Bay patients throughout the 10-month programme of works.

Design and procurement is now complete to improve the NBS rating

of the Apollo Health and Wellness Centre with work to progress

in Q1FY23. Work to create sliding structural connections between

levels 2 and 3 of the centre is isolated to the 4x stairwells on site and

will not impact our tenant’s ability to provide care to patients.

Vital has committed to carrying out seismic strengthening of 68 Saint

Asaph St to achieve a 100% IL3 rating, which is designed for a 1/1000

year event. This is in line with the DHB requirements for the seismic rating

of any buildings they occupy and will provide safety and continuity

for our healthcare tenants. The design works to achieve this rating are

underway with work expected to commence in the last quarter of 2022.

WAKEFIELD HOSPITAL

WELLINGTON

NAPIER HEALTH CENTRE

HAWKE'S BAY

APOLLO HEALTH & WELLNESS CENTRE

AUCKLAND

68 SAINT ASAPH STREET

CHRISTCHURCH

ANNUAL REPORT

|

69

Hutt Valley Health Hub, Wellington, NZ
CASE STUDY

Hutt Valley Health Hub is a near new, purpose built

medical office building located immediately adjacent to

Vital’s existing Boulcott Hospital and the region’s Public

Hospital – Hutt Hospital.

The safety of the staff and patients onsite

is of critical importance to Vital, and

we also understand the importance that

these community services can have in the

recovery of a seismic event. Hutt Valley

Health Hub was designed and constructed

to meet importance level 4 (IL4), which

is a very high level of seismic resilience,

almost 2x the minimum code requirements.

The building itself is located close to

several bus stops and within 10 minutes

walking distance of the Epuni train station.

Finalist in the 2022

Property Council Property

Industry Awards

70

|

VITAL HEALTHCARE PROPERTY TRUST

Kawarau Park, Queenstown, NZ
CASE STUDY

Natural

light

Insulation unbridged

warm roof

Thermally broken

window joinery

LVL framing

Optional natural

ventilation in ward rooms

Utilisied local labour

during construction

Predominantly native

and resilient planting

Local materials, NZ

manufactured products

The hospital operated by Southern Cross aims to create an

environment where wellness is at the foundation of the patient

experience. It has been designed to set a new benchmark for

energy use in New Zealand for both public and private hospitals.

The Hospital

Kawarau Park Precinct

Patients and visitors alike are immersed in sustainable

design in this facility. From high levels of insulation

throughout, maximised use of natural light and

the choice of natural ventilation in ward rooms

occupants receive the benefit of wellness-in-design

while simultaneously maintaining control standards

expected of a medical facility. Building system

technology addresses regulation of traditional

boiler usage in cooler months in favour of more

efficient heatpump systems to warm the facility,

in addition to control of daylight and CO2 to

ensure energy is only consumed where required.

Construction of a health precinct enables patients to attend to a set of

harmonised specialists in one location, minimising time spent traveling to

receive care. Each building within the Kawarau Park Health Hub features NZ

manufactured building products and utilised local labour in its construction.

The precinct grounds feature native planting and overall design reflects the

surroundings to minimise the visual impact of the site on the community.

Southern Cross Central Lakes Hospital designed

by Warren and Mahoney Architects is shortlisted

in the Southern Architecture Awards 2022

ANNUAL REPORT

|

71

Enablers
We must evolve our ways of working and ensure the integration

of sustainability throughout our operations, strategy and

decision-making to deliver on our sustainability commitments for

our healthcare tenants, Unit Holders and broader stakeholders.

72

|

VITAL HEALTHCARE PROPERTY TRUST

A sustainability governance model has been adopted
to lead and oversee the effective execution of our

sustainability efforts in order to drive accountability

throughout NorthWest. We recognise that effective

sustainability governance requires executive and Board-

level oversight, leadership, strong central support, and

integration into lines of business to effectively achieve

our goals. In 2021, we established a sustainability

committee to guide progress towards our ambition.

The committee regularly engages with the Board of

Trustees on priority topics including sustainability risks

and opportunities, targets, and alignment to our overall

organisational strategy and vision. We have established

working groups to convene relevant cross-functional

stakeholders to coordinate and drive the implementation

of our sustainability initiatives, and facilitate sharing

of best practices across our global organisation.

Governance and team

ESG and the

investment process

Green leases

We are committed to integrating sustainability

across the building lifecycle, including our investment

process, enabling us to support our commitments

in achieving net-zero and providing high-quality

spaces for our healthcare tenant partners.

As part of our current acquisition due diligence process,

we already include select sustainability dimensions that

align to GRESB guidelines, such as building safety, land

contamination, compliance, energy supply, flooding,

infrastructure and water supply. We will continue to integrate

sustainability into our standard investment process by

using Moody’s Four Twenty Seven modelling software to

measure the physical climate risks of each acquisition target

through Measurabl. This process will allow us to mitigate

risks that could impact the long-term value of our portfolio.

NorthWest have committed to embed a green lease

clause within all new leases in recognition of the

importance of having the right mechanisms in place to

ensure we are able to measure the environmental impact

of our buildings and tenants, but also guide tenants

towards taking a more sustainable approach to their

operations and initial fit-out. The green lease clause

should be in all new leases going forward and all tenants

will receive a copy of the landlords fit-out guide.

ANNUAL REPORT

|

73

Executive Sustainability Committee

Board of Trustees

Sustainability

Governance Structure

Global Leadership Team

Working Groups

Head of Sustainability

Chief Administrative

Officer

(Canada)

Managing Director

(Europe)

President and

Managing Director

(ANZ)

Managing Director

(Americas)

• Review of existing documentation, including
the outputs of internal workshops and climate

risk management-related documents

• Review of existing process for identifying and assessing climate-

related risks, including methodology for identifying and assessing

scope, size and impact, time horizons, value chain stages

• Identify processes for managing climate-related risks

• Full gap analysis completed

• Roadmap for achieving CRD

compliance delivered

Reporting and disclosures

• Review of existing documents, process, and

policies for climate risk accountability

• Board’s oversight of climate related risks and opportunities

• Management’s role on assessing and managing

climate-related risks and opportunities

• Choice of cross-industry metrics & consistency

with XRB’s climate-related metric categories

• Relevance and rationale for choice of industry-specific metrics

(as defined by XRB), and any other performance indicators

• Description and rationale for target and process for GHG

report compliance (considering 3rd-party assurance

over inventory and its link to the XRB CRD report)

Governance documentation review and gap analysisTargets and metrics – documentation review and gap analysis

Risk management and strategy – documentation

review and gap analysis

Final CRD recommendations

and roadmap

SEPTEMBERNOVEMBER

OCTOBERDECEMBER

FY22

DISCOVERSTRATEGISE

DEFINEDELIVER

TCFD Framework

Vital is required to provide Climate-related disclosures under Financial Sector

(Climate-related Disclosures and Other Matters) Amendment Act 2021 with the

first report likely to be required for the year ended 30 June 2024. The External

Reporting Board (XRB) is currently developing the Aotearoa New Zealand

Climate Standards that will apply to this reporting. We have engaged Deloitte

to provide gap analysis activities based on current exposure drafts of the

standards to assist us in our development of a roadmap for compliance that is

informed by market experts and understood by our Board and executive team.

Through our partnership with Measurabl and the integration with Moody’s Four

Twenty Seven modelling software, we have measured the physical climate risks

of each of our assets which will form part of our strategy to implement various

sustainability initiatives and manage our climate risks and opportunities.

The below timeline outlines our objectives which will support the rapid

adoption of TCFD, in line with our reporting capabilities and expectations.

74

|

VITAL HEALTHCARE PROPERTY TRUST

• Undertake portfolio climate risk stress testing
(physical and transition risks)

• Generate physical risk heat mapping

• Test portfolios for emissions intensity

• Draft CRD ready to

present to Board

• Present key findings of gap analysis and the road map

for CRD compliance to the Board and executive team

• Identify options for strengthening portfolio resilience

• Identify options for decarbonising portfolios

Report to Vital BoardAdaptation and transition planning

Portfolio stress tests

FEBRUARYNOVEMBER

JUNEAPRIL

FY23FY24

DISCOVERSTRATEGISE

DEFINEDELIVER

GHG emissions tracking, GRESB & CDP

As part of our GHG emissions tracking, NorthWest and Vital have

participated in the Global Real Estate Sustainability Benchmark (GRESB)

survey and will disclose our score in Q2 FY23. Alongside increased efforts

to track environmental and social data, we have also incorporated GRESB

management guidelines into our corporate processes and policies.

Vital has also participated in the Carbon Disclosure Project (CDP) as a

commitment to tracking Scope 1 and Scope 2 emissions in line with GHG

Protocol definitions. By understanding our complete carbon footprint we can

identify ways to actively reduce our emissions, positioning us to reach our

net-zero goals. We will publicly release our CDP score later this year.

ANNUAL REPORT

|

75

Graham Stuart
Independent Chair and

Member of the Audit Committee

(65, Auckland)

Graham Stuart is an experienced corporate

Director with an established track record of

performance in governance and in prior executive

roles. He is currently the Independent Chairman

of EROAD Limited and an Independent Director

and Chair of the Audit Committee at Tower, and

an Independent Director of Metro Performance

Glass. He served for 7 years as the Chief Executive

Officer of Sealord Group and prior to that was

Director, Strategy and Growth and Chief Financial

Officer of Fonterra Co-operative Group.

Graham is a Fellow of Chartered Accountants

Australia & New Zealand (CAANZ). Graham has

a Masters of Science from Massachusetts Institute

of Technology and a Bachelor of Commerce with

first class honours from the University of Otago

Paul Dalla Lana

Director and Member

of the Audit Committee

(56, Toronto)

Paul Dalla Lana is the founder and Chief

Executive Officer of NorthWest Healthcare

Properties REIT – the 100% owner of NorthWest

Healthcare Properties Management Limited,

the Manager of Vital Healthcare Property Trust.

Over the past 25 years, Paul has led NorthWest

in the acquisition and development of over $7.0

billion worth of real estate transactions, with a

significant focus on healthcare properties.

Prior to founding NorthWest, Paul was a

professional in the Real Estate Capital Markets

Group of Citibank, N.A. and an economist with

B.C. Central Credit Union. Paul received his BA

(Economics) and his MBA (Finance and Real

Estate) from The University of British Columbia.

Paul serves as Chairman of the Board of NorthWest

Healthcare Properties REIT. Additionally, he is

actively involved in addressing public health and

education issues in Canada and around the world.

He is an Advisory Board member of the Dalla Lana

School of Public Health and on the President’s

Advisory Council at the University of Toronto.

Angela Bull

Independent Director and

Member of the Audit Committee

(47, Auckland)

Angela Bull is the Chief Executive of Tramco

Group, a large New Zealand owned property

investment company which specialises in large

scale land holdings, notably the Viaduct Harbour

precinct in Auckland and Wairakei Estate in

the Waikato. She holds a Bachelor of Laws

and a Bachelor of Arts (Political Science) and

practised property and environmental law prior

to her executive career. Previously, Angela held a

number of senior positions over a 10-year period

with Foodstuffs Auckland and Foodstuffs North

Island Ltd, most recently being General Manager

Property Development for Foodstuffs North Island.

Angela is an independent director of the Real

Estate Institute of New Zealand, realestate.co.nz,

Foodstuffs South Island Ltd and Foodstuffs NZ Ltd.

Our Board

The Board (as at the date of this report) comprises five highly qualified

directors; three of whom are independent. Both the Chair of the Board

and the Chair of the Audit Committee are independent directors.

76

|

VITAL HEALTHCARE PROPERTY TRUST

Directors are based in Auckland, Toronto, Sydney
and Melbourne. Their current and prior executive

experience includes healthcare, property and finance.

Andrew Evans

Independent Director and Member 

of the Audit Committee

(58, Auckland)

Andrew Evans has over 25 years’ experience in

commercial real estate and asset management,

previously holding executive positions in listed

and unlisted real estate investment businesses.

Andrew is Chairperson of Accessible Properties

NZ Limited and Infinity Investment Group

Holdings Limited, is a Director of Holmes

Group Limited, Holmes GP Fire Limited and

Trust Investments Management Limited, and is

a former director of Argosy Property Limited.

In addition, Andrew is a past National President

of the Property Council of New Zealand, a fellow

of the New Zealand Property Institute, and a

government appointee to the Land Valuation

Tribunal (Waikato No.1). He is a Chartered

Fellow of the Institute of Directors of New Zealand

and is on the Auckland Branch Committee.

Andrew has a Bachelor of Business Studies and

MBA (with distinctions) from Massey University and

a Diploma in Finance from Auckland University.

Dr Michael Stanford AM

Independent Director and Chair 

of the Audit Committee (63, Melbourne)

Dr Michael Stanford has more than 30 years’

experience in the health sector in either Group

CEO or Board roles. Michael’s current Board

roles include Australian Clinical Labs (ASX:ACL),

Australia’s third largest private pathology provider;

Nucleus Networks, one of the world’s largest Phase

one clinical research organisations, and Diabetes

Australia, a significant Not-for-Profit of which

Michael Is President and Board Chair. Other

Board roles in the last three years have included

Healthscope (ASX:HSO), Australia’s second largest

hospital operator; and Virtus Health (ASX:VRT),

one of the world’s top five providers of Assisted

Reproductive Services.

Michael was the Group CEO of St John of God

Healthcare, Australasia’s third largest private hospital

provider, for 16 years during which time the company

increased revenue fivefold through organic and

M&A growth plus more than A$1 billion greenfield

and brownfield developments. Michael’s other

Managing Director roles included the ASX listed

Australian Hospital Care and two public hospital

Networks in Victoria. Michael holds an MBA from

Macquarie University and Bachelor of Medicine and

Bachelor of Surgery from UNSW. He is a Fellow of

the Australian Institute of Company Directors.

In 2018 Michael was awarded a Member of the

Order of Australia for significant service to the

health sector through executive roles, to tertiary

education and the WA community. In 2010 he

received the WA Citizen of the Year Award –

Industry and Commerce category.

Craig Mitchell

Director and Member of the

Audit Committee (54, Sydney)

Craig Mitchell has more than 20 years'

experience specialising in the property

industry in Australia. His previous roles include

Executive Director and Chief Operating

Officer of Dexus, an ASX top 50 listed REIT.

Craig is President of the NorthWest Group,

having joined in 2018 as CEO of Australia

and New Zealand. He is responsible for funds

management globally including establishment of

new funds, providing strategic direction as part of

the REIT’s global leadership team, and has overall

accountability for the Australian and New Zealand

region, including strategy, performance and leading

the team of over 40 real estate professionals.

Craig has a Master of Business Administration

(Executive) from the Australian Graduate School

of Management, a Bachelor of Commerce

and is a Fellow of CPA Australia. He has

also completed the Advanced Management

Program at Harvard University, Boston

After 15 years on the board of Vital’s

Manager Andrew Evans retired

from the board on 30 June 2022.

ANNUAL REPORT

|

77

Aaron Hockly
Senior Vice President

– New Zealand and Vital Fund Manager

(44, Auckland)

Aaron Hockly returned to New Zealand in 2018

after 17 years in senior management and advisory

roles in Australia. He has an extensive property,

funds management and legal background with

his last role in Australia being the Chief Operating

Officer for Growthpoint Properties Australia.

Growthpoint is a A$4.1bn ASX listed real estate

investment trust with a portfolio of quality office

and industrial properties. At Growthpoint Aaron

had direct management responsibility for strategy,

transaction structuring and execution (property,

debt and equity), reporting and investor relations.

Among other qualifications, Aaron has a Masters

in Applied Finance and a BA/LLB from the

University of Auckland. He is a Fellow of both

Governance New Zealand and the Financial

Services Institute of Australasia (FINSIA).

Aaron currently serves on the board of

Mercy Healthcare (Auckland).

Chris Adams

Executive Director – Projects

(52, Melbourne)

Chris Adams has extensive experience in

the property industry in Australia, New

Zealand and the United Kingdom, including

over 20 years' experience in health sector

property acquisitions, transaction structuring

and large scale hospital development.

Responsibilities with respect to NorthWest include

overseeing development management and

joint responsibility for acquisitions undertaken

by the business. Chris was one of the founding

Executives at Generation Healthcare REIT (now

NorthWest Healthcare Properties Australia REIT).

Prior to joining Generation, Chris established

Vital Health Care’s presence in Australia in

1999 and served as General Manager –

Australia following various roles with the group

in New Zealand. Chris holds a Bachelor

of Property from Auckland University.

Alex Belcastro

Senior Vice President –

Medical Precincts

(34, Sydney)

Alex Belcastro joined the team in April 2021,

prior to which she was the Chief Business

Development Officer at Ramsay Health Care,

where she managed a multi-billion-dollar

portfolio of 73 hospital assets in Australia.

Alex has over 13 years of specialised healthcare

real estate experience across the public and

private sectors, having been involved in over $8b

of hospital, laboratory, and research projects.

Alex holds a Master of Construction Management,

and a Bachelor of Planning and Design

(Property and Construction) from the University

of Melbourne. Alex has undertaken executive

education at Harvard Business School.

Our executive team

Vital’s executive team comprises real estate professionals with

extensive experience in New Zealand, Australia and beyond.

78

|

VITAL HEALTHCARE PROPERTY TRUST

Vanessa Flax
Regional General Counsel

A/NZ and Company Secretary

(51, Melbourne)

Vanessa Flax joined the team on 1 May 2019,

prior to which she was a special counsel at

Ashurst Australia. Vanessa has 25 years of deep

and broad ranging property law experience in

Australia and New Zealand, including acting (for

approximately 15 years) for Vital and NorthWest.

Vanessa's experience covers all aspects of real

property transactions, including acquisitions,

divestments and sales, leasing and Crown leasing,

development transactions and due diligence.

Michael Groth

Chief Financial Officer – A/NZ Region

(48, Melbourne)

Michael Groth is a qualified Chartered

Accountant, has over thirteen years’ experience

in senior finance roles in the listed and unlisted

property funds and funds management industry.

His most recent role has been as the Group Chief

Financial Officer of the Melbourne based and ASX

listed APN Property Group Limited (APN). APN is a

specialist real estate investment manager currently

managing 2 ASX listed and 10 unlisted funds, with

total Funds under Management of A$2.8bn.

Michael has over 5 years’ experience in

healthcare property funds management through

his involvement with Generation Healthcare REIT,

which was in the APN stable of funds before

it was privatised and delisted from the ASX.

Richard Roos

Executive Director – Portfolio

(57, Melbourne)

Richard Roos has over 20 years’ career

experience in commercial real estate financing,

acquisitions and property management, 14 years

of which have been in healthcare real estate.

In his role as Executive Director, Richard is

responsible along with his Melbourne and

Auckland-based teams for the asset management

of the NorthWest Group’s Australian and New

Zealand portfolio, including leasing and tenant

relationships, and joint responsibility for acquisitions

and business development. In particular, Richard’s

strong relationships with healthcare operators

are a crucial element of NorthWest’s success

in sustainability achieving its growth targets.

ANNUAL REPORT

|

79

Corporate governance
Joint Investment Policy

Under the terms of the Joint Investment Policy, which applies to

NWH REIT and its owned and controlled entities (including

the Manager), an Investment Committee has been established

to avoid, manage and resolve actual or perceived conflicts

of interests between members of the NWH REIT group in a

manner which complies with any relevant legal obligations

and is equitable to each party. The Joint Investment Policy

can be found on Vital’s website www.vhpt.co.nz.

The Board of Directors

The role of the Board of Directors is to set the strategic direction of

Vital and to support management in monitoring the delivery of this

against specific performance objectives. The Board also ensures

all business risks are appropriately identified and managed and

compliance with all applicable regulatory, statutory, financial,

health and safety and social responsibilities of the Manager.

Board composition

The Manager is committed to having an effective

Board providing a balance of independent skills,

knowledge, experience and perspectives.

All Directors bring a significant breadth and depth of expertise

and have the composite skills to optimise the financial and

portfolio performance of Vital and returns to Unit Holders.

Attendance at

Board meetings

Attended /

Eligible to attend

Date of appointment

Paul Dalla Lana6/616 January 2012

Andrew Evans

*

6/620 August 2007

Craig Mitchell6/629 June 2021

Michael Stanford6/619 November 2019

Graham Stuart6/612 November 2018

(Appointed Chair

17 November 2020)

Angela Bull1/126 April 2022

*

Retired 30 June 2022

The Board does not impose a restriction on the tenure

of any Director as it considers such a restriction may

lead to the loss of experience and expertise.

The table below shows all relevant interests of Directors

and Officers in units, which include legal and beneficial

interests in Vital units as at 30 June 2022.

DirectorsHoldings (number of

units) non-beneficial

Holdings (number

of units) beneficial

Paul Dalla Lana

1

-17 9 , 415 , 78 8

Andrew Evans78,234686,381

Graham Stuart-50,629

Officers

Aaron Hockly

2

-7 6 , 113

1

Paul Dalla Lana is the founder, Chairman, CEO, Trustee and largest Unit Holder of

NorthWest Healthcare Properties Real Estate Investment Trust (a trust organised under

the laws of Ontario, Canada, Corporation). NorthWest Healthcare Properties Real

Estate Investment Trust directly or indirectly holds approximately 179,415,788 units in

Vital Healthcare Property Trust, in respect of which Mr Dalla Lana is considered to

have a relevant interest.

2

Aaron Hockly makes a voluntary disclosure that members of his immediate family

own an additional 104,777 units in Vital.

Independent Directors

The Manager recognises that Independent Directors are important

in assuring Unit Holders that the Board is properly fulfilling

its role and is diligent in holding management accountable

for its performance. The procedures in place for determining

independence is whether the director is independent of

management and free of any business or other relationship

which might materially interfere with, or might reasonably

be perceived to materially interfere with, the exercise of

their independent judgement. Biographies of each Board

member including their skills, experience and expertise are

included in the Board of Directors section on pages 77-78.

Audit Committee

The Audit Committee is responsible for overseeing

the financial and reporting practices of Vital.

At financial year end and at the date of this report,

the Audit Committee assists the Board in fulfilling its

corporate governance and disclosure responsibilities with

particular reference to financial matters, and internal and

external audit, and is specifically responsible for:

• Recommending to the Board the appointment /

removal of Vital’s external auditor; and

• Reviewing the performance of the external auditor.

Vital Healthcare Property Trust and NorthWest Healthcare Properties Management Limited.

Dated as at 30 June 2022

80

|

VITAL HEALTHCARE PROPERTY TRUST

Attendance at Audit
Committee meetings

Attended /

Eligible to attend

Date of appointment

Paul Dalla Lana4/46 October 2020

Andrew Evans

*

4/414 November 2011

Craig Mitchell4/429 June 2021

Michael Stanford4/46 October 2020

Graham Stuart4/49 May 2019

Angela Bull0/126 April 2022

*

Retired 30 June 2022

Management contract

NorthWest manages Vital in accordance with Vital’s Trust

Deed in return for which NorthWest receives management

fees. From these management fees, NorthWest pays salaries

and other people related costs (including taxes, rent, IT, travel

and training) to its employees approximately 30 of whom are

solely or majority engaged with managing Vital, as well as the

Directors not appointed by all Unit Holders (four at the date of this

report). As a result, the details in this section relate to NorthWest’s

employees rather than Vital’s employees (as there are none).

Remuneration

As noted above, Vital does not have any direct employees.

Instead, NorthWest receives management fees to manage

Vital from which it provides remuneration to employees. As a

result, there is no reporting on individual employee salaries.

Notwithstanding the above, the following is

provided to enhance transparency:

1. Details of the holdings in Vital by Directors and officers as

at 30 June 2022 is provided on the previous page.

2. As at the date of this report, all New Zealand based

Directors and executives own units. Currently the tax

regime for Vital makes it uneconomic for the offshore

based Directors and officers to hold units in Vital.

3. As at the date of this report, Vital’s most senior executive

officer, Fund Manager Aaron Hockly, holds units in Vital

equivalent to more than 50% of his base salary.

4. Details of the costs of Independent Directors appointed

by Unit Holders and, as a result, paid for from Vital are

included in note 22 to the accounts in this report.

5. Over two thirds of the Fund Manager’s annual potential

bonus, and over 1/6th of other key personnel, directly relates

to the performance of Vital. In addition, all NorthWest’s

executive bonuses globally are linked to NorthWest’s unit

price as 100% of these bonuses are paid in NorthWest units.

Vital represents approximately 27% of NorthWest’s assets

under management and 10% of its assets on balance sheet

(accounting for its 26% stake in Vital). As a result, NorthWest

REIT’s investment in Vital is material to the REIT and, accordingly

all executive remuneration is aligned with Vital’s success.

6. The following clawback / malus provisions are included in the

bonus plans for all NorthWest executives globally (including

Vital’s Fund Manager, CFO and other key personnel):

• Where the Participant (i) has been terminated for cause, or

(ii) voluntarily resigns from his or her position with the Trust then

any Deferred Units granted on a discretionary basis pursuant

to Section 7.04 of the NorthWest Healthcare Properties Real

Estate Investment Trust Deferred Unit Plan (2018) which have not

yet vested at the time of the termination for cause or voluntary

resignation, shall be immediately forfeited by such Participant.

Directors’ remuneration

Paid in FY22*

DirectorBase

Audit

Committee

Member

ChairTotal

Andrew Evans

**


Independent Director and

Audit Committee member

NZ$80KNZ$10K-NZ$90K

Angela Bull

Independent Director

and Audit Committee

member

1,3

NZ$90KNZ$10K-NZ$100K

Craig Mitchell

Director and Audit

Committee member

N/A

2

---

Graham Stuart

Independent Director,

Board Chair and Audit

Committee member

NZ$90KNZ$10KNZ$70K

(Board)

NZ$170K

Michael Stanford

Independent Director and

Audit Committee Chair

3

A$90K-A$20K

(Audit

Committee)

A$110K

Paul Dalla Lana

Director and Audit

Committee member

N/A

2

---

Total

NZ$470K

(NZ$260K paid by Unit Holders, and

$210K paid by the Manager)

a) Leasing

Vital pays the Manager leasing fees where the Manager

has negotiated leases instead of or alongside a real

estate agent. Consistent with general market rates, these

fees are charged at 11% of the annual rental for terms

of three years or less (to a minimum of $2,500).

12% of the annual rental for terms of three years, and

12% plus an additional 1% for each year greater

than three years (to a maximum of 20%).

Lease renewals are charged at 50% of a new lease.

*

Fees are pro rata

**

Retired 30 June 2022


1

Appointed 26 April 2022.

2

Executive of NorthWest paid by the Manager. Accordingly, no separate directors’ fees

are payable.

3

Paid by the Manager from management fees. All other amounts listed are paid by the Trust.

ANNUAL REPORT

|

81

Structured rent reviews or market reviews which do not
result in a rental increase are charged an administration

fee of $1,000. Open market reviews are charged at

10% of the rental increase achieved in the first year.

Leasing fees are capitalised to the respective investment or

development property in the Statement of Financial Position

and amortised over the term of the life of the lease.

b) Property management

Vital pays the Manager property management fees

where the Manager acts as the property manager.

Incentive fee

The incentive fee is an amount equal to 10% of the average

annual increase in the Net Tangible Assets of Vital over the

relevant financial year and two preceding financial years

subject to a three year high-water mark. The Manager and

the Supervisor are both entitled to be reimbursed out of the

Trust Fund for all expenses, costs or liabilities incurred by

them respectively in acting as Manager and Supervisor.

Insurance and indemnities

In accordance with the Board Charter, the Manager has

provided insurance and indemnities to its Directors and officers

for any liability / losses arising in respect of actions or omissions

occurring during the normal carrying out of their duties.

Health and safety

The Directors and Manager are committed to ensuring

that as far as practical, a safe and healthy working

environment is provided for all employees, tenants,

contractors and others who may visit our properties.

The Trust’s Health and Safety policy aims to reflect this commitment.

Vital and the Manager have implemented site specific hazard

registers in New Zealand which can be updated in real time and

similar processes apply in Australia. The Manager has implemented

an Operational Risk and Compliance Committee which meets on

a regular basis and a standing agenda item is Health and Safety.

Board diversity and relevant skills

At a Board level, diversity of experience is critical to ensure a

healthy exchange of ideas and opinions to deliver higher quality

decision making and outcomes. All Board appointments are always

based on merit and diversity (including gender and ethnicity).

A majority of the Directors are members of professional

organisations such as the Institute of Directors (or equivalent) or

other industry specific and relevant organisations which support

the ongoing education and training of professional directors.

Healthcare real estate is a specialised sector and the Board

believes it is important to have members with a diverse range

of backgrounds, skills and experience to ensure robust

discussion. It is also important to balance skills and knowledge

gained through length of tenure and the value of fresh ideas

in decision making. The table below summarises the skills,

experience and length of service of the current Board.

Modern slavery

In FY21, the Australian manager of the Vital trusts, NorthWest

Healthcare Australian Property Limited again published a

statement under the Australian Modern Slavery Act 2018,

which underpinned Vital’s philosophical approach and

commitment to ensuring our operations have sufficient risk

mitigation strategies to address supply-chain risks. Vital

committed to training employees to identify these risks.

Our entire organisation has engaged with tenants and suppliers

to conduct further and ongoing due diligence to identity possible

modern slavery supply chain risks. Vital will continue to assess

the potential modern slavery risks in our operations and develop

and review company policies on these possible impacts.

We have also committed to reviewing supplier contracts to ensure

they contain terms consistent with the principles underlying the Act.

Skills & ExperienceGraham

Stuart

Angela

Bull

Paul

Dalla Lana

Andrew

Evans

1

Craig

Mitchell

Michael

Stanford

Accounting/finance/economics ● ● ● ● ● ●•••••

Commercial real estate /asset

management/valuation

•••••

Corporate governance ••••••

Legal / regulatory••••

Healthcare practitioner•

Tenure (years)4<1111513

1

Retired on 30 June 2022

82

|

VITAL HEALTHCARE PROPERTY TRUST

ReferenceRecommendationApproach
Principle 1 – Code of ethical behaviour

1.1

The board should document minimum standards of ethical

behaviour to which the issuer’s directors and employees

are expected to adhere (a code of ethics).

The code of ethics and where to find it should be

communicated to the issuer’s employees. Training should

be provided regularly. The standards may be contained

in a single policy document or more than one policy.

The code of ethics should outline internal reporting procedures

for any breach of ethics, and describe the issuer’s expectations

about behaviour, namely that every director and employee:

a. acts honestly and with personal integrity in all actions;

b. declares conflicts of interest and proactively

advises of any potential conflicts;

c. undertakes proper receipt and use of corporate

information, assets and property;

d. in the case of directors, gives proper

attention to the matters before them;

e. acts honestly and in the best interests of the issuer,

shareholders and stakeholders and as required by law;

f. adheres to any procedures around giving and

receiving gifts (for example, where gifts are given

that are of value in order to influence employees and

directors, such gifts should not be accepted);

g. adheres to any procedures about whistle blowing (for

example, where actions of a whistle blower have complied

with the issuer’s procedures, an issuer should protect and

support them, whether or not action is taken); and

h. manages breaches of the code

In recognition of Vital’s role in the communities in which

we operate, and where our investors live, we continue

to implement and refine policies and practices which

encourage responsible investment practices and

compliance with all legal and regulatory requirements.

All Vital Directors and employees must abide by Vital’s Code of

Conduct and Business Ethics (refreshed in August 2021), which

documents policies on conflicts of interest, fair dealing, compliance

with applicable laws and regulations, maintaining confidentiality of

information, dealing with Vital’s assets and use of Vital’s information.

The Code recognises the importance of a work environment

which actively promotes best practice and does not compromise

business ethics or principles, and the Code’s purpose is to

uphold the highest ethical standards, acting in good faith

and in the best interests of Unit Holders at all times.

Employees, where appropriate, are provided with regular

training, updates and insights in relation to governance.

The Code of Conduct and Business Ethics is supplemented by

a number of other policies including the Joint Investment Policy

and Whistleblower Policy which are available on the website

at https://www.vitalhealthcareproperty.co.nz/governance/.

1.2

An issuer should have a financial product dealing

policy which applies to employees and directors

The Manager’s Directors, officers and employees, their families

and related parties must comply with the Security Trading Policy.

The Manager is committed to ensuring compliance with legal and

regulatory requirements with respect to insider trading and restricted

persons trading. To assist with such compliance, the Manager’s

Security Trading Policy identifies circumstances where directors,

officers and other restricted persons are permitted to trade or are

prohibited from trading units in Vital. Compliance with these policies

is monitored by the Board. In addition, all trading by Directors

and officers of the Manager is required to be reported to NZX

in accordance with the Financial Markets Conduct Act 2013. The

holdings of Directors of the Manager are disclosed on page 80.

Before trading of Vital units a restricted person must get consent

in writing from the Fund Manager or the Chief Financial

Officer of the Manager. Vital has set black-out periods

for directors and staff throughout the year. Also, blackout

periods can be invoked when specific events occur.

Emails are periodically sent to directors and employees

providing information as to the status of the trading

window in relation to the blackout periods.

The Security Trading Policy can be found on Vital’s website at

https://www.vitalhealthcareproperty.co.nz/governance/.

NZX Corporate Governance Code

The NZX Corporate Governance Code (NZX Code) applies to all

issuers of Equity Securities listed on the NZX Main Board. The NZX

Corporate Governance Code does not apply to Vital Healthcare

Properties Trust (Vital), as it is an Issuer of Fund Securities under the

NZX Listing Rules.

Notwithstanding the foregoing, the Board of NorthWest Healthcare

Properties Management Limited (Manager) considers it important

from a governance perspective to identify how, as at 30 June

2022, Vital and the Manager comply with the NZX Code dated 10

December 2020.

The NZX Code is structured around eight principles. The table sets

out each principle and an explanation as to if, and how, Vital and

the Manager comply with the recommendations in the NZX Code.

ANNUAL REPORT

|

83

ReferenceRecommendationApproach
Principle 2 – Board composition and performance

2 .1

The board of an issuer should operate under

a written charter which sets out the roles

and responsibilities of the board. The board

charter should clearly distinguish and disclose

the respective roles and responsibilities

of the board and management.

The Board has adopted a formal Board Charter which is available on Vital’s

website at https://www.vitalhealthcareproperty.co.nz/governance/.

The Charter sets out the roles and responsibilities of the Board,

including in relation to distinguishing between the respective roles

and responsibilities of the Board and management.

The terms of a Director’s appointment are contained in the Board Charter. The

Charter reaffirms Directors must comply with their duties as set out in the Companies

Act 1993, including to act in good faith, together with other duties which include

(but are not limited to) conducting themselves in an appropriate manner.

The Board’s specific responsibilities include approving the Manager’s strategic objectives,

including those applicable to Vital and ensuring that effective risk management

procedures for the Manager and Vital are in place and are being observed.

2.2

Every issuer should have a procedure

for the nomination and appointment

of directors to the board.

Vital partially complies with this recommendation as the process for

appointment of directors is different for a listed managed investment scheme.

Vital is a trust and does not have directors. Its supervisor is Trustees Executors

Limited, which is also the trustee of the Vital Healthcare Property Trust.

The Manager has a Board of Directors, which, subject to the below, is

appointed by its sole shareholder, NWI Healthcare Properties LP.

Two Independent Directors are appointed to the Manager’s Board by Unit

Holders in the manner described in the Trust Deed. A copy of the Trust Deed

is available on Vital’s website and also on the Disclose Register through the

Companies Office https://companies-register.companiesoffice.govt.nz/.

Unit Holders have the opportunity to appoint two of the Independent Directors of

the Manager. Unit Holders are able to nominate and vote on one Independent

Director of the Manager each year. The nominee receiving the most votes will

be approved as a Director of the Manager by the Manager’s shareholders.

2.3

An issuer should enter into written agreements

with each newly appointed director

establishing the terms of their appointment.

The Manager enters into a written agreement with each newly appointed director

setting out the terms of their appointment, including expectations of the director in his

or her role, remuneration entitlements and indemnity and insurance arrangements.

2.4

Every issuer should disclose information about

each director in its annual report or on its website,

including a profile of experience, length of

service, independence and ownership interests.

Vital’s Annual Report includes a profile of experience, length of service,

independence and ownership interest of each director.

2.5

An issuer should have a written diversity policy

which includes requirements for the board or a

relevant committee of the board to set measurable

objectives for achieving diversity (which, at a

minimum, should address gender diversity) and

to assess annually both the objectives and the

entity’s progress in achieving them. The issuer

should disclose the policy or a summary of it.

A breakdown of the Manager’s staff specific diversity is included in the Annual Report.

2.6

Directors should undertake appropriate

training to remain current on how to best

perform their duties as directors of an issuer.

Directors are encouraged to maintain and enhance their skills and capabilities

through ongoing professional development to be undertaken to satisfy the

membership requirements of their respective institutes, including the Institute

of Directors, New Zealand. The Manager also seeks to provide additional

appropriate training relevant to their role as a Director of Vital.

2.7

The board should have a procedure to regularly

assess director, board and committee performance.

Assessment of the Board and each director’s performance is determined by the Chair

and takes into account overall attendance, contribution, training and experience of each

member concerned. In 2021 the Manager conducted a director self-assessment process

and proposes conducting an externally managed self-assessment process in 2022.

2.8

A majority of the board should

be independent directors.

The Board of the Manager is comprised of a majority of independent directors.

2.9

An issuer should have an independent chair of

the board. If the chair is not independent, the

chair and the CEO should be different people.

The Board of the Manager is chaired by an Independent Director.

Principle 3 – Board committees

3 .1

An issuer’s audit committee should operate

under a written charter. Membership on the

audit committee should be majority independent

and comprise solely of non-executive directors

of the issuer. The chair of the audit committee

should not also be the chair of the board.

The Board has adopted a formal written Audit Committee Charter which is available

on Vital’s website at https://www.vitalhealthcareproperty.co.nz/governance/.

The minimum number of members on the Audit Committee is three members who must be

Directors and at least one member must have an accounting or financial background.

The audit committee of the Manager is majority independent but otherwise

comprises the whole Board. The Chair of the audit committee is an independent

director and is not the same person as the Chair of the Board.

3.2

Employees should only attend audit committee

meetings at the invitation of the audit committee.

Management and other employees may attend an audit committee meeting on invitation.

84

|

VITAL HEALTHCARE PROPERTY TRUST

ReferenceRecommendationApproach
3.3

An issuer should have a remuneration committee

which operates under a written charter (unless

this is carried out by the whole board). At least

a majority of the remuneration committee should

be independent directors. Management should

only attend remuneration committee meetings at

the invitation of the remuneration committee.

A key feature of the external management structure under which Vital operates is that

remuneration of management is the responsibility of the Manager, not Vital. As Vital

Unit Holders are not economically exposed to employment remuneration costs, a

remuneration committee is not considered necessary by the Board at this time.

3.4

An issuer should establish a nomination committee

to recommend director appointments to the

board (unless this is carried out by the whole

board), which should operate under a written

charter. At least a majority of the nomination

committee should be independent directors.

Vital does not have a nomination committee and does not comply

with this recommendation. Given its structure and the terms of the

Trust Deed, the process for nomination of directors to the Board of

the Manager is not the same as for a listed company.

3.5

An issuer should consider whether it is appropriate

to have any other board committees as standing

board committees. All committees should

operate under written charters. An issuer should

identify the members of each of its committees,

and periodically report member attendance.

From time to time the Board establishes Due Diligence Committees (DDC) to report on

the due diligence process in relation to any potential transaction for Vital of material

size or complexity. An example would be the recent capital raisings undertaken by

Vital. A DDC will normally comprise an independent director, executive director,

relevant management staff and external consultants appropriate for the transaction.

3.6

The board should establish appropriate protocols

that set out the procedure to be followed if

there is a takeover offer for the issuer including

any communication between insiders and

the bidder. It should disclose the scope of

independent advisory reports to shareholders.

These protocols should include the option of

establishing an independent takeover committee,

and the likely composition and implementation

of an independent takeover committee.

The Takeovers Code does not apply to Vital, as a listed managed

investment scheme. Vital’s Trust Deed includes some provisions which

would regulate takeover-like transactions relating to units in Vital.

As a result of the above, the Board of the Manager has not established protocols

that set out the procedure to be followed if a takeover offer is received.

Principle 4 – Reporting and disclosure

4 .1

An issuer’s board should have a written

continuous disclosure policy.

It is important that the market and investors feel confident in the timing or manner

of any buying or selling of Vital units. As a NZX issuer, the Manager is acutely

aware of the need to ensure the market, investors and regulators remain fully

informed of any material or price sensitive information relevant to Vital. The Board

and all management employees are aware of the NZX Continuous Disclosure

requirements and Vital has internal procedures in place to ensure compliance.

The Continuous Disclosure Policy can be found on Vital’s

website at https://www.vitalhealthcareproperty.co.nz/app/

uploads/2021/09/210927-Continuous-Disclosure-Policy.pdf.

4.2

An issuer should make its code of ethics, board and

committee charters and the policies recommended

in the NZX Code, together with any other key

governance documents, available on its website.

A copy of all relevant policies noted in this document can be viewed on Vital’s website.

4.3

Financial reporting should be balanced, clear

and objective. An issuer should provide non-

financial disclosure at least annually, including

considering environmental, economic and

social sustainability factors and practices. It

should explain how operational or non-financial

targets are measured. Non-financial reporting

should be informative, include forward looking

assessments, and align with key strategies

and metrics monitored by the board.

Vital’s Annual Report includes non-financial disclosures, including environmental,

economic and social sustainability factors and practices. The Manager

maintains and regularly reviews a risk management framework as part of

its compliance assurance programme. Reports are provided to both the

Audit Committee and Board along with an annual risk assessment.

Principle 5 – Remuneration

5 .1

An issuer should recommend director remuneration

to shareholders for approval in a transparent

manner. Actual director remuneration should be

clearly disclosed in the issuer’s annual report.

Vital is a trust and does not have directors. Subject to the below, the

remuneration costs of the Manager’s directors are borne by the Manager. As

a result, Vital Unit Holders are not economically exposed to those costs.

Vital’s Trust Deed provides that the costs associated with the two Independent Directors

appointed to the Board of the Manager by Unit Holders are reimbursed out of the

trust fund. Refer to page 81 of this Annual Report for details of Director remuneration.

5.2

An issuer should have a remuneration policy for

remuneration of directors and officers, which

outlines the relative weightings of remuneration

components and relevant performance criteria.

As noted above, all officers and some Directors’ remuneration is paid by the

Manager not Vital. Any Directors paid by Vital are paid a flat fee for each

service provided (currently a base director fee and additional fees for being the

Chair, Audit Committee Chair and / or Audit Committee Member. Such fees are

market based by reference to other NZX listed entities; this is assessed annually.

Accordingly, the Board considers that it is unnecessary for Vital to maintain a

remuneration policy. As a result, Vital does not comply with this recommendation.

ANNUAL REPORT

|

85

ReferenceRecommendationApproach
5.3

An issuer should disclose the remuneration arrangements

in place for the CEO in its annual report. This should

include disclosure of the base salary, short term incentives

and long term incentives and the performance criteria

used to determine performance based payments.

Vital does not have any employees as it is externally managed by the

Manager. The remuneration of the Fund Manager (CEO equivalent) is

not paid by Vital. The remuneration is paid by the Manager or its related

parties. Accordingly, Vital does not comply with this recommendation.

Principle 6 – Risk management

6 .1

An issuer should have a risk management framework for its

business and the issuer’s board should receive and review

regular reports. An issuer should report the material risks

facing the business and how these are being managed

The Board of Directors maintains a sound understanding of key risks faced

by Vital. Effective management of all financial and nonfinancial risks is

fundamental to the delivery of the Board’s strategy. In addition, the Manager

will engage other external advisers as appropriate to deal with specific risks.

The Manager has a risk management framework that is integrated

into day-to-day operations. As part of this framework, the Board and

Audit Committee work closely with management and external auditors

to support the identification, management and reporting of risks.

This risk management framework is part of Vital’s compliance

assurance requirements under the FMCA. Higher risk groups are

reviewed yearly with lower risk groups reviewed biennially. The

risk management framework/Compliance Assurance Programme

is reviewed on an annual basis and approved by the Board.

6.2

An issuer should disclose how it manages its health

and safety risks and should report on their health

and safety risks, performance and management

The Manager has implemented a site-specific hazard register which can

be updated in real time. The Manager works alongside tenants, suppliers

and contractors to assist in providing a safe working environment. The

Manager has implemented an Operational Risk Committee that meets

once a month to review health and safety and risk management systems.

Health and safety is a standing item on the agenda for Board meetings.

Principle 7 – Auditors

7.1

The board should establish a framework

for the issuer’s relationship with its external

auditors. This should include procedures:

(a) for sustaining communication with

the issuer’s external auditors;

(b) to ensure that the ability of the external auditors to

carry out their statutory audit role is not impaired, or

could reasonably be perceived to be impaired;

(c) to address what, if any, services (whether by type

or level) other than their statutory audit roles may

be provided by the auditors to the issuer; and

(d) to provide for the monitoring and approval by the issuer’s

audit committee of any service provided by the external

auditors to the issuer other than in their statutory audit role.

The Board has established an Audit Committee with a majority of independent

directors. A copy of the Audit Committee Charter can be found on Vital’s

website https://www.vitalhealthcareproperty.co.nz/governance/.

The Audit Committee Charter sets out the procedures to be

followed to ensure the independence of the Trust’s external

auditor. The Audit Committee is responsible for recommending the

appointment of the external auditor and maintaining procedures

for the rotation of the external audit engagement partner.

Under the Audit Committee Charter, the external audit engagement

partner must be rotated at least every five years.

The Audit Committee Charter covers provision of non-audit services with

the general principle being that the external auditor should not have any

involvement in the production of financial information or preparation of financial

statements such that they might be perceived to be auditing their own work.

The Board facilitates regular and full dialogue between its Audit Committee, the

external auditors and management as reflected in the Audit Committee charter.

7. 2

The external auditor should attend the issuer’s

Annual Meeting to answer questions from

shareholders in relation to the audit.

To maximise the effectiveness of communication at the Annual Meeting, the

Manager also requires its external auditors to attend the meeting and be

prepared to answer Unit Holders’ questions about the conduct of the audit,

as well as the preparation and content of the independent auditor’s report.

Vital undertakes an annual audit engagement with its external auditor. As

part of the process the Audit Committee identifies any key areas of focus

and reporting required of the auditors. Management is required to attend

the meeting to discuss the findings of the report and respond to queries.

Any recommendationsfor improvement are discussed and management

is required to agree a timetable for the implementation of the changes.

7. 3

Internal audit functions should be disclosed.Following careful consideration and recommendation from the Audit

Committee, the Board appointed the firm of Deloitte as the Trust’s

statutory external auditor. The firm of KPMG has been appointed as

the auditor of the Manager. Ernst & Young has been appointed as

the global internal auditor by the Manager’s ultimate parent.

No separate internal audit function is currently in place noting that

Vital has a Supervisor in place who undertake assurance functions

on behalf of Unit Holders including in relation to management

fees and conduct and the Manager is audited by KPMG.

86

|

VITAL HEALTHCARE PROPERTY TRUST

ReferenceRecommendationApproach
Principle 8 – Shareholder rights and relations

8 .1

An issuer should have a website where investors

and interested stakeholders can access financial

and operational information and key corporate

governance information about the issuer.

Vital’s website www.vhpt.co.nz enables Unit Holders to access

financial and operational information and key corporate governance

information about Vital. The website’s allows key stakeholders

to access and navigate important information with ease.

8.2

An issuer should allow investors the ability to easily

communicate with the issuer, including providing the option

to receive communications from the issuer electronically.

A key focus of investor relations is to ensure the market and

investors are informed of all details necessary to assess their

investment and Vital’s performance as specified by NZX Listing

Rules. The Board aims to foster constructive communications

and encourages all stakeholders to engage with Vital.

A key element of corporate communication is the Trust’s website at www.

vhpt.co.nz. Vital’s website was recently refreshed and updated to make it

easier for Unit Holders to locate and understand key information. The website

enables all existing and potential Unit Holder to view information including:

an overview of the business and corporate structure, a history of financial

and investment performance, key calendar dates and the ability to access

and download all NZX announcements, presentations and investor forms.

The website also includes key corporate governance documents

including the Board Charter, Statement of Investment Policies and

Objectives (SIPO) and other key policy documentation.

The Manager also actively encourages engagement

through a communication strategy which includes:

• The Annual Meeting for the Unit Holders to meet with and ask questions

of the Board, the Supervisor, management and external auditors;

• Any other meetings called to obtain approval for

the Manager’s action as appropriate;

• Results webcasting providing all investors with the ability

to listen and ask questions of Management; and

• Various investor communications including Annual and Interim Reports.

Through Vital’s external registrar investors have the ability to easily communicate

with the issuer, including providing the option to receive communications from

the issuer electronically. There is a NZ toll free number 0800 225 264 and

email address enquiry@vhpt.co.nz to which general enquiries can be directed.

8.3

Quoted equity security holders should have the right

to vote on any major decisions which may change

the nature of the issuer in which they are invested.

Terms of Vital’s Trust Deed and the FMCA set out requirements under

which the Manager must obtain the approval of Unit Holders.

As a managed investment scheme regulated by the FMCA, investment

objectives, investment philosophy, investment strategy and categories of

authorised investments are required to be set out in a Statement of Investment

Policy and Objectives (SIPO). A copy of Vital’s SIPO is available here:

https://www.vitalhealthcareproperty.co.nz/app/

uploads/2021/02/SIPO_Vital_New.pdf

Changes to the SIPO may only be made in accordance

with section 165 of the FMCA after having given written

notice to Vital’s supervisor, Trustees Executors Limited.

8.4

If seeking additional equity capital, issuers of quoted

equity securities should offer further equity securities to

existing equity security holder of the same class on a

pro rata basis, and on no less favourable terms, before

further equity securities are offered to other investors.

Vital’s most recent equity capital raising was implemented in April

and May 2022 as an accelerated entitlement offer. Eligible Unit

Holders were entitled to subscribe for 1 new unit for every 8.54 units

held at the record date. This structure allowed existing Unit Holders to

participate on a pro rata basis, on no less favourable terms (subject to

certain exceptions, like for Unit Holders outside New Zealand).

Previous equity capital raisings completed in 2020 and 2021 were

structured as a combination of a non-pro rata placement and a Unit

Holder purchase plan and were undertaken as close to a pro-rata

structure as practicable in accordance with the Board approved allocation

policy. The Board of the Manager considers a range of factors when

assessing capital raising options. Those factors include the interests of

existing Unit Holders, cost of capital and register composition.

8.5

The board should ensure that the notices of annual

or special meetings of quoted equity security holders

is posted on the issuer’s website as soon as possible

and at least 20 days prior to the meeting.

Under Vital’s Trust Deed at least 14 days’ notice is required for notices

of meeting to be sent by post. Vital will continue to follow the Trust Deed

when determining the period of notice to be given. Having said that, the

Notices of Meeting for Vital’s annual meeting in 2020 and 2021 were

provided at least 20 days prior to the meeting, as was the Notice of

Meeting for the special meeting of Unit Holders held in 2021. The notice

of meeting is released on the NZX and included on our website.

ANNUAL REPORT

|

87

Financial
statements

88

|

VITAL HEALTHCARE PROPERTY TRUST

ANNUAL REPORT 2022|89
Contents

Consolidated Statement of Comprehensive Income90

Consolidated Statement of Financial Position91

Consolidated Statement of Changes in Equity92

Consolidated Statement of Cash Flows93

Notes to the Consolidated Financial Statements94

ABOUT THIS REPORT94

1. Reporting Entity 94

2. Basis of Preparation94

3. Significant Accounting Policies96

PERFORMANCE97

4. Segment Information 97

5. Taxation99

6. Investment Properties 102

7. Other Expenses110

CAPITAL STRUCTURE, FINANCING AND RISK MANAGEMENT111

8. Units on Issue111

9. Earnings per Unit112

10. Distributable Income 113

11. Borrowings114

12. Lease Liabilities 116

13. Derivative Financial Instruments116

14. Financial and Risk Management 118

15. Commitments and Contingencies 123

EFFICIENCY OF OPERATIONS124

16. Statement of Cash Flows Reconciliation from Operating Activities124

17. Trade and Other Receivables125

18. Other Assets126

19. Trade and Other Payables126

OTHER NOTES127

20. Investment in Subsidiaries 127

21. Subsequent Events 127

22. Related Party Transactions 127

90|VITAL HEALTHCARE PROPERTY TRUST
Consolidated Statement of

Comprehensive Income

For the year ended 30 June 2022

Note

2022

$000s

2021

$000s

Gross property income from rentals127,397113,622

Gross property income from expense recoveries16,23612,522

Property expenses(20,615)(16,481)

Net property income4123,018109,663

Other expenses7(37,235)(30,915)

Strategic transaction expenses(283)-

Finance income21235

Finance expense11.b(29,195)(27,719)

Operating profit56,51751,064

Other gains/(losses)

Revaluation gain on investment property6.a244,239235,383

Net gain/(loss) on disposal of investment property6.a70011,310

Fair value gain/(loss) on foreign exchange derivatives(664)280

Fair value gain/(loss) on interest rate derivatives61,46822,375

Realised gain/(loss) on foreign exchange(11)(4,399)

Unrealised gain/(loss) on foreign exchange262,454

305,758267,403

Profit before income tax362,275318,467

Taxation expense5(58,753)(40,075)

Profit for the year attributable to unit holders of the Trust303,522278,392

Other comprehensive income

Items that may be reclassified subsequently to profit and loss:

Movement in foreign currency translation reserve36,5561,711

Realised foreign exchange gain/(loss) on hedges14.e-46,613

Current taxation (expense)/credit338(6,921)

Fair value gain/(loss) on net investment hedges14.e-(46,352)

Deferred taxation (expense)/credit-7,074

Total other comprehensive income/(loss) after tax36,8942,125

Total comprehensive income after tax340,416280,517

Earnings per unit

Basic and diluted earnings per unit (cents)953.3355.91

The notes on pages 94 to 131 form part of and are to be read in conjunction with these financial statements.

ANNUAL REPORT 2022|91
Consolidated Statement of

Financial Position

As at 30 June 2022

Note

2022

$000s

2021

$000s

Non-current assets

Investment properties63,339,1692,634,588

Derivative financial instruments1320,692-

Deferred tax5-6,477

Total non-current assets3,359,8612,641,065

Current assets

Cash and cash equivalents1622,0556,880

Trade and other receivables172,4421,634

Other current assets1815,45112,736

Derivative financial instruments1325245

Total current assets39,97321,495

Total assets3,399,8342,662,560

Unit holders' funds

Units on issue81,150,881777,199

Reserves44,5904,208

Retained earnings970,405722,044

Total unit holders' funds2,165,8761,503,451

Non-current liabilities

Borrowings111,012,952814,895

Lease liability - ground lease123,9034,094

Derivative financial instruments1315040,379

Deferred tax5178,316129,361

Total non-current liabilities1,195,321988,729

Current liabilities

Trade and other payables1931,94641,005

Income in advance621854

Derivative financial instruments13535640

Lease liability - ground lease12170142

Taxation payable5,36513,334

Borrowings11-114,405

Total current liabilities38,637170,380

Total liabilities1,233,9581,159,109

Total unit holders' funds and liabilities3,399,8342,662,560

For and on behalf of the Manager, NorthWest Healthcare Properties Management Limited

G Stuart, Independent Chair

11 August 2022

M Stanford,

Independent Director

The notes on pages 94 to 131 form part of and are to be read in conjunction with these financial statements.

92|VITAL HEALTHCARE PROPERTY TRUST
Consolidated Statement of

Changes in Equity

For the year ended 30 June 2022

Units on

issue

$000s

Retained

earnings

$000s

Translation

of foreign

operations

$000s

Foreign

exchange

hedges

$000s

Share

based

payments

$000s

Total

unit

holders'

funds

$000s

For the year ended 30 June 2021

Balance at the start of the period594,752488,096(73,003)62,6596,4751,078,979

Changes in unit holders' funds182,447---(6,475)175,972

Manager's incentive fee----12,42712,427

Profit for the period-278,392---278,392

Distributions to unit holders-(44,444)---(44,444)

Other comprehensive income for the period

Movement in foreign currency translation reserve--1,711--1,711

Realised foreign exchange gains on hedges---39,692-39,692

Fair value gains on net investment hedges---(39,278)-(39,278)

Balance at the end of the year777,199722,044(71,292)63,07312,4271,503,451

For the year ended 30 June 2022

Balance at the start of the period777,199722,044(71,292)63,07312,4271,503,451

Changes in unit holders' funds373,682---(12,427)361,255

Manager's incentive fee----15,91515,915

Profit for the period-303,522---303,522

Distributions to unit holders-(55,161)---(55,161)

Other comprehensive income for the period

Movement in foreign currency translation reserve--36,556--36,556

Realised foreign exchange gains on hedges---338-338

Balance at the end of the year1,150,881970,405(34,736)63,41115,9152,165,876

The notes on pages 94 to 131 form part of and are to be read in conjunction with these financial statements.

ANNUAL REPORT 2022|93
Consolidated Statement of

Cash Flows

For the year ended 30 June 2022

Note

2022

$000s

2021

$000s

Cash flows from operating activities

Property income126,517118,196

Recovery of property expenses15,93411,814

Interest received21235

Property expenses(18,762)(13,139)

Management and trustee fees(17,478)(14,610)

Interest paid(26,514)(28,089)

Tax paid(15,849)(13,776)

Other trust expenses(3,573)(3,855)

Net cash provided by/(used in) operating activities1660,48756,576

Cash flows from investing activities

Receipts from foreign exchange derivatives5041,296

Capital additions on investment properties(137,780)(147,586)

Purchase of properties(299,858)(242,784)

Deposits and acquisiton costs paid – Investment Property(10,178)(2,539)

Proceeds from disposal of properties14,35599,056

Tenant fitout reimbursement proceeds31,527-

Payments for foreign exchange derivatives(506)(2,026)

Strategic transaction expenses(283)(925)

Net cash provided by/(used in) investing activities(402,219)(295,508)

Cash flows from financing activities

Debt drawdown835,1151,204,354

Repayment of debt(780,338)(1,092,839)

Issue of units342,817159,652

Loan issue costs(3,963)(2,523)

Costs associated with new equity raised(5,353)(2,637)

Distributions paid to unit holders(31,371)(25,460)

Net cash from/(used in) financing activities356,907240,547

Net increase/(decrease) in cash and cash equivalents15,1751,615

Cash and cash equivalents at the beginning of the period6,8805,265

Cash and cash equivalents at the end of the year22,0556,880

The notes on pages 94 to 131 form part of and are to be read in conjunction with these financial statements.

94|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements

About this Report

1. Reporting Entity


Vital Healthcare Property Trust (“VHP” or the “Trust”) is a unit trust established under the Unit Trusts Act 1960 by a Trust Deed dated

11 February 1994 (as subsequently amended and replaced), domiciled in New Zealand. The Trust is managed by NorthWest Healthcare

Properties Management Limited (the “Manager”), with its registered office at Level 17, HSBC Tower, 188 Quay Street, Auckland

Central 1010.

The consolidated financial statements of VHP for the year ended 30 June 2022 comprise VHP and its subsidiaries (together referred to as

the “Group”). VHP is listed on the New Zealand Stock Exchange (NZX) and is a FMC reporting entity for the purpose of the Financial

Markets Conduct Act 2013. The Group's principal activity is direct and/or indirect investments in healthcare real estate.

These consolidated financial statements were approved by the Board of Directors of the Manager on 11 August 2022.

2.

 Basis of Preparation

(a) Statement of compliance

These financial statements have been prepared in accordance with Generally Accepted Accounting Practice in New Zealand (NZ GAAP)

and comply with New Zealand equivalents to International Financial Reporting Standards (NZ IFRS) and other applicable Financial

Reporting Standards, as appropriate for

profit-oriented entities. Accordingly these financial statements comply with International Financial

Reporting Standards (IFRS).

(b)

 Basis of consolidation

The Group’s financial statements incorporate the financial statements of the Trust and entities controlled by the Trust (its subsidiaries) as

set out in Note 20. Control is achieved where the Trust has power over the investees; is exposed, or has rights, to variable returns from

its involvement with the investees; and has the ability to use its power to affect its returns. The results of subsidiaries are included in the

consolidated financial statements from the date of acquisition to the date of disposal. All intra-group transactions, balances, cashflows,

income and expenses are eliminated on consolidation.

(c)

 Basis of measurement

The Group uses the historical cost basis except for derivative financial instruments and investment properties which are measured at fair

value. Historical cost is based on the fair value of the consideration given or received in exchange for assets or liabilities. Fair value is

the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the

measurement date, regardless of whether that price is directly observable or estimated using another valuation technique.

(d)

 Functional and presentation currency

These financial statements are presented in New Zealand Dollars ($), which is the Trust's functional and presentation currency. All

information has been rounded to the nearest thousand dollars ($000), unless stated otherwise.

In preparing the financial statements, transactions in currencies other than the Trust’s functional currency (i.e. a foreign currency transaction)

are recorded at the rates of exchange prevailing at the dates of the transactions. At the end of each reporting period, foreign currency

denominated monetary items are retranslated at the rate of exchange prevailing at that time. Exchange differences are recognised in profit

or loss in the period in which they arise, except for exchange differences on transactions entered into to hedge foreign currency exposure.

The assets and liabilities of the Group’s foreign operations are translated to New Zealand Dollars using exchange rates prevailing at the

end of the reporting period. Income and expense items are translated at the average exchange rates for the period. Exchange differences

arising on translation are recognised in other comprehensive income and the foreign currency translation reserve.

ANNUAL REPORT 2022|95
(e) Changes in accounting policy and presentation

All accounting policies have been applied on a basis consistent with the prior year's financial statements.

(f) Standards and Interpretations in issue not yet effective

At the date of authorisation of these financial statements, the Group has not applied new and revised NZ IFRS standards and amendments

that have been issued but are not yet effective. It is not expected that the adoption of these standards and amendments will have a material

impact on the financial statements of the Group.

(g) Other accounting policies

Significant accounting policies that summarise the measurement basis used and are relevant to an understanding of the consolidated

financial statements are provided throughout the notes to the consolidated financial statements.

(h) Impact of COVID-19

In March 2020 the World Health Organisation declared the outbreak of a novel coronavirus (‘COVID-19’) as a pandemic, which has

now spread throughout New Zealand, Australia and the world. Governments in New Zealand and Australia responded with lock-downs,

business trading restrictions and social distancing measures all of which impacted large parts of the economy, including the ability for the

Group’s tenants to operate on a business as usual basis.

The widespread uptake of COVID-19 vaccination and booster programs has resulted in the Governments of New Zealand and Australia

adopting a strategy of managing COVID-19, within the context of open international borders and minimising cases in the community without

introducing on-going restrictions or lock-downs. Periodic outbreaks that directly or indirectly disrupt normal business as unusual activity

persist for the Group’s tenants. As at the reporting date, trade receivables and loss allowances related to rent deferral arrangements with

tenants impacted by previous lock-downs and trading restrictions remain.

COVID-19 continues to create transactional market uncertainty in the evidence used by a small number of independent professionally

qualified valuers to inform their assumptions and opinions that determine the fair value of investment property in the markets the Group

operates (refer Note 6.g for further details).

Currently there remains the potential for further community transmission outbreaks caused by a more transmissible and/or virulent COVID-19

mutation. Should this occur the viability of the Group’s tenants and therefore potentially the operating performance and the financial position

of the Group may be adversely impacted if the Governments of New Zealand and Australia were forced to respond with prolonged

lock-downs and business trading restrictions to protect the community and manage the demand of the health systems.


(i)

 The notes to the consolidated financial statements

The following notes include information required to understand these financial statements that is relevant and material to the operations,

financial position and performance of the Group. The notes have been collated into sections to help users find and understand inter-related

information. Information is considered material and relevant if, for example:

•the amount in question is significant by virtue of its size or nature;

•it is important to understand the results of the Group;

•it helps explain the impact of significant changes in the Group's business; or

•it relates to an aspect of the Group's operations that is important to its future performance.

96|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements

3. Significant Accounting Policies

Critical accounting estimates and judgements


In the application of NZ IFRS, the Board and management are required to make judgements, estimates and assumptions about carrying

values of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on

experience and other factors that are believed to be reasonable under the circumstances, however actual results may differ from these

estimates and assumptions.

Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in

which the estimate is revised and in any future periods affected.

The critical judgements, estimates and assumptions made in the current period are contained in the following notes:

NoteDescription

Note 5Current and deferred taxation

Note 6Valuation of investment properties

Note 22Related party transactions

ANNUAL REPORT 2022|97
Performance

This section shows the results and performance of the Group and its reporting segments and includes detailed information in respect to its

revenues, expenses and profitability. It also provides information on the investment properties that underpin the Group's performance.

4. Segment Information


The principal business activity of the Group is to invest in Health Sector related properties. Segment profit represents the profit earned by

each segment including allocation of identifiable administration costs, finance costs, revaluation gains/(losses) on investment properties,

and gains/(losses) on disposal of investment properties. This is the measure reported to the Board, who are the chief operating decision

makers for the purposes of resource allocation and assessment of segment performance. The Group operates in both Australia and

New Zealand.

The following is an analysis of the Group’s results by reportable segment.

Australia

$000s

New Zealand

$000s

Total

$000s

Segment profit/(loss) for the year ended 30 June 2022:

Gross property income from rentals91,79235,605127,397

Gross property income from expense recoveries6,6589,57816,236

Property expenses(10,200)(10,415)(20,615)

Net property income88,25034,768123,018

Other expenses(14,888)(22,347)(37,235)

Strategic transaction expenses-(283)(283)

Net finance expense(14,991)(13,992)(28,983)

Operating profit58,371(1,854)56,517

Fair value gain/(loss) on interest rate derivatives-61,46861,468

Revaluation gains on investment properties188,64855,591244,239

Net gain/(loss) on disposal of investment property700-700

Other foreign exchange gains/(losses)(11)(638)(649)

Total segment profit before income tax247,708114,567362,275

Taxation expense(58,753)

Profit for the year303,522

Segment profit/(loss) for the year ended 30 June 2021:

Gross property income from rentals83,60530,017113,622

Gross property income from expense recoveries6,3056,21712,522

Property expenses(9,325)(7,156)(16,481)

Net property income80,58529,078109,663

Other expenses(12,607)(18,308)(30,915)

Net finance expense(8,297)(19,387)(27,684)

Operating Profit59,681(8,617)51,064

Fair value gain/(loss) on interest rate derivatives-22,37522,375

Revaluation gains on investment properties162,64772,736235,383

Net gain/(loss) on disposal of investment property11,310-11,310

Other foreign exchange gains/(losses)(3)(1,662)(1,665)

Total segment profit before income tax233,63584,832318,467

Taxation expense(40,075)

Profit for the year278,392

98|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements

Net property income comprises rental income and expense recoveries from tenants less property expenses. The Group has three Australian

tenants that contributed $72.5m of gross property income (2021: four Australian tenants that contributed $77.4m).

There were no inter-segment sales during the year (2021: nil).

Australia

$000s

New Zealand

$000s

Total

$000s

Segment assets at 30 June 2022:

Investment properties2,391,228947,9413,339,169

Other non-current assets-20,69220,692

Current assets18,78221,19139,973

Consolidated assets2,410,010989,8243,399,834

Segment assets at 30 June 2021:

Investment properties1,933,502701,0862,634,588

Other non-current assets-6,4776,477

Current assets16,3695,12621,495

Consolidated assets1,949,871712,6892,662,560

Segment liabilities at 30 June 2022:

Borrowings993,23419,7181,012,952

Other liabilities190,10630,900221,006

Consolidated liabilities1,183,34050,6181,233,958

Segment liabilities at 30 June 2021:

Borrowings800,950128,350929,300

Other liabilities173,31356,496229,809

Consolidated liabilities974,263184,8461,159,109

All assets and liabilities have been allocated to reportable segments.

ANNUAL REPORT 2022|99
5. Taxation

Income tax recognised in the consolidated statement of comprehensive income

2022

$000s

2021

$000s

Profit/(loss) before tax for the period362,275318,467

Taxation (charge)/credit - 28% on profit before income tax(101,437)(89,171)

Effect of different tax rates in foreign jurisdictions32,20330,393

Tax exempt income16,74821,899

Tax impact of leasing deals1914,653

Tax impact of profit on property sales-(1,880)

Foreign tax credits4,7539,890

Tax charges on overseas investments(11,500)(13,494)

Over/(under) provided in prior periods449(470)

Other adjustments(160)(1,895)

Taxation expense(58,753)(40,075)

The taxation (charge)/credit is made up as follows:

Current taxation(8,280)(7,858)

Deferred taxation(50,473)(32,217)

Total taxation expense(58,753)(40,075)

The key assumptions used in the preparation of the Group’s tax calculation are as follows:

Tax rate:

The Group's New Zealand entities are subject to New Zealand tax on assessable income at a rate of 28% while its Australian subsidiary

trusts are subject to Australian witholding tax on assessable income at a rate of 10% for interest income or 15% for 'fund payment' amounts as

they are Australian Managed Investment Trusts (MIT).

100|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements

Deferred Tax balances

Interest rate

swaps

$000s

Revaluation

of investment

properties

$000s

Borrowings

$000s

Other

$000s

Total

$000s

At 1 July 202017,750(108,221)(7,074)187(97,358)

Charge to profit and loss for the year(6,265)(25,899)(38)(15)(32,217)

Change in exchange rate-(383)--(383)

Charge to other comprehensive income--7,074-7,074

At 30 June 202111,485(134,503)(38)172(122,884)

At 1 July 202111,485(134,503)(38)172(122,884)

Charge to profit and loss for the year(17,211)(33,274)(48)60(50,473)

Change in exchange rate-(5,112)-153(4,959)

At 30 June 2022(5,726)(172,889)(86)385(178,316)

2022

$000s

2021

$000s

Deferred tax asset-6,477

Deferred tax liability(178,316)(129,361)

Total deferred tax(178,316)(122,884)

ANNUAL REPORT 2022|101
Imputation credits

2022

$000s

2021

$000s

Imputation (deficit)/credits at end of year(410)(2,534)

Recognition and measurement


Income tax comprises current and deferred tax. It is recognised in the consolidated profit or loss unless it relates to items recognised in other

comprehensive income, in which case the current or deferred tax is recognised in other comprehensive income.

Current tax

Current tax is the expected tax payable on the taxable income for the financial year, determined using tax rates enacted or substantively

enacted at the reporting date in the countries where the Group operates, and any adjustments to tax payable in respect of previous

financial years. Management periodically evaluates positions taken in tax returns where the applicable tax regulation is subject to

interpretation and establishes appropriate provisions on the basis of amounts expected to be paid to the tax authorities.

Deferred tax

Deferred tax is provided using the balance sheet liability method, recognising temporary differences between the carrying amounts of assets

and liabilities for financial reporting purposes and their amounts for taxation purposes.

Deferred tax liabilities are recognised for all taxable temporary differences. Deferred tax assets are recognised for all deductible temporary

differences and carried forward tax losses, to the extent that it is probable that taxable profit will be available to utilise them.

The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer

probable that sufficient taxable profits will be available to utilise them.

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply to the period(s) when the asset or liability giving

rise to them is realised or settled, based on the tax rates and laws enacted or substantively enacted at balance date.

Deferred tax assets and liabilities are offset where there is a legally enforceable right to set off, they relate to the same taxation authority,

and the Group intends to settle its obligations on a net basis.

Significant

estimates and judgements


Significant estimates and judgements made in the determination of deferred tax include:

•Deferred tax on depreciation: Deferred tax is provided in respect of New Zealand based properties for the depreciation expected to be

recovered on the sale of investment property.

•Deferred tax on changes in fair value of investment properties: Deferred tax for Australian based properties is provided on the capital

gain expected to be assessable on the land and building component from the sale of investment properties at fair value.

•Deferred tax on fixtures and fittings: It is assumed that all fixtures and fittings will be sold at their tax book value.

•Deferred tax positions are based an estimated split between land and buildings as determined by registered valuers

102|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements

6. Investment Properties


Investment properties comprise real estate predominately leased, or targeted to be leased, to health sector tenants that is held for either

deriving rental income, for capital appreciation or both.

(6.a) Reconciliation of Carrying Amounts

2022

$000s

2021

$000s

Carrying value of investment property at the beginning of the year2,634,5882,086,309

Acquisition of properties298,745237,072

Capitalised costs94,549121,642

Capitalised interest costs5,9214,852

Net capitalised incentives

1

(382)31,631

Disposal of properties(13,186)(87,771)

Foreign exchange translation difference74,6954,901

Revaluation gain on investment property244,239235,383

Right of use asset recognised-569

Carrying value of investment property at the end of the year3,339,1692,634,588

12021: Includes payments associated with the Belmont Private Hospital rent being rebased to market and lease extension.

The Group holds the freehold to all properties except the car parks at the rear of Ascot Hospital and Ascot Central, which are the subject of

a ground lease ("right-of-use" asset) that has a weighted average term remaining of 16.8 years (2021: 17.8 years). As at reporting date the

fair value of this right-of-use asset totals $8.1m (2021: $7.9m).

(6.b)

 Acquisition of Property

During the year the Group:

•acquired a development site of 20,131 square metres at 187–195 Foxwell Rd, Coomera, Queensland, Australia for an acquisition price

of A$9.4 million (excluding transaction costs) on 15 July 2021.

•acquired a development site of 982 square metres at 1 Beck Court, Noble Park, Victoria, Australia (adjacent to Vital’s South Eastern

Hospital) for an acquisition price of A$1.95 million (excluding transaction costs) on 28 September 2021.

•acquired a development site of 749 square metres at 61 – 71 Park Rd, Grafton, Auckland, New Zealand for an acquisition price of

NZ$7.25 million (excluding transaction costs) on 30 September 2021.

•acquired a “Cancer Centre of Excellence” in Adelaide known as Tennyson Centre at 520 South Road, Kurralta Park, SA, Australia,

as well as an adjoining development site of 1,920 square metres at 502–504 South Road for A$90 million and A$2.75 million

respectively (excluding transaction costs) on 11th October 2021.

•settled on a ambulatory care facility at 120 Thames St, Box Hill, Victoria, Australia for an acquisition price of A$10.1 million (excluding

transaction costs), which had previously been accrued for in Other Payables (refer Note 19).

•acquired residential properties throughout the year to be held for future development in Meadowbrook, Queensland, Australia for

A$10.2 million (excluding transaction costs).

•acquired Hutt Valley Health Hub, an ambulatory care facility at 135 Witako Street, Lower Hutt, New Zealand for NZ$46.5 million

(excluding transaction costs) on 1 February 2022.

•acquired a development site of 4,340 square metres adjacent to The Hills Clinic in north-west Sydney, Australia for an acquisition price

of A$13.5 million (excluding transaction costs) on 8 February 2022.

•acquired 68 Saint Asaph Street, a medical office building in Christchurch, New Zealand for NZ$50.7million (excluding transaction

costs) on 1 April 2022.

•acquired Endoscopy Auckland, an endoscopy centre at 148 Gillies Ave, Auckland, New Zealand for NZ$13.0 million and

development land at 22 Kipling Ave, Auckland, New Zealand for NZ$6.3 million (both excluding transaction costs) on 13 May 2022.

•acquired a development / repositioning site at 2 Mount Eliza Way and 1 St Johns Lane, Mt Eliza, Victoria, Australia for A$11.0 million

(excluding transaction costs) on 30 May 2022.

ANNUAL REPORT 2022|103
•acquired a development site of 3,415 square metres at 80 Ascot Ave, Auckland, New Zealand adjacent to Ascot Hospital and Ascot

Central for an acquisition price of NZ$16.0 million (excluding transaction costs) on 30 June 2022.

(6.c) Disposal of Property

During the period the Group:

•sold Gold Coast Surgery Centre (QLD) for A$12.75 million (excluding transaction costs) on 27 October 2021.

•sold a development site at 4 Pearl St, Hurstville, NSW for A$1.4 million on 7 March 2022.

(6.d) Leasing Arrangements

The majority of the investment properties are leased to tenants under long term operating leases. Rentals are receivable from tenants

monthly. Minimum lease payments to be received under non-cancellable operating leases of investment properties not recognised in the

consolidated

financial statements as receivable are as follows:

2022

$000s

2021

$000s

Not later than one year137,989110,304

Later than one year and not later than five years482,909514,869

Later than five years1,339,2531,191,333

1,960,1511,816,506

(6.e) Contractual arrangements

The Group was party to contracts to purchase or construct property (including in respect to Epworth Eastern, Victoria and Wakefield

Hospital, Wellington) or provide lease incentives to tenants which are not recognised in the financial statements for the following amounts:

2022

$000s

2021

$000s

Capital expenditure commitments214,878135,952

Property acquisition commitments109,70118,593

Tenant incentive commitments11,06610,742

At 30 June 2022 the Group has:

•committed to acquiring Kawarau Park Health Precinct, a newly developed health precinct comprising 6 tenanted buildings including

Queenstown's only private hospital, situated in Kawarau Park in Queenstown, New Zealand for NZ$94m (plus transaction costs).

Settlement occured on 7 July 2022.

•committed to acquiring a 7,693 sqm parcel of land in Newtown, Hobart, Australia for A$9.5m (plus transaction costs) for future

development. Settlement occured on 6 July 2022.

In addition, excluded from the above property acquisition committments, the Group has entered into a conditional contract to acquire a

multi-stage ground lease development site in Campbelltown, Sydney, Australia, comprising:

•A$52.0m for the acquisition, tenant incentive and development costs (Stage 1) of a cancer centre of excellence pre-leased to

GenesisCare from completion; and

•A$24.6m for the development rights for Stages 2 and 3 that provide capacity for Vital to develop up to 40,000 square metres of

additional gross floor area.

An incentive of A$10m (plus GST) is payable to Epworth in return for a term extension of 3 years on the 3

rd

anniversary of the

commencement of the lease on the Epworth Camberwell property. Following this payment Epworth’s tenancy (before extension options) at

this property will expire on 30 June 2044.

(6.f)

 Individual Valuations and Carrying Amounts

The details of the New Zealand and Australian investment property portfolio, including its location, sub sector, fair value, market

capitalisation rate, occupancy and weighted average lease expiry term are as follows:

104|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements

Latest

independent

valuationFair valueMarket capitalisation rateOccupancyWALE

PropertiesLocationSub sectorMajor TenantDate

$M

Jun-22

$M

Jun-21

%

Jun-22

%

Jun-21

%

Jun-22

%

Jun-21

Years

Jun-22

Years

Jun-21

Australia

New South Wales

Lingard Private HospitalMerewether, New South WalesHospital (Acute)Healthe CareJun-22224.6193.94.14.5100.0100.023.724.7

Maitland Private HospitalEast Maitland, New South WalesHospital (Acute/Specialty)Healthe CareJun-22133.9118.34.85.1100.0100.015.516.5

Hurstville Private HospitalHurstville, New South WalesHospital (Acute)Healthe CareDec-2191.380.65.85.8100.0100.019.820.8

The Hills ClinicKellyville, New South WalesHosptial (Specialty)AuroraJun-2264.254.44.04.5100.0100.025.026.0

Toronto Private HospitalToronto, New South WalesHospital (Acute/Specialty)AuroraJun-2254.047.75.05.4100.0100.020.121.1

Mons Road Medical CentreWestmead, New South WalesAmbulatory CareCastlereagh ImagingJun-2248.739.74.85.494.594.52.93.6

Lingard Day CentreMerewether, New South WalesAmbulatory CareHealthe CareJun-2247.340.64.14.5100.0100.023.724.7

Hirondelle Private HospitalChatswood, New South WalesHospital (Specialty)AuroraJun-2234.030.25.05.3100.0100.019.920.9

Fairfield Aged CareFairfield, New South WalesAged CareHall & PriorDec-2121.619.36.36.3100.0100.013.714.7

Darlington Aged CareBanora Point, New South WalesAged CareBolton ClarkeJun-2219.918.36.06.3100.0100.014.315.3

Clover Lea Aged CareBurwood Heights, New South WalesAged CareHall & PriorDec-2115.414.16.36.3100.0100.013.714.7

Grafton Aged CareSouth Grafton, New South WalesAged CareHall & PriorDec-2112.811.97.07.0100.0100.014.815.8

Victoria

Epworth Eastern HospitalBox Hill, VictoriaHospital (Acute)Epworth FoundationDec-21448.8375.24.04.395.0100.020.517.8

South Eastern Private HospitalNoble Park, VictoriaHospital (Specialty)AuroraJun-22100.186.04.34.8100.0100.018.719.7

Epworth CamberwellCamberwell, VictoriaHospital (Specialty)Epworth FoundationJun-2284.778.14.24.3100.0100.019.020.0

Ekera Medical CentreBox Hill, VictoriaAmbulatory CareImaging AssociatesDec-2136.533.35.05.3100.0100.02.93.3

Epworth Rehabilitation

1

Brighton, VictoriaHospital (Specialty)Epworth FoundationJun-2229.929.05.35.5100.0100.01.62.6

120 Thames StreetBox Hill, VictoriaAmbulatory CareEpworth FoundationDec-2113.313.05.56.559.6100.02.53.6

Queensland

Belmont Private HospitalCarina Heights, QueenslandHospital (Specialty)AuroraDec-21161.8133.54.04.3100.0100.023.224.2

Palm Beach Currumbin ClinicCurrumbin, QueenslandHospital (Specialty)AuroraJun-2281.969.24.34.8100.0100.013.214.2

The Southport Private HospitalSouthport, QueenslandHospital (Acute/Specialty)Ramsay Health CareDec-2157.551.44.85.0100.0100.022.723.7

Eden Rehabilitation

1

Cooroy, QueenslandHospital (Acute/Specialty)AuroraJun-2235.733.05.35.3100.0100.015.416.4

Baycrest Aged CareHervey Bay, QueenslandAged CareBolton ClarkeJun-2221.619.86.06.3100.0100.014.015.0

Gold Coast Surgery CentreSouthport, QueenslandAmbulatory CareSouth Coast Radiologyn.a.-12.2-7.5-88.9-1.4

Tantula Rise Aged CareAlexandra Headland, QueenslandAged CareBolton ClarkeJun-2226.824.76.06.3100.0100.014.015.0

Western Australia

Marian CentreWembley, Western AustraliaHospital (Specialty)AuroraDec-2166.357.84.44.6100.0100.012.113.1

Abbotsford Private HospitalWest Leederville, Western AustraliaHospital (Specialty)AuroraDec-2154.737.94.34.5100.0100.019.620.6

Hamersley Aged CareSubiaco, Western AustraliaAged CareHall & PriorDec-2114.913.56.56.8100.0100.013.714.7

Rockingham Aged CareRockingham, Western AustraliaAged CareHall & PriorDec-218.17.36.87.0100.0100.013.714.7

South Australia

Tennyson CentreKurralta Park, South AustraliaAmbulatory CareICON Cancer CareJun-22106.8-4.5-100.0-3.8-

Sportsmed Hospital, Clinic & Cons.Stepney, South AustraliaHospital (Acute)Sportsmed SAJun-2292.483.35.05.3100.0100.013.614.6

Playford Health - Retail & CarparkElizabeth Vale, South AustraliaAmbulatory CareSA HealthJun-2224.3-5.5-53.9-9.5-

Total Australia2233.81827.04.54.898.699.717.118.2

1The independent valuer, in determining or informing the fair value for this property, has advised that the transactional market evidence used is continuing to be impacted by uncertainty caused by the COVID-19 pandemic. Therefore less certainty and a higher degree of caution should be applied to the properties reported value than normally the case.

ANNUAL REPORT 2022|105
Latest

independent

valuationFair valueMarket capitalisation rateOccupancyWALE

PropertiesLocationSub sectorMajor TenantDate

$M

Jun-22

$M

Jun-21

%

Jun-22

%

Jun-21

%

Jun-22

%

Jun-21

Years

Jun-22

Years

Jun-21

Australia

New South Wales

Lingard Private HospitalMerewether, New South WalesHospital (Acute)Healthe CareJun-22224.6193.94.14.5100.0100.023.724.7

Maitland Private HospitalEast Maitland, New South WalesHospital (Acute/Specialty)Healthe CareJun-22133.9118.34.85.1100.0100.015.516.5

Hurstville Private HospitalHurstville, New South WalesHospital (Acute)Healthe CareDec-2191.380.65.85.8100.0100.019.820.8

The Hills ClinicKellyville, New South WalesHosptial (Specialty)AuroraJun-2264.254.44.04.5100.0100.025.026.0

Toronto Private HospitalToronto, New South WalesHospital (Acute/Specialty)AuroraJun-2254.047.75.05.4100.0100.020.121.1

Mons Road Medical CentreWestmead, New South WalesAmbulatory CareCastlereagh ImagingJun-2248.739.74.85.494.594.52.93.6

Lingard Day CentreMerewether, New South WalesAmbulatory CareHealthe CareJun-2247.340.64.14.5100.0100.023.724.7

Hirondelle Private HospitalChatswood, New South WalesHospital (Specialty)AuroraJun-2234.030.25.05.3100.0100.019.920.9

Fairfield Aged CareFairfield, New South WalesAged CareHall & PriorDec-2121.619.36.36.3100.0100.013.714.7

Darlington Aged CareBanora Point, New South WalesAged CareBolton ClarkeJun-2219.918.36.06.3100.0100.014.315.3

Clover Lea Aged CareBurwood Heights, New South WalesAged CareHall & PriorDec-2115.414.16.36.3100.0100.013.714.7

Grafton Aged CareSouth Grafton, New South WalesAged CareHall & PriorDec-2112.811.97.07.0100.0100.014.815.8

Victoria

Epworth Eastern HospitalBox Hill, VictoriaHospital (Acute)Epworth FoundationDec-21448.8375.24.04.395.0100.020.517.8

South Eastern Private HospitalNoble Park, VictoriaHospital (Specialty)AuroraJun-22100.186.04.34.8100.0100.018.719.7

Epworth CamberwellCamberwell, VictoriaHospital (Specialty)Epworth FoundationJun-2284.778.14.24.3100.0100.019.020.0

Ekera Medical CentreBox Hill, VictoriaAmbulatory CareImaging AssociatesDec-2136.533.35.05.3100.0100.02.93.3

Epworth Rehabilitation

1

Brighton, VictoriaHospital (Specialty)Epworth FoundationJun-2229.929.05.35.5100.0100.01.62.6

120 Thames StreetBox Hill, VictoriaAmbulatory CareEpworth FoundationDec-2113.313.05.56.559.6100.02.53.6

Queensland

Belmont Private HospitalCarina Heights, QueenslandHospital (Specialty)AuroraDec-21161.8133.54.04.3100.0100.023.224.2

Palm Beach Currumbin ClinicCurrumbin, QueenslandHospital (Specialty)AuroraJun-2281.969.24.34.8100.0100.013.214.2

The Southport Private HospitalSouthport, QueenslandHospital (Acute/Specialty)Ramsay Health CareDec-2157.551.44.85.0100.0100.022.723.7

Eden Rehabilitation

1

Cooroy, QueenslandHospital (Acute/Specialty)AuroraJun-2235.733.05.35.3100.0100.015.416.4

Baycrest Aged CareHervey Bay, QueenslandAged CareBolton ClarkeJun-2221.619.86.06.3100.0100.014.015.0

Gold Coast Surgery CentreSouthport, QueenslandAmbulatory CareSouth Coast Radiologyn.a.-12.2-7.5-88.9-1.4

Tantula Rise Aged CareAlexandra Headland, QueenslandAged CareBolton ClarkeJun-2226.824.76.06.3100.0100.014.015.0

Western Australia

Marian CentreWembley, Western AustraliaHospital (Specialty)AuroraDec-2166.357.84.44.6100.0100.012.113.1

Abbotsford Private HospitalWest Leederville, Western AustraliaHospital (Specialty)AuroraDec-2154.737.94.34.5100.0100.019.620.6

Hamersley Aged CareSubiaco, Western AustraliaAged CareHall & PriorDec-2114.913.56.56.8100.0100.013.714.7

Rockingham Aged CareRockingham, Western AustraliaAged CareHall & PriorDec-218.17.36.87.0100.0100.013.714.7

South Australia

Tennyson CentreKurralta Park, South AustraliaAmbulatory CareICON Cancer CareJun-22106.8-4.5-100.0-3.8-

Sportsmed Hospital, Clinic & Cons.Stepney, South AustraliaHospital (Acute)Sportsmed SAJun-2292.483.35.05.3100.0100.013.614.6

Playford Health - Retail & CarparkElizabeth Vale, South AustraliaAmbulatory CareSA HealthJun-2224.3-5.5-53.9-9.5-

Total Australia2233.81827.04.54.898.699.717.118.2

1The independent valuer, in determining or informing the fair value for this property, has advised that the transactional market evidence used is continuing to be impacted by uncertainty caused by the COVID-19 pandemic. Therefore less certainty and a higher degree of caution should be applied to the properties reported value than normally the case.

106|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements

Latest

independent

valuationFair valueMarket capitalisation rateOccupancyWALE

PropertiesLocationSub sectorMajor TenantDate

$M

Jun-22

$M

Jun-21

%

Jun-22

%

Jun-21

%

Jun-22

%

Jun-21

Years

Jun-22

Years

Jun-21

New Zealand

Ascot Hospital & ClinicsGreenlane, AucklandHospital (Acute)Ascot Hospital and Clinics LimitedDec-21140.5126.34.44.6100.099.515.817.0

Grace HospitalTauranga, Bay of PlentyHospital (Acute)Norfolk Southern Cross LimitedDec-21115.5104.54.64.8100.0100.028.529.5

Wakefield HospitalNewtown, WellingtonHospital (Acute)Evolution HealthcareDec-21128.199.64.84.9100.0100.025.426.4

Royston HospitalHastings, Hawkes BayHospital (Acute)Evolution HealthcareDec-2198.381.34.85.0100.0100.027.428.4

Bowen HospitalCrofton Downs, WellingtonHospital (Acute)Evolution HealthcareDec-2178.263.54.54.8100.0100.027.428.4

Ormiston HospitalFlatbush, AucklandHospital (Acute)Ormiston Surgical and Endoscopy LimitedDec-2152.645.44.85.3100.0100.01.92.6

68 Saint Asaph StChristchurch Central, ChristchurchAmbulatory CareSyft Technologies LimitedJun-2252.2-4.5-100.0-7.8-

Boulcott HospitalLower Hutt, WellingtonHospital (Acute)Boulcott Pulse Health LimitedDec-2151.547.04.85.0100.0100.016.017.0

Ascot CentralGreenlane, AucklandAmbulatory CareFertility Associates LimitedDec-2144.843.34.85.3100.080.96.76.5

Hutt Valley Health HubLower Hutt, WellingtonAmbulatory CareRopata Health LimitedJun-2241.7-4.3-100.0-13.7-

Apollo Health & Wellness CentreAlbany, AucklandAmbulatory CareApollo Medical LimitedDec-2132.327.65.35.884.884.07.28.1

Kensington HospitalWhangarei, NorthlandHospital (Acute)Kensington Hospital LimitedDec-2127.523.25.15.3100.0100.024.025.0

Endoscopy AucklandEpsom, AucklandAmbulatory CareEvolution HealthcareJun-2220.3-4.5-100.0-19.9-

Napier Health CentreNapier, Hawkes BayAmbulatory CareHawke's Bay District Health BoardDec-2118.016.35.96.0100.0100.011.512.5

Ascot Carpark (right of use asset)Greenlane, AucklandHospital (Acute)Ascot Hospital and Clinics LimitedDec-218.17.98.48.892.289.813.514.6

Total New Zealand909.6685.84.75.099.297.518.720.7

Properties held for development195.8121.5

TOTAL FAIR VALUE OF

INVESTMENT PROPERTIES3339.22634.34.64.998.899.217.618.7

ANNUAL REPORT 2022|107
Latest

independent

valuationFair valueMarket capitalisation rateOccupancyWALE

PropertiesLocationSub sectorMajor TenantDate

$M

Jun-22

$M

Jun-21

%

Jun-22

%

Jun-21

%

Jun-22

%

Jun-21

Years

Jun-22

Years

Jun-21

New Zealand

Ascot Hospital & ClinicsGreenlane, AucklandHospital (Acute)Ascot Hospital and Clinics LimitedDec-21140.5126.34.44.6100.099.515.817.0

Grace HospitalTauranga, Bay of PlentyHospital (Acute)Norfolk Southern Cross LimitedDec-21115.5104.54.64.8100.0100.028.529.5

Wakefield HospitalNewtown, WellingtonHospital (Acute)Evolution HealthcareDec-21128.199.64.84.9100.0100.025.426.4

Royston HospitalHastings, Hawkes BayHospital (Acute)Evolution HealthcareDec-2198.381.34.85.0100.0100.027.428.4

Bowen HospitalCrofton Downs, WellingtonHospital (Acute)Evolution HealthcareDec-2178.263.54.54.8100.0100.027.428.4

Ormiston HospitalFlatbush, AucklandHospital (Acute)Ormiston Surgical and Endoscopy LimitedDec-2152.645.44.85.3100.0100.01.92.6

68 Saint Asaph StChristchurch Central, ChristchurchAmbulatory CareSyft Technologies LimitedJun-2252.2-4.5-100.0-7.8-

Boulcott HospitalLower Hutt, WellingtonHospital (Acute)Boulcott Pulse Health LimitedDec-2151.547.04.85.0100.0100.016.017.0

Ascot CentralGreenlane, AucklandAmbulatory CareFertility Associates LimitedDec-2144.843.34.85.3100.080.96.76.5

Hutt Valley Health HubLower Hutt, WellingtonAmbulatory CareRopata Health LimitedJun-2241.7-4.3-100.0-13.7-

Apollo Health & Wellness CentreAlbany, AucklandAmbulatory CareApollo Medical LimitedDec-2132.327.65.35.884.884.07.28.1

Kensington HospitalWhangarei, NorthlandHospital (Acute)Kensington Hospital LimitedDec-2127.523.25.15.3100.0100.024.025.0

Endoscopy AucklandEpsom, AucklandAmbulatory CareEvolution HealthcareJun-2220.3-4.5-100.0-19.9-

Napier Health CentreNapier, Hawkes BayAmbulatory CareHawke's Bay District Health BoardDec-2118.016.35.96.0100.0100.011.512.5

Ascot Carpark (right of use asset)Greenlane, AucklandHospital (Acute)Ascot Hospital and Clinics LimitedDec-218.17.98.48.892.289.813.514.6

Total New Zealand909.6685.84.75.099.297.518.720.7

Properties held for development195.8121.5

TOTAL FAIR VALUE OF

INVESTMENT PROPERTIES3339.22634.34.64.998.899.217.618.7

108|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements

(6.g) Recognition and Measurement

Recognition and measurement

Investment Property

Investment properties are initially measured at cost, including any related transaction costs. Expenditure is capitalised to a property's

carrying value only when its cost can be measured reliably and it is probable that future economic benefits will flow to the Group. All other

repairs and maintenance expenditure is charged to the statement of comprehensive income.

Subsequent to initial recognition, investment properties, including investment properties held for sale, are measured at fair value (inclusive

of adjustments for straight line rental revenue recognition, unamortised lease incentives and costs, and capital expenditure obligations) with

any gains or losses arising on re-measurement recognised in

profit or loss.

Lessee arrangements and Right-of-Use assets

On inception of a lease arrangement, the lease liability is initially measured as the aggregate of fixed and variable lease payments due

(net of incentives receivable), expected residual value guarantees and the exercise price of purchase options (if reasonably certain to be

exercised) and expected lease termination payments, discounted using the interest rate implicit in the lease, or if this cannot be determined,

the Group's incremental cost of borrowing.

Subsequent to initial recognition, lease payments are allocated between finance costs (which is expensed to the consolidated statement

of comprehensive income over the term of the lease using the effective interest rate method) and a reduction of the initial lease liability

recognised. Refer to Note

12 for the lease liabilities recognised by the Group.

Right-of-Use assets are initially measured at cost, comprising the aggregate of the initial measurement of the lease liability (net of

incentives received), lease payments made before commencement date, initial direct costs and restoration costs and are classified as

Investment Property.

Subsequent to initial recognition right-of-use assets are measured at fair value.

Development of investment property

Investment property that is being developed is measured at cost until either its fair value becomes reliably measurable or the development

reaches practical completion. Borrowing costs are capitalised from when activities to prepare the property for development commence, until

the property is substantially ready for use.

Rental income

Rental income from investment properties is comprised of lease components (including base rent, recovery of property taxes and insurance)

and non-lease components (including property outgoings recoveries). Rental income is recognised at the fair value of consideration

receivable (excluding GST).

Rental income relating to lease components is recognised on a straight-line basis over the term of the lease for the period where the rental

income is fixed and determinable. For leases where the rental income is determined based on unknown future variables such as inflation,

market reviews or other factors, rental income is recognised on an accruals basis in accordance with the terms of the lease.

Rental income from property outgoing recoveries is recognised as the costs are incurred, which is typically when the services are provided.

Rental income not received at reporting date is reflected in the consolidated statement of financial position as a receivable or, if paid in

advance, as income in advance.

Lease incentives, commissions and other costs

Lease incentives provided to tenants, such as fit-outs or rent free periods, and leasing commissions and other costs incurred when entering

into a lease are recognised as a reduction of net property income on a straight-line basis over the non-cancellable term of the lease.

ANNUAL REPORT 2022|109
Derecognition


An investment property is derecognised upon disposal or when no future economic benefits are expected from use. The gain or loss arising

on derecognition of the property is measured as the difference between the net proceeds from disposal and the carrying amount at disposal

date and is recognised in the consolidated statement of comprehensive income in the period in which the property is derecognised.

Valuation process

The purpose of the valuation process is to ensure that investment properties are held at fair value. In accordance with the Group's valuation

policy, external valuations are performed by independent professionally

qualified valuers who hold a recognised and relevant professional

qualification and have specialised expertise in the type of investment property being valued. The valuation policy requires that a valuer

may not value the same property for more than two consecutive valuations. All valuations are reviewed by the Manager and approved by

the Board.

The fair value of investment property as at 30 June 2022 was determined through independent professional valuers for approximately 42%

of the portfolio and the remainder was determined by the Manager. The Manager's valuations were informed by market data and valuation

advice provided by independent valuers, comparable transactional evidence and current period leasing activities. The valuers of properties

which have been independently valued at 30 June 2022 included: Ernst & Young, Colliers International, Jones Lang LaSalle Australia,

Valued Care, Absolute Value and CBRE. The properties which have been independently valued at 30 June 2022 are disclosed above in

Note 6.f.

The methods used for assessing the fair value of investment property are the Direct Comparison, Discounted Cash Flow (using a risk adjusted

discount rate), Capitalisation of Contract and Market Income approaches and are unchanged from the prior year. The principal factors

that

influence a valuation include the market capitalisation / discount rates, occupancy, market rent assessments and the weighted average

lease term to expiry (WALE).

COVID-19 impact

In determining the fair value of investment properties at 30 June 2022, some independent professionally qualified valuers advise that due

to the continued uncertainty caused by the COVID-19 pandemic, asset values could change quickly if market circumstances change, and

therefore general caution should be exercised when relying on reported valuations. While market evidence and transactional activity has

increased in the period to 30 June 2022, some valuers still advise that less certainty and a high degree of caution should be attached to

independent property valuations. Directors’ valuations at 30 June 2022 have been informed by this recent evidence. Refer to note 6.f.

Fair Value Hierarchy

Investment properties are classified as Level 3 under the fair value valuation hierarchy. This level 3 classification refers to a valuation

technique that uses inputs that are not based on observable market data (i.e. unobservable inputs are used).

Significant

estimates and judgements


Generally, as:

•occupancy and weighted average lease term, term to expiry increase, yields firm, resulting in increased fair values for investment

properties and vice versa;

•capitalisation rates and discount rates used in the valuation approaches decrease (firm), the fair value of the investment property will

increase, and vice versa.

110|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements

7. Other Expenses

2022

$000s

2021

$000s

Other Expenses

Auditor's remuneration:

Audit and review of financial statements197197

AGM scrutineering33

Manager's fees15,73713,014

Manager's incentive fee15,91412,402

Trustee fees532654

Other operating expenses4,8524,645

Total other expenses37,23530,915

Deloitte has been engaged to provide gap analysis activities as the Group prepares for the Climate-related Disclosures standards.

ANNUAL REPORT 2022|111
Capital Structure, Financing and Risk Management

This section outlines how the Group manages its capital structure and related financing activities and presents the resultant returns delivered

to unit holders via distributions and earnings per unit.

8. Units on Issue

2022

$000s

2021

$000s

Balance at the beginning of the year777,199594,752

Issue of units under Distribution Reinvestment Plan23,79118,983

Issue of units under placement and unit purchase plan142,803159,650

Issue of units under rights issue200,014-

Issue of units to satisfy Manager's incentive fee12,4276,450

Issue costs of units(5,353)(2,636)

Balance at the end of the year1,150,881777,199

2022

000s

2021

000s

Reconciliation of number of units

Balance at the beginning of the year519,753453,783

Issue of units under the Distribution Reinvestment Plan8,1096,388

Issue of units under placement and unit purchase plan49,40157,017

Issue of units under rights issue67,801-

Units issued to satisfy Manager's incentive fee4,0912,565

Balance at the end of the year649,155519,753

Distributions for the financial year were 9.625 cents per unit (2021: 8.875 cents per unit) including the final quarter distribution of 2.4375

cents per unit (2021: 2.25 cents per unit) declared subsequent to the reporting date. Refer Note 21.

On 20 October 2021, 39,655,172 units were issued at $2.90 per unit under an underwritten placement and on 10 November 2021,

9,746,042 units were issued at $2.852 per unit under a unit purchase plan. (2021: On 13 October 2020, 44,642,858 units were issued

at $2.80 per unit under an underwritten placement and on 4 November 2020, 11,607,176 units were issued at $2.80 per unit under a unit

purchase plan).

On 6 May 2022, 37,238,343 units were issued at $2.95 per unit under an underwritten institutional rights offer and on 19 May 2022,

30,562,909 units were issued at $2.95 per unit under an underwritten retail rights offer.

Recognition and measurement

Issued capital

Issued and paid up units are recognised at the fair value of the consideration received by the Group, net of directly incurred transaction

costs. Fully paid ordinary units carry one vote per unit and carry the right to distributions.

Distributions are recognised as a liability in the Group’s financial statements in the period in which the distributions are declared.

112|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements

Share based payments (Managers incentive fee)

Subject to the Trust Deed, the Manager is entitled to an incentive fee that is settled in newly issued units (i.e. a share based payment). As

such, the incentive fee expense is recognised in the share based payment reserve as the services are provided until such a time as it is settled

via the issuance of new units, at which point the amount is reclassifed to units on issue.

On 30 August 2021, 4,090,950 units were issued against the 2021 Manager’s incentive fee of $12.4 million (2021: 2,565,076 were

issued against the 2020 Manager’s incentive fee of $6.5 million).

Capital risk management


The Manager's objective when managing the capital of the Group is to ensure compliance with the capital requirements under the Trust

Deed (i.e. total borrowings do not exceed 50% of the gross value of the Trust Fund) and that the Group will be able to continue as a going

concern while maximising the return to investors through the optimisation of the Group's cost of capital. The Manager maintains or adjusts the

capital of the Group through various methods including by adjusting the quantum of distributions paid, raising or repaying debt, issuing or

buying back units, or buying or selling assets.

As at reporting date, the Group's total borrowings to the Gross Value of the Group (as defined in the Trust Deed) was 30.0% (2021: 35.0%).

The Group’s policies in respect of capital management and allocation are reviewed regularly by the Board of Directors. There have been

no material changes in the Group’s overall capital risk management strategy during the year.

9.

 Earnings per Unit

20222021

Profit attributable to unit holders of the Trust ($000s)303,522278,392

Weighted average number of units on issue (000's of units)569,104497,892

Basic and diluted earnings per unit (cents)53.3355.91

Recognition and measurement


Basic and diluted earnings per unit is calculated by dividing the profit attributable to unit holders of the Trust by the weighted average

number of ordinary units on issue during the year.

ANNUAL REPORT 2022|113
10. Distributable Income


Statutory profit attributable to unit holders is determined in accordance with NZ GAAP and includes a number of non-cash items including

fair value movements, straight line lease accounting adjustments and amortisation of borrowing and leasing costs and incentives.

The Manager uses Adjusted Funds from Operations (AFFO) and AFFO per unit as the Group's key performance metric, representative of

the Group's underlying performance, and as a guide to informing the Group's distribution policy. AFFO adjusts statutory operating profit for

certain items that are non-cash, unrealised, capital in nature or are one-off or non-recurring (i.e. outside the Group's ordinary operations or

not reflective of its underlying performance). As AFFO is a non GAAP measure it may not be directly comparable with AFFO presented by

the Group's peers.

A reconciliation of statutory operating profit to AFFO and AFFO per unit is outlined as follows:

2022

$000s

2021

$000s

Adjusted funds from operations

Operating profit before tax and other income56,51751,064

Add/(deduct):

Current tax expense(8,280)(7,858)

Incentive fee15,91412,402

Strategic transaction expenses283-

Current tax on translation of foreign currency funding transactions98227

Amortisation of borrowing costs1,270878

Amortisation of leasing costs & tenant inducements2,7782,421

IFRS 16 Operating lease accounting(163)(144)

Funds from operations (FFO)68,41758,990

Add/(deduct):

Actual capex from continuing operations(593)(1,533)

Adjusted funds from operations (AFFO)67,82457,457

AFFO (cpu)11.9211.54

Distribution per unit (cpu)9.6258.875

AFFO payout ratio81%77%

Units on issue (weighted average, 000s)569,104497,892

114|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements

11. Borrowings

2022

$000s

2021

$000s

AUD denominated loans1,018,777807,377

NZD denominated loans-125,000

Borrowing costs(5,825)(3,077)

Total borrowings1,012,952929,300

Current liability-114,405

Non current liability1,012,952814,895

Total borrowings1,012,952929,300

2022

$000s

2021

$000s

Total borrowings at the beginning of the year929,300813,515

Drawdowns during the year835,1111,204,354

Repayments during the year(780,338)(1,092,839)

Additional facility refinancing fee(4,018)(2,523)

Facility refinancing fee amortised during the year1,270878

Foreign exchange movement31,6275,915

Total borrowings at the end of the year1,012,952929,300

Recognition and measurement


Borrowings are initially measured at fair value, net of transaction costs. Subsequent to initial recognition, borrowings are measured at

amortised cost using the effective interest rate method. Gains and losses on derecognition are recognised in the consolidated statement of

comprehensive income in the period in which they arise. The carrying values of these balances are approximately equivalent to their fair

values because the loans have floating rates of interest that generally reset every 90 days.

Borrowings are classified as current liabilities unless the Group has an unconditional right to defer settlement of the facility for at least 12

months after the reporting date.

ANNUAL REPORT 2022|115
(11.a) Summary of Borrowing Arrangements

On 25th February 2021 the Group replaced its syndicated revolving multi-currency facility with a club financing arrangement governed by

a common terms deed and bi-lateral facility agreements. Currently there are six financiers (2021: 5 financiers) that provide facilities to the

Group. The facilities' expiry profile and undrawn limits are as follows:

Jun-22Jun-21

A$m LimitA$m UndrawnExpiryA$m LimitA$m UndrawnExpiry

Common Terms Deed - AUD

Facility A1100.0-Oct-28--n.a.

Facility A2125.0-Oct-23125.0-Oct-23

Facility A475.075.0Mar-29--n.a.

Facility A575.044.3Mar-25--n.a.

Facility B1100.0-Apr-24--n.a.

Facility C162.5-Mar-2662.5-Mar-25

Facility C262.5-Mar-2762.5-Mar-25

Facility C3125.0-Mar-27--n.a.

Facility D1125.0-Mar-27125.0-Feb-26

Facility D275.0-Mar-25--n.a.

Facility K170.170.1Mar-2670.1-Feb-26

Facility K221.0-Oct-26--n.a.

Facility L75.0-Sep-28--n.a.

Facility M19.0-Oct-26--n.a.

Facility A3---62.5-Jul-22

Facility B2---137.5-Jul-22

Facility E1---50.050.0Nov-21

Facility E2---50.022.8Nov-21

Facility F1---75.070.7Jan-22

Facility F2---75.0-Jan-22

Total AUD Facility1,110.1189.4895.1143.5

Common Terms Deed - NZD

NZ$m LimitNZ$m UndrawnExpiryNZ$m LimitNZ$m UndrawnExpiry

Facility A50.050.0Oct-2350.0-Oct-23

Facility B75.075.0Mar-2675.0-Mar-26

Total NZD Facility125.0125.0125.0-

In addition to the above, the Group has available a A$5.0m (2021: $Nil) bank guarantee facility of which A$0.6m (2021: $Nil) has been

utilised at the reporting date.

The facilities provided are governed by the common terms deed and are secured and cross collateralised over the Group's investment

properties (by first ranking real property mortgages) and other assets (via a first ranking general 'all assets' security agreement).

The common terms deed contains both financial and non-financial covenants and undertakings that are customary for secured facilities of

this nature. The key financial covenants (with capitalised terms being defined terms in the common terms deed) are as follows:

116|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements

Covenant

2022

Actual

2021

Actual

Banking Covenants

Loan to value ratio< 55%32.1%38.0%

Interest cover> 2.00x3.202.88

Total EBITDA of Obligors v total EBITDA of GroupNot < 95%100%100%

Total assets of Obligors v total assets of GroupNot < 95%100%100%

Total value of unmortgaged properties v total assets of GroupNot > 10%3.4%4.8%

(11.b) Finance Expense

2022

$000s

2021

$000s

Expenses

Interest expense35,11632,571

Borrowing costs capitalised(5,921)(4,852)

Total finance expenses29,19527,719

The effective interest rate on borrowings, incorporating interest rate hedges, as at the reporting date was 3.73% per annum (2021: 3.32%).

Recognition and measurement


Interest expense is recognised in the consolidated statement of comprehensive income using the effective interest rate method except where

it is incurred in relation to a qualifying asset, where it is capitalised during the period of time that is required to hold, complete and/or

prepare the asset for its intended use. It comprises interest payable on borrowings and interest paid on interest rate hedging instruments.

The effective interest rate method calculates the amount to be recognised over the relevant period at the rate that exactly discounts estimated

future cash payments through the expected life of the financial instrument or a shorter period where appropriate, to the net carrying amount

on initial recognition.

12.

 Lease Liabilities


The Group holds a ground lease over the car parks at the rear of Ascot Hospital and Ascot Central that has a weighted average term

remaining of 16.8 years (2021: 17.8 years).

13.

 Derivative Financial Instruments

(13.a) Interest Rate Swaps

The Group has exposure to debt facilities that are subject to floating interest rates. The Group uses derivative financial instruments, on a

portfolio basis, to manage its exposure to interest rates such as interest rate swaps (to lock-in fixed interest rates) and/or interest rate caps

(to limit exposure to rising floating interest rates). At the reporting date, 44.5% of borrowings were at fixed rates (2021: 49.0%). Refer

Note14.c for further information on the Group's exposure to interest rate risk.

All derivative financial instrument providers receive the benefit of pari-passu security and cross collateralisation rights over the

Group’s investment properties (via first registered real property mortgages) and other assets (via a first ranking general 'all assets'

security agreement).

Generally, interest rate contracts settle on a quarterly basis coinciding with the dates on which the interest is payable on the underlying debt.

The floating rate incurred on the debt is based on New Zealand BKBM or Australian BBSW. The difference between the fixed and floating

interest rate is generally settled on a net basis by the relevant counterparty. The interest rate contracts have not been identified as hedging

instruments and any movements in their fair value are recognised immediately in the consolidated statement of comprehensive income.

ANNUAL REPORT 2022|117
2022

$000s

2021

$000s

Non-current assets

Interest rate derivative assets20,692-

Current liabilities

Interest rate derivative liabilities(93)(640)

Non-current liabilities

Interest rate derivative liabilities(149)(40,379)

Total20,450(41,019)

During the period the Group recognised a fair value gain of $61.5m (2021: $22.4m gain) on interest rate contracts. The Group's interest

rate swaps outstanding at the reporting date are as follows:

2022

$000s

2021

$000s

Nominal value of interest rate swaps - AUD410,000425,000

Average fixed interest rate2.89%2.94%

Floating rates based on AUD BBSW1.51%0.12%

Interest rate derivatives mature over the next eight years and have fixed interest rates ranging from 1.54% to 4.23% (2021: from 1.54%

to 4.35%).

Recognition and measurement


Interest rate derivatives are categorised as financial instruments at fair value through profit or loss and are initially recognised and

subsequently measured at fair value derived from counterparty bank valuations. Counterparty bank valuations are tested for reasonableness

by discounting the estimated future cashflows and using market interest rates for a substitute instrument at the measurement date. The resulting

gain or loss is recognised immediately in the consolidated statement of comprehensive income as hedge accounting has not been applied.

(13.b)

 Forward Exchange Contracts

The Group has exposure to foreign currency risk arising from owning investment property in Australia. Derivative financial instruments, such

as forward exchange contracts, may be used to reduce its exposure to foreign exchange risk by locking in the conversion of Australian

dollar denominated income (transaction hedging) or net assets (translation hedging) to New Zealand dollars. Refer Note14.c for further

details on the Group's exposure to foreign exchange risk.

Transaction hedging arrangements generally settle on a quarterly basis while translation hedging arrangements settle on a periodic basis

depending on the term of the contract. At reporting date forward exchange contracts have not been designated as hedging instruments and

any movements in the fair value are recognised immediately in the consolidated statement of comprehensive income.

118|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements

2022

$000s

2021

$000s

Current assets

Foreign exchange derivative assets2542

Current liabilities

Foreign exchange derivative liabilities(442)(77)

Non-current liabilities

Foreign exchange derivative liabilities(1)-

Total(418)(35)

During the period the Group recognised a fair value loss of $0.66m (2021: $0.28m gain) on forward exchange contracts. The Group's

forward exchange contracts outstanding at the reporting date are as follows:

2022

$000s

2021

$000s

Nominal value of foreign exchange contracts - AUD26,50018,100

Average foreign exchange rate0.91340.9199

Recognition and measurement


Foreign exchange derivatives are categorised as financial instruments at fair value through profit or loss and are initially recognised and

subsequently measured at fair value derived from counterparty bank valuations. Counterparty bank valuations are tested for reasonableness

by using a valuation model based on the applicable forward price curves derived from observable forward prices. As hedge accounting

has not been applied any resulting gain or loss is recognised immediately in the consolidated statement of comprehensive income.

(13.c)

 Fair value hierarchy

The fair value hierarchy categorises the inputs used in valuation techniques into the following three categores based on the degree to which

the inputs used to measure fair value are observable:

Level 1 fair value measurements are those derived from quoted prices in active markets for identical assets or liabilities.

Level 2 fair value measurements are those derived from inputs other than quoted prices included within Level 1 that are observable for the

asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices).

Level 3 fair value measurements are those derived from valuation techniques that include inputs for the asset or liability that are not based on

observable market data (unobservable inputs).

The Group has determined that interest rate swaps and foreign exchange contract derivatives are valued using Level 2 inputs (observable

prices of similar instruments). There have been no reclassifications between levels in the current year (2021: nil).

14.

 Financial and Risk Management


The Group’s activities expose it primarily to credit risk, market risk (interest rate risk and foreign exchange risk) and liquidity risk. The Group’s

overall risk management programme focuses on the unpredictability of financial markets and seeks to minimise potential adverse effects on

the Group’s financial performance. The Group uses financial derivatives to manage market risks. The use of financial derivatives is governed

by the Group’s policies approved by the Board, which provide written principles that are consistent with the Group’s risk management

strategy. The Group does not use derivative financial instruments for speculative purposes.

ANNUAL REPORT 2022|119
(14.a) Financial Instruments

The Group has the following financial instruments:

•cash and cash equivalents;

•receivables;

•payables;

•borrowings; and

•derivative financial instruments.

Transactions in these instruments expose the Group to a variety of financial risks including market risk (which includes interest rate risk, foreign

exchange risk and other price risks), credit risk and liquidity risks.

Categories of financial instruments


The Group’s financial instruments are classified as:

Financial assets

at amortised

cost

$000s

Financial

liabilities at

amortised cost

$000s

Financial

assets at fair

value through

profit or loss

$000s

Financial

liabilities at fair

value through

profit or loss

$000s

30 June 202224,497(1,048,970)20,717(685)

30 June 20218,514(974,542)245(41,019)

Cash, cash equivalents, trade and other receivables, trade and other payables and borrowings


The carrying values of these financial instruments approximate their fair values because of their short terms to maturity or interest reset dates.

(14.b)

 Credit Risk

The Group is subject to credit risk (the risk that a counterparty will default on its contractual obligations resulting in financial loss to the

Group) predominately through its trade and other receivables, derivatives and cash exposures. The maximum exposure to credit risk at a

reporting date is the carrying value of each financial asset as disclosed in the applicable note to the financial statements.

Credit risk is managed by:

•ensuring that at the time of entering into a contractual arrangement or acquiring a property, counterparties or tenants are of appropriate

credit worthiness, provide appropriate security or other collateral and/or do not show a history of default;

•seeking to optimise tenant mix by actively managing the property portfolio composition and leasing arrangements; and

•only entering into foreign exchange and interest rate derivative transactions and placing cash and deposits with high credit quality

financial institutions.

The Group applies an expected credit losses (ECL's) model (simplified approach) that uses historical experience, external indicators and

forward looking information to calculate the expected lifetime credit loss for financial assets carried at amortised cost.

The expected lifetime credit loss of trade receivables is assessed on a collective basis (grouped based on days past due), reflecting shared

credit characteristics, and is determined based on the forecast shortfalls in contractual cash flows considering the potential for default at any

point during the life of the financial instrument. Details of the expected credit loss recognised in relation to trade receivables is disclosed

in Note17.a.

(14.c)

 Market Risk

The Group is subject to market risk (the risk that borrowings or derivatives are repriced to different interest rate margins on refinance or

renewal arising from changes in the debt markets), interest rate risk (the risk of a change in interest rates may impact the Group’s profitability,

cashflows and/or financial position) and foreign exchange risk (the risk of a change in foreign exchange rates on translation of foreign

120|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements

currency denominated assets, liabilities, revenue and expenses) predominantly through its investment property, borrowings, derivatives and

cash exposures.

The interest rates applicable to each category of financial instrument are disclosed in the relevant note to the financial statements.

Interest rate risk


The following table indicates the effective interest rates and the earliest period in which financial instruments reprice. Fixed rate balances are

presented with the effect of hedging derivatives:

Weighted

effective

interest rate

%

Less than

1 year

$000s

1-2 years

$000s

2-3 years

$000s

3+ years

$000s

Total

$000s

30 June 2021

Cash and cash equivalents

(floating rates)

0.12%6,880---6,880

Borrowings (floating rates)1.28%(475,829)---(475,829)

Borrowings (fixed rates)4.10%(16,113)(21,485)(32,227)(386,723)(456,548)

(485,062)(21,485)(32,227)(386,723)(925,497)

30 June 2022

Cash and cash equivalents

(floating rates)

1.51%22,055---22,055

Borrowings (floating rates)2.39%(565,087)---(565,087)

Borrowings (fixed rates)3.77%(22,131)(33,197)(22,131)(376,231)(453,690)

(565,163)(33,197)(22,131)(376,231)(996,722)

Interest rate sensitivity

The Group’s sensitivity to interest rate risk can be expressed in two ways:

Fair value sensitivity

A change in interest rates impacts the fair value of the Group’s fixed rate financial instruments. Fair value changes impact profit or loss or

equity only where the instruments are carried at fair value. Accordingly, the fair value sensitivity to a 100 bps movement in interest rates

(based on the financial instruments held at reporting date) is:

Impact on

profit/(loss)

2022

$000s

Impact on

unit holders'

funds

2022

$000s

Impact on

profit/(loss)

2021

$000s

Impact on

unit holders'

funds

2021

$000s

If interest rates had been 100 bps higher:17,42917,42924,01824,018

If interest rates had been 100 bps lower:(18,423)(18,423)(25,591)(25,591)

Cash flow sensitivity analysis

A change in interest rates impacts interest income and expense on the Group’s interest bearing floating rate financial instruments.

Accordingly, the one-year cash flow sensitivity to a 100 bps movement in interest rates (based on the financial instruments held at reporting

date) is:

ANNUAL REPORT 2022|121
Impact on

profit/(loss)

2022

$000s

Impact on

unit holders'

funds

2022

$000s

Impact on

profit/(loss)

2021

$000s

Impact on

unit holders'

funds

2021

$000s

If interest rates had been 100 bps higher:(5,651)(5,651)(3,223)(3,223)

If interest rates had been 100 bps lower:5,6515,6513,2233,223

Foreign exchange risk


The following table presents the foreign currency risk that the Group is exposed to arising from Australian dollar (AUD) denominated assets

and liabilities:

2022

$000s

2021

$000s

Non-financial instrument assets and liabilities denominated in Australian dollars

Investment properties2,391,2271,933,502

Other assets12,66011,824

Deferred tax(166,724)(129,361)

Total non-financial instrument assets and liabilities2,237,1631,815,965

Non-derivative financial instruments

Cash and cash equivalents4,4163,208

Trade and other receivables1,7021,337

Trade and other payables(23,370)(43,953)

Borrowings(1,018,777)(807,377)

Total exposure from non-derivative financial instruments(1,036,029)(846,785)

Derivative financial instruments

Foreign exchange derivatives(418)245

Interest rate swaps20,450(41,019)

Total exposure from derivative instruments20,032(40,774)

Net exposure to currency risk1,221,166928,406

Foreign currency sensitivity

A change in the New Zealand dollar (NZD) / AUD exchange rate impacts profit after tax and equity on the conversion of AUD

denominated assets, liabilities, revenue and expenses. A 10% change in the exchange rate (2021:10%), based on year end exposures, has

the following effect:

2022

$000s

2021

$000s

If the New Zealand Dollar versus the Australian Dollar was 10% higher for the year:

Profit and loss2,8644,837

Other comprehensive income(106,633)(90,198)

Unit Holders' funds(103,769)(85,361)

If the New Zealand Dollar versus the Australian Dollar was 10% lower for the year:

Profit and loss(3,501)(5,912)

Other comprehensive income130,329110,242

Unit Holders' funds126,828104,330

122|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements

(14.d) Liquidity Risk

The Group is subject to liquidity risk (the risk that the Group will not be able to meet its contractual or other operating obligations).

Liquidity risk is managed by continuously monitoring forecast and actual cash flows, maintaining appropriate head room under debt

facilities and matching the maturity profiles of financial assets and liabilities. To help reduce liquidity risks the Group:

•has readily accessible unutilised credit facilities and other funding arrangements in place;

•seeks a debt maturity profile that limits the total debt maturing in any one 12-month period; and

•seeks to maintain sufficient loan covenant headroom to ensure that the Group can withstand downward movements in investment

property valuations, a reduction in revenue and/or an increase in interest rates without breaching loan facility covenants.

Liquidity risk exposure

The following table details the Group’s exposure to liquidity risk based on the contractual undiscounted cash flows relating to financial

liabilities, foreign exchange contracts and interest rate derivatives:

Carrying

value

$000s

Contractual

cash flows

$000s

Less than 1

year

$000s

1-2 years

$000s

2-3 years

$000s

3+ years

$000s

30 June 2021

Non-derivative

financial instruments

Borrowings (excluding

borrowing costs)(932,377)(951,815)(115,660)(218,393)(189,221)(428,541)

Trade and other payables(41,006)(41,006)(41,006)---

Lease liability - ground lease(4,236)(4,236)(163)(170)(178)(3,725)

(977,619)(997,057)(156,829)(218,563)(189,399)(432,266)

Derivative

financial instruments

Interest rate swaps(41,019)(43,078)(12,858)(10,227)(7,900)(12,093)

Foreign exchange derivatives245245245---

(40,774)(42,833)(12,613)(10,227)(7,900)(12,093)

30 June 2022

Non-derivative

financial instruments

Borrowings (excluding

borrowing costs)(1,018,777)(1,164,084)(31,947)(281,961)(144,008)(706,168)

Trade and other payables(31,945)(31,945)(31,945)---

Lease liability - ground lease(4,073)(4,073)(170)(178)(185)(3,540)

(1,054,795)(1,200,102)(64,062)(282,139)(144,193)(709,708)

Derivative

financial instruments

Interest rate swaps20,45022,394334,6354,25213,474

Foreign exchange derivatives(418)(418)(418)---

20,03221,976(385)4,6354,25213,474

ANNUAL REPORT 2022|123
(14.e) Hedge Accounting

The Group is exposed to foreign exchange risk on its net investment in its AUD functional currency subsidiaries and seeks to hedge this risk

using AUD-denominated borrowings and foreign exchange derivatives (net investment hedges).

As a result of the February 2021 refinancing exercise the Group paid down all of its NZ domiciled AUD borrowings which it had

designated a portion as net investment hedges.

Recognition and measurement


For a financial instrument to be classified and accounted for as an effective hedge there must be:

•an economic relationship between the hedged item and the financial instrument;

•the effect of credit risk does not dominate the value changes that result from that economic relationship; and

•the hedge ratio of the hedging relationship is the same as that resulting from the quantity of the hedged item that the Group actually

hedges and the quantity of the financial instrument that the Group actually uses to hedge that quantity of hedged item.

The Group documents its hedging relationships at their inception in accordance with the requirements of NZ IFRS 9 and the Board

approved risk management strategy.

Hedge effectiveness is determined by the Group at the inception of the hedge relationship, and through semi-annual prospective

effectiveness assessments, to ensure that an economic relationship exists between the hedged item and the financial instrument. That portion

of the foreign exchange differences arising on the financial instruments determined to be an effective hedge is recognised directly in other

comprehensive income. Any ineffective portion is recognised in

profit or loss.

On disposal of the foreign operation, the cumulative value of such gains or losses recognised in other comprehensive income is reclassified

to the profit and loss in the statement of comprehensive income.

15.

 Commitments and Contingencies


Other than the contractual obligations disclosed in Note6.e and Note15.a, there are no other commitments and contingencies in effect at

the reporting date (2021: nil).

(15.a)

 NZSX Bank Bond

As a condition of listing on the New Zealand Stock Exchange (NZSX), NZSX requires all issuers to provide a bank bond to NZSX under

NZSX/DX Listing Rule 1.23.2. The bank bond required by the Group for listing on the NZSX is $50,000.

124|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements

Efficiency of Operations

This section presents the Group's working capital position and the efficiency in which it converts operating profits into cash available for unit

holders or reinvestment back into the operations of the Group.

16. Statement of Cash Flows Reconciliation from Operating Activities

2022

$000s

2021

$000s

Cash and cash equivalents

Australian financial institutions4,4173,208

New Zealand financial institutions17,6383,672

Cash at bank22,0556,880

Reconciliation of profit after income tax to net cash flows from operating activities

Profit after tax for the year303,522278,392

Adjustments for non-cash items

Change in fair value of investment properties(244,239)(235,383)

Fair value (gain)/loss on derivative financial instruments(60,804)(22,655)

Unrealised foreign exchange (gain)/loss(26)(2,454)

Realised foreign exchange (gain)/loss114,399

Deferred taxation50,47332,217

Income in advance(233)(16)

Manager's incentive fee15,91412,402

Other2,173903

Operating cash flow before changes in working capital66,79167,805

Change in trade and other payables3,5321,467

Change in taxation payable(7,969)2,181

Change in trade and other receivables(1,450)(2,876)

Items classified as investing activities(417)(12,001)

Net cash from operating activities60,48756,576

Excluded from investing and financing activities are distributions paid during the year of $23.8m (2021: $19.0m) that have been reinvested

under the Distribution Reinvestment Plan (DRP).

Recognition and measurement


Cash and cash equivalents comprise cash at bank and call deposits, net of outstanding bank overdrafts.

The statement of cash flows is prepared on a GST exclusive basis. The GST component of cash flows arising from investing and financing,

which is recoverable from, or payable to, the taxation authority, is classified as part of operating cash flows.

ANNUAL REPORT 2022|125
17. Trade and Other Receivables

2022

$000s

2021

$000s

Trade receivables1,931968

Loss allowance(291)(345)

1,640623

Other receivables8021,011

Total trade and other receivables2,4421,634

(17.a) Ageing of receivables Past Due

2022

$000s

2021

$000s

0-30 days past due785656

31-60 days past due32050

61-90 days past due82433

1,929739

2022

$000s

2021

$000s

Movement in the loss allowance

Balance at the beginning of the year345281

(Decrease)/increase in allowance recognised in profit or loss(54)64

Balance at the end of the year291345

During the year the Group recognised bad debt write offs of $0.06m (2021: nil) in the statement of comprehensive income.

The Group holds $2.5m security or other collateral (2021: $2.3m) in respect of rent receivables past due. The Group does not have

significant credit risk exposure to any single counterparty or counterparties having similar characteristics in respect of rent receivables

past due (2021: nil). There are no significant financial assets that have had renegotiated terms that would otherwise have been past due

(2021: nil).

Recognition and measurement

Rent receivables

Rent receivables are recorded initially at fair value (including GST) and subsequently at amortised cost in accordance with NZ IFRS 9

Financial Instruments (“NZ IFRS 9”).

Impairment of financial assets and rent receivables

Loss allowances for rent receivables and other financial assets (other than those measured at fair value through profit and loss) are

measured using the simplified approach based on a lifetime expected loss allowance. Refer Note14.b for further details.

126|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements

18. Other Assets

2022

$000s

2021

$000s

Current

Deposits paid on property acquisitions8,6352,012

GST refundable1,0039,698

Other5,8131,026

Total Current15,45112,736

19. Trade and Other Payables

2022

$000s

2021

$000s

Current liabilities

Interest accrued on borrowings3,6202,209

Other creditors and accruals28,32629,031

Other payables (Thames St)-9,765

Total trade and other payables31,94641,005

Recognition and measurement


Trade and other payables are recognised initially at fair value (inclusive of GST) and subsequently measured at amortised cost using the

effective interest method. The average credit term on purchases is generally 30 days and they are non-interest bearing. The Group has

management policies in place to ensure that all amounts are paid within the applicable credit terms.

ANNUAL REPORT 2022|127
Other Notes

20. Investment in Subsidiaries


The Trust has control over the following subsidiaries:

Holding

Name of subsidiaryPrincipal activity

Place

of incorporation

and operation20222021

Vital Healthcare Australian Property TrustProperty investmentAustralia100%100%

Vital Healthcare Investment TrustProperty investmentAustralia100%100%

Vital Healthcare Property LimitedProperty investmentNew Zealand100%100%

Colma Services LimitedHolding companyNew Zealand100%100%

All subsidiaries have the same reporting date as the Trust.

21.

 Subsequent Events


On 11 August 2022 a final cash distribution of 2.4375 cents per unit was announced by the Trust. The Record Date for the final distribution

is 8 September 2022 and a payment is scheduled to unit holders on 22 September 2022. Imputation credits of nil cents per unit will be

attached to the distribution.

Post 30 June 2022 the Group has:

•settled the acquisition of Kawarau Park Health Precinct, a newly developed health precinct comprising 6 tenanted buildings including

Queenstown's only private hospital, situated in Kawarau Park in Queenstown, New Zealand for NZ$94m (plus transaction costs).

Settlement occured on 7 July 2022.

•settled the acquisition of a 7,693 sqm parcel of land in Newtown, Hobart, Australia for A$9.5m (plus transaction costs) for future

development. Settlement occured on 6 July 2022, and subsequently agreed terms with Nexus Hospitals to fund through the development

of a new day hospital and ambulatory care facility for ~A$98m (including land).

•unconditionally agreed to acquire a strata lot at 1/173 Chisholm Road, Ashtonfield, NSW Australia for A$3.97m (plus transaction

costs). This property adjoins Vital's East Maitland Private Hospital and is expected to settle in September 2022.

•received approval from Campbelltown City Council to be nominated as the tenant to the multi-stage ground lease development site

in Campbelltown, Sydney, Australia (refer note 6.e) on 15 July 2022, resulting in all contractual conditions now being satisfied for the

acquisition of this development site.

22.

 Related Party Transactions


The Trust has control over the following subsidiaries:

The Manager


Vital is managed by NorthWest Healthcare Properties Management Limited (the "Manager"), a wholly owned subsidiary of NWI

Healthcare Properties LP (NWI LP).

The ultimate parent of NWI LP is Toronto listed NorthWest Healthcare Properties Real Estate Investment Trust (NWH REIT) that, as at

reporting date, holds a 27.6% (2021: 26.0%) interest in Vital. NWH REIT and its controlled entities (including the Manager) are considered

related parties to Vital and its controlled entities by virtue of common ownership and/or directorships.

128|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements

Other related parties by virtue of common ownership and/or directorship to the Manager of Vital include Australian Properties Limited and

NorthWest Healthcare Australian Property Limited.

Remuneration of the Manager


Vital pays fees to the Manager in accordance with the Trust Deed. The aggregate of Base Fees, Incentive Fees and Activity Fees is capped

at 1.75% per annum of Vital's gross asset value (GAV) as at the end of a financial year.

Current fee arrangements


In accordance with and from the effective date of the amended Trust Deed, the fee arrangements are as follows:

Base Fee

The Base Fee structure is as follows:

•65 bps per annum up to $1bn of GAV:

•55 bps per annum from $1bn to $2bn of GAV;

•45 bps per annum from $2bn to $3bn of GAV; and

•40 bps per annum over $3bn of GAV.

Incentive Fee

The Incentive Fee is determined as 10% of the average annual increase in Vital’s Net Tangible Assets (NTA) (as defined by the Trust Deed)

over the respective

financial year and the two preceding financial years, with payment being made by way of subscribing for new units. The

incentive fee calculations are also subject to a ‘three year high watermark”, such that the Manager will not be paid an Incentive Fee in a

year where NTA grows if it is still below where it was on the last business day of any of the past three financial years.

Activity Fees

The Activity Fee structure is as follows:

a. Leases or licences

Vital pays the Manager leasing or licence fees where the Manager has negotiated leases or licences. The fees are charged at 11% of the

aggregate annual rental for terms less than 3 years, 12% of the aggregate annual rental for terms of 3 years, and 12% plus an additional 1%

for each full year (pro rata for part years) for terms greater than three years (to a maximum of 20%), subject to a minimum fee of $2,500.

Lease or licence renewals are charged at 50% of a new lease or licence fee.

Leasing or licence fees are capitalised to the respective investment or property in the consolidated statement of financial position and

amortised over the term of the lease.

b. Property management

Vital pays the Manager property management fees where the Manager acts as the property manager. These fees are charged at 1%

- 2% of gross income depending on the number of tenants at the property and may be recovered from tenants if permitted under

lease agreements.

Property management fees, net of recoveries from tenants, are expensed through the consolidated statement of comprehensive income in the

year in which they arise.

c. Facilities management

Vital pays the Manager a facilities management fee where the Manager acts as a property facilities manager based on the market rate

(referenced to a reputable and high-quality third party service provider) for similar services at similar properties. This fee may be recovered

from tenants if permitted under lease agreements.

Facilities management fees are expensed, net of recoveries from tenants, through the consolidated statement of comprehensive income in the

year in which they arise.

ANNUAL REPORT 2022|129
d. Project management

Vital pays project management fees to the Manager for managing capital expenditure projects where the purpose of the project is to

upgrade, repair or otherwise extend the life of the property, including via the replacement or repair of major plant and equipment, structural

items and building envelope.

Project management fees for projects with a budget of between $0.2m and $2.5m are 2% of the committed spend where the Manager is

the project lead and 1% of committed spend where the Manager has an oversight role, increasing to 4% and 2% respectively for projects

with a budget greater than $2.5m.

Project management fees are capitalised to the respective investment or property in the consolidated statement of financial position.

Additional Costs

The Additional Costs structure is as follows:

a. Acquisitions

Vital pays fees to the Manager for managing the due diligence, financing, legal aspects and settlement of the purchase of an investment or

property instead of, or alongside, a third party agent. These fees are charged at 1.5% of the capitalised cost of the relevant investment or

property, being the contracted price payable, excluding any deductions netted off the settlement price (such as rates), together with other

related capitalised acquisition costs.

Acquisition fees are capitalised to the respective investment or property in the consolidated statement of financial position.

b. Disposals

Vital pays fees to the Manager for managing the due diligence, legal aspects and settlement of the sale of an investment or property

instead of, or alongside, a third party agent. These fees are charged at 1% of the contracted sale price of the relevant investment or property

actually received, provided that, if a third party agent has been engaged to provide services for the disposal, then the fee payable to the

Manager will be net of the third party agent’s costs and commissions.

Disposal fees are expensed through the consolidated statement of comprehensive income in the year in which they arise.

c. Development Management

Vital pays fees where the Manager acts as a development manager on Vital developments. These fees are charged at 4% of the committed

spend (excluding land) approved by the Board of the Manager provided that, if a third party agent has been engaged to provide

development management services, then the fee payable to the Manager will be reduced by the non-rentalisable third party costs paid.

Development management fees are capitalised to the respective property in the consolidated statement of financial position.

130|VITAL HEALTHCARE PROPERTY TRUST
Notes to the Consolidated Financial Statements

Transactions with related parties


Amounts charged by the Manager and related parties and owing are as follows:

30 June 2022

$000s

30 June 2021

$000s

Statement of

Comprehensive

Income

Statement

of Financial

PositionTotal

Amounts

Owing/

(Receivable)

Statement of

Comprehensive

Income

Statement

of Financial

PositionTotal

Amounts

Owing/

(Receivable)

Base fee15,737-15,737-13,014-13,01453

Incentive Fee

1

15,914-15,91415,91412,402-12,40212,427

Activity Fees:

Leasing/licensing

2

1573,1363,2931,1391471,3451,4921,375

Property management

3

1,541-1,5412581,500-1,500326

Facilities management

3

--------

Project management

4

-157157161-158158158

AFSL fee1,210-1,210-995-995-

34,5593,29337,85217,47228,0581,50329,56114,339

Additional Costs:

Acquisitions

5

-7,8647,8644,446-4,0504,0501,852

Disposals----1,011-1,011-

Development management

6

-4,3564,3562,771-3,4473,4473,709

-12,22012,2207,2171,0117,4978,5085,561

Other Amounts:

Reimbursement of third

party expenses:

Other expenses141-141-92-92-

Amounts paid to directors:

7

Andrew Evans90-90-90-90-

Graham Stuart171-171-143-143-

402-402-325-325-

34,96115,51350,47424,68929,3949,00038,39419,900

1Manager's incentive fee outstanding at 30 June 2022 of $15.9m (Jun 20: $12.4m) is payable to NorthWest Healthcare Properties Management Limited

2Amounts outstanding at 30 June 2022 are: NorthWest Healthcare Properties Management Limited $1.0m (Jun 21:$0.2m); NorthWest Healthcare Australian Property Limited $0.1m (Jun

21: $1.2m)

3Property Management and Facilities Management fees, exclusive of recoveries from tenants, incurred by the Trust totalled $1.5m and nil respectively for the 30 June 2022 year (Jun 21:

$1.5m and nil respectively).

Amounts outstanding at 30 June 2022 are: NorthWest Healthcare Properties Management Limited $0.1m (Jun 21: $0.1m); NorthWest Healthcare Australian Property Limited $0.2m

(Jun 21:$0.2m)

4Amounts outstanding at 30 June 2022 are: NorthWest Healthcare Properties Management Limited $0.1m (Jun 21: $0.1m) NorthWest Healthcare Australian Property Limited $0.1m (Jun

21: $0.1m)

5Amounts outstanding at 30 June 2022 are: NorthWest Healthcare Properties Management Limited $1.3m (Jun 21: $0.1m); NorthWest Healthcare Australian Property Limited $3.1m (Jun

21: $1.7m)

6Amounts outstanding at 30 June 2022 are: NorthWest Healthcare Properties Management Limited $1.6m (Jun 21: $1.4m); NorthWest Healthcare Australian Property Limited $1.2m (Jun

21: $2.3m)

7Directors' fees for Michael Stanford and Angela Bull are currently paid by the Manager

ANNUAL REPORT 2022|131
Other Related Parties


There have been no transactions that occurred during the reporting period or remain outstanding at the reporting date with other

related parties.

On 21 August 2020 the Group acquired the remaining 50% interest in Playford Health Hub in South Australia from the NorthWest Australia

Real Estate Investment Trust for A$7.4m, excluding transaction costs.

132|VITAL HEALTHCARE PROPERTY TRUST
Independent auditor’s report

Independent Auditor’s Report

To the Unitholders of Vital Healthcare Property Trust

Opinion

Basis for opinion

Audit materiality

Key audit matters

We have audited the consolidated financial statements of Vital Healthcare Property Trust

and its subsidiaries (the ‘Group’ ), wh ich comprise the consolidated statemen t of financial

position as at 30 June 2022, and the consolidated statement of comprehensive income,

statement of changes in equity and statement of cash flows for the year then ended, and

notes to the consolidated financial statements, including a summary of significant

accounting policies.

In our opinion, the accompanying consolidated financial statements, on pages 92 to 131,

present fairly, in all material respects, the consolidated financial position of the Group as at

30 June 2022, and its consolidated financial performance and cash flows for the year then

ended in accordance with New Zealand Equivalents to International Financial Reporting

Standards (‘NZ IFRS’) and International Financial Reporting Standards (‘IFRS’).

We conducted ou r aud it in accordance with International Standards on Auditing (‘ISAs’) and

International Standards on Auditing (New Zealand) (‘ISAs (NZ)’). Ou r responsibilities under

those standards are further described in the Auditor’s Responsibilities for the Audit of the

Consolidated Financial Statements section of our report.

We believe that the audit evidence we have obtained is sufficient and appropriate to

provide a basis for our opinion.

We are independent of the Group in accordance with Professional and Ethical Standard 1

International Code of Ethics for Assurance Practitioners (including International

Independence Standards) (New Zealand) issued by the New Zealand Auditing and Assurance

Standards Board and the International Ethics Standards Board for Accountants’

International Code of Ethics for Professional Accountants (including International

Independence Standards), and we have fulfilled our other ethical responsibilities in

accordance with these requirements.

Our firm carries out other assignments for the Group in the area of sustainability reporting

non-assurance services and as independent AGM vote scutineer. These services have not

impaired our independence as auditor of the Group. The firm has no other relationships

with, or interests in, the Group.

We consider materiality primarily in terms of the magnitude of misstatement in the financial

statements of the Group that in our judgement would make it probable that the economic

decisions of a reasonably knowledgeable person would be changed or influenced (the

‘quantitative’ materiality). In addition, we also assess whethe r othe r matters that come to

our attention during the audit would in our judgement change or influence the decisions of

such a person (the ‘qualitative’ materiality). We use materiality both in planning the scope

of our audit work and in evaluating the results of our work.

We determined materiality for the Group financial statements as a whole to be $2.8 million.

Key audit matters are those matters that, in our professional judgement, were of most

significance in our audit of the consolidated financial statements of the current period.

These matters were addressed in the context of our audit of the consolidated financial

statements as a whole, and in forming our opinion thereon, and we do not provide a

separate opinion on these matters.

ANNUAL REPORT 2022|133
Key audit matter How our audit addressed the key audit matter

Valuation of Investment Properties

The Group’s investment properties consist of health sector

properties totalling $3,339 million as at 30 June 2022.

Revaluation gains on the Group’s investment properties for

the year ended 30 June 2022 of $244 million were

recognised in profit or loss. Information about the Group’s

property portfolio and valuation are set out in Note 6.

Investment properties are carried at fair value. Where

significant development is in progress at a property, this is

carried at cost, until either its fair value becomes reliably

measurable or the development reaches practical

completion.

The valuation of investment property is highly dependent on

forecasts and estimates including a number of unobservable

inputs to take into account property-specific attributes.

The Group’s policy is to engage external valuers for no more

than two years as per the Trust Deed, to perform valuations

for each of the properties on an annual basis (either at the

interim or annual reporting date). Independent registered

valuers determined the fair value of approximately 42

percent of the investment properties at 30 June 2022, and

the Board of Directors of the Manager determined the fair

value of the remaining properties.

The valuation methods used for assessing the fair value

include a combination of direct comparison, discounted

cash flow, capitalisation of contract and market income

approaches.

The external valuers and the Manager, amongst other

matters, take into consideration occupancy rates, weighted

average lease term to expiry (‘WALE’) and capitalisation

rates.

COVID-19 continues to cause disruption to economies in

which the Group operates. Note 6g discloses information

about the ongoing impact of COVID-19 on the valuation of

investment properties. operates. Some independent

valuations are reported on the basis of significant valuation

uncertainty.

The valuation of investment properties is a key audit matter

due to the subjective judgements and assumptions in the

valuation models, including those that relate to the

continued impacts of COVID-19.

We have evaluated the appropriateness of the valuation of

investment property by performing the following:

•Reviewing the external valuers’ valuation reports

and the valuation reports prepared by the Board

of the Manager. We evaluated the key metrics,

including capitalisation rate, market rent and

contract rent on a property and portfolio basis for

year on year movements and assessed whether in

our judgement, the movements represented outliers

to investigate. We held discussions, on a sample

basis, with the valuers and separately, with

representatives of the Manager and challenged

assumptions, including the possible outliers

identified.

•Agreeing property specific information supplied to

the external valuer and used in the Manager’s

valuations, including occupancy data, current rentals,

and lease terms, to the underlying records held by

the Group.

•Evaluating the objectivity, independence and

expertise of the external valuers.

•Evaluating the expertise of the Board of Directors of

the Manager.

•With respect to significant property developments:

owhere the Group has determined the

development has reached practical completion,

obtaining evidence supporting the Group’s

estimates of the expected future rental cash

flows that will apply upon completion and the

costs to complete the development;

owhere property developments are carried at

cost, testing the cost incurred to date on a

sample basis.

•Involving our valuation specialists to consider and

challenge, on a sample basis, the reasonableness of

the assumptions and valuation methodology applied,

including comparing assumptions to market data

where available.

•Reviewing valuation reports for continued impacts

of COVID-19 and how this was considered in the

valuation, including rental deferrals or abatements.

•Reviewing the valuations for any limitations of scope,

as a result of the continued COVID-19 pandemic, that

would impact the reliability of the valuations.

134|VITAL HEALTHCARE PROPERTY TRUST
Other information

The Board of Directors of the Manager are responsible on behalf of the Group for the

other information. The other information comprises the information in the Annual Report

that accompanies the consolidated financial statements and the audit report.

Our opinion on the consolidated financial statements does not cover the other

information and we do not express any form of assurance conclusion thereon.

Our responsibility is to read the other information and consider whether it is materially

inconsistent with the consolidated financial statements, or our knowledge obtained in the

audit or otherwise appears to be materially misstated. If so, we are required to report that

fact. We have nothing to report in this regard.

Board of Directors’

responsibilities for the

consolidated financial

statements

The Board of Directors of the Manager are responsible on behalf of the Group for the

preparation and fair presentation of the consolidated financial statements in accordance

with NZ IFRS and IFRS, and for such internal control as the directors determine is

necessary to enable the preparation of consolidated financial statements that are free

from material misstatement, whether due to fraud or error.

In preparing the consolidated financial statements, the Board of Directors of the Manager

are responsible on behalf of the Group for assessing the Group’s ability to continue as a

going concern, disclosing, as applicable, matters related to going concern and using the

going concern basis of accounting unless the Board of Directors of the Manager either

intend to liquidate the Group or to cease operations, or have no realistic alternative but to

do so.

Auditor’s responsibilities for the

audit of the consolidated

financial statements

Our objectives are to obtain reasonable assurance about whether the consolidated

financial statements as a whole are free from material misstatement, whether due to

fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable

assurance is a high level of assurance but is not a guarantee that an audit conducted in

accordance with ISAs and ISAs (NZ) will always detect a material misstatement when it

exists. Misstatements can arise from fraud or error and are considered material if,

individually or in the aggregate, they could reasonably be expected to influence the

economic decisions of users taken on the basis of these consolidated financial statements.

A further description of our responsibilities for the audit of the consolidated financial

statements is located on the External Reporting Board’s website at:

https://www.xrb.govt.nz/standards-for-assurance-practitioners/auditors-

responsibilities/audit-report-1

This description forms part of our auditor’s report.

Restriction on use

This report is made solely to the Group’s unitholders, as a body. Our audit has been

undertaken so that we might state to the Group’s unitholders those matters we are

required to state to them in an auditor’s report and for no other purpose. To the fullest

extent permitted by law, we do not accept or assume responsibility to anyone other than

the Group’s shareholders as a body, for our audit work, for this report, or for the opinions

we have formed.

Silvio Bruinsma, Partner

for Deloitte Limited

Auckland, New Zealand

11 August 2022

ANNUAL REPORT 2022|135
Unit Holder statistics

Analysis of unit holders as at 30 June 2022

Holding RangeNumber of unit holdersTotal units% of total units issued

1 - 49923042,0550.01

500 - 9998560,2320.01

1,000 - 1,999270394,7640.06

2,000 - 4,9998102,772,8500.43

5,000 - 9,9991,0497,488,7721.15

10,000 - 49,9992,05045,259,6876.97

50,000 - 99,99929019,508,8593.01

100,000 - 499,99912621,868,1293.37

500,000 - 999,99995,771,9950.89

1,000,000 Over17545,987,85384.11

Rounding-0.01

Total4,936649,155,196100

Substantial unit holders as at 30 June 2022

Unit holdersDate notice of filesNumber of units% of total units issued

1

NORTHWEST HEALTHCARE PROPERTIES REAL ESTATE

INVESTMENT TRUST1-Jul-22179,415,78827.64

FORSYTH BARR INVESTMENT MANAGEMENT LIMITED21-Mar-2240,830,7147.07

ACCIDENT COMPENSATION CORPORATION31-Mar-2229,235,9515.05

ANZ NEW ZEALAND INVESTMENTS LTD21-Mar-2226,304,8415.06

1On date notice filed

Twenty largest unit holders as at 30 June 2022

Unit holdersTotal% of units

NZGT SECURITY TRUSTEE LIMITED173,085,62526.66

FORSYTH BARR CUSTODIANS LIMITED56,518,6398.71

CUSTODIAL SERVICES LIMITED51,147,2447.88

CITIBANK NOMINEES (NEW ZEALAND) LIMITED - NZCSD33,996,9255.24

ACCIDENT COMPENSATION CORPORATION - NZCSD32,870,3265.06

HSBC NOMINEES (NEW ZEALAND) LIMITED - NZCSD31,647,5104.88

HSBC NOMINEES (NEW ZEALAND) LIMITED A/C STATE STREET -NZCSD21,059,2313.24

ANZ WHOLESALE TRANS-TASMAN PROPERTY SECURITIES FUND - NZCSD18,259,8322.81

JPMORGAN CHASE BANK NA NZ BRANCH- SEGREGATED CLIENTS ACCT - NZCSD16,497,4272.54

NEW ZEALAND DEPOSITORY NOMINEE LIMITED14,854,5692.29

JBWERE (NZ) NOMINEES LIMITED12,495,9091.92

TEA CUSTODIANS LIMITED CLIENT PROPERTY TRUST ACCOUNT - NZCSD10,892,6761.68

BNP PARIBAS NOMINEES (NZ) LIMITED - NZCSD10,463,0661.61

FNZ CUSTODIANS LIMITED10,224,4461.58

INVESTMENT CUSTODIAL SERVICES LIMITED6,696,9601.03

ANZ WHOLESALE PROPERTY SECURITIES - NZCSD5,202,6860.80

MFL MUTUAL FUND LIMITED - NZCSD <MFLA90>5,060,1840.78

NORTHWEST HEALTHCARE PROPERTIES MANAGEMENT LIMITED4,569,9840.70

BNP PARIBAS NOMINEES (NZ) LIMITED - NZCSD4,536,3220.70

FORSYTH BARR CUSTODIANS LIMITED3,877,8630.60

Top 20 holders of Units523,957,42480.71

Total Remaining Holders Balance125,197,77219.29

About Vital
Vital Healthcare Property Trust (Vital, the Trust) is an NZX-

listed investment fund (NZX:VHP) that invests in high-

quality healthcare properties in New Zealand and

Australia. The Trust is externally managed by NorthWest

Healthcare Properties Management Limited.

Vital's portfolio of 47

1

properties is valued at

~$3.3 billion with 72% (by value) located in Australia

and the balance in New Zealand. The portfolio

has over 135 tenants and over 2,800 beds.

Vital’s tenants include hospital operators and healthcare

providers who deliver a wide range of services

across the full spectrum of health services.

Further information is available at vhpt.co.nz

About the Manager

NorthWest Healthcare Properties Management Limited

(NWHPM, the Manager) is an external manager that

provides management services to Vital and its Unit Holders.

The Manager’s primary responsibilities include the day-to-

day administration of Vital, portfolio management, sourcing

new opportunities and conducting due diligence on potential

acquisitions. The Manager is also responsible for providing

specialist property management, project management,

development management and leasing services to the Trust.

The Manager’s Board of five comprises three

independent directors and two NorthWest

appointees. Refer to page 76 for more details.

Vital’s leadership team is led by Aaron Hockly (Fund

Manager), and draws on the skills and experience of over

60 real estate professionals across New Zealand and

Australia with offices in Auckland, Melbourne, Sydney

and the Gold Coast. Refer to page 78 for more details.

NorthWest

The Manager is a subsidiary of Toronto Stock

Exchange-listed NorthWest Healthcare Properties REIT

(NorthWest REIT). NorthWest REIT operates across

seven countries in four continents and was founded

by its current CEO, Paul Dalla Lana, in 2004. Among

other roles, Paul is a director of Vital’s Manager.

NorthWest REIT has ~NZ$12.4 billion of assets under

management globally and over 300 real estate professionals.

In Australia and New Zealand, NorthWest is led by regional

CEO and NorthWest REIT President, Craig Mitchell.

Vital is the only NZX listed specialist

landlord of healthcare property and the

fourth largest NZX listed property vehicle.

Vital’s structure

Vital benefits from being managed by a global

healthcare property owner and manger.

1

Includes post 30 June 2022 acquisition of Kawarua Park Health Precinct, Queenstown

13 6

|

VITAL HEALTHCARE PROPERTY TRUST

OUR STRUCTURE – A UNIT TRUST
Vital Unit Holders

New Zealand’s largest specialist and

only listed owner of healthcare real estate

~NZ$12.4bn7

assets under

management

number of countries

NorthWest

operates in

Vital’s Manager and largest Unit Holder

Management of Vital in accordance with the Trust Deed

Majority NZ based institutions and retail investors

~$3.3bn portfolio healthcare

real estate in Australia and New Zealand

~27%

~73%

>300

healthcare

real estate

professionals

In Australia and New Zealand, NorthWest has

a 60+ team of healthcare property professionals.

ANNUAL REPORT

|

137

Healthy properties
deliver healthy returns

13 8

|

VITAL HEALTHCARE PROPERTY TRUST

MANAGER
NorthWest Healthcare Properties

Management Limited

Level 17, HSBC Tower,

188 Quay Street

Auckland 1010

Telephone: 0800 225 264 (NZ freephone);

+64 9 973 7300

Email: enquiry@vhpt.co.nz

NorthWest Healthcare Properties

Management – Australia

Level 45, Rialto South Tower,

525 Collins Street

Melbourne 3000

Sydney Office

NorthWest Healthcare Properties REIT

Level 2, 285 George Street

Sydney, NSW 2000, Australia


Gold Coast Office

Gold Coast, QLD 4218, AU

BOARD AND OFFICERS

OF THE MANAGER

Graham Stuart – Independent Chair

Angela Bull – Independent Director

(Appointed 26 April 2022)

Paul Dalla Lana – Director

Andrew Evans – Independent Director

(retired on 30 June 2022)

Craig Mitchell – Director

Dr Michael Stanford – Independent Director

Aaron Hockly – Fund Manager

Michael Groth – Chief Financial Officer

Vanessa Flax – Regional General Counsel

A/NZ and Company Secretary

AUDITOR

Deloitte Limited

Deloitte Centre

80 Queen Street

Auckland 1010

Private Bag 115-033

Auckland 1140

Telephone: +64 9 303 0700

Facsimile: +64 9 303 0701

LEGAL ADVISERS TO THE

TRUST AND THE MANAGER

Bell Gully

Vero Centre

48 Shortland Street

PO Box 4199

Auckland 1140

Telephone: +64 9 916 8800

Facsimile: +64 9 916 8801

Ashurst Australia

Level 16, 80 Collins Street,

South Tower,

GPO Box 4958

Melbourne, Victoria 3001

Telephone: +61 3 9679 3000

SUPERVISOR

Trustees Executors Limited

Level 11/51 Shortland Street

Auckland 1010

PO Box 4197

Auckland 1140

Telephone: 0800 878 783

Facsimile: +64 9 308 7101

BANKERS TO THE TRUST

ANZ Bank New Zealand Limited

ANZ Centre

23–29 Albert Street

Auckland 1010

Australia and New Zealand

Banking Group Limited

ANZ Centre Melbourne, Level 9

833 Collins Street, Docklands

Victoria 3008, Australia

Bank of New Zealand

Deloitte Centre

80 Queen Street

Auckland 1010

Westpac Banking Corporation

Westpac Place

275 Kent St

Sydney NSW 2000

Australia

The Hongkong and Shanghai

Banking Corporation Limited

International Towers

100 Barangaroo Avenue

Sydney NSW 2000

Australia

Industrial and Commercial Bank

of China Limited – Australia

International Towers

100 Barangaroo Avenue

Sydney NSW 2000

Australia

Industrial and Commercial Bank of

China Limited – New Zealand

2 Queen Street,

Auckland CBD,

Auckland 1010

New Zealand

Credit Agricole CIB Australia Limited

Aurora Place

88 Phillip Street

Sydney NSW 2000

Australia

UNIT REGISTRAR

Computershare Investor Services Limited

159 Hustmere Road

Takapuna, Auckland 0622

Private Bag 92119

Auckland 1142

New Zealand

vital@computershare.co.nz

Telephone: +64 9 488 8777

Facsimile: +64 9 488 8787

This document is printed on an environmentally responsible

paper, produced using Elemental Chlorine Free (ECF),

FSC(R) certified, Mixed Source pulp from Responsible

Sources, and manufactured under the strict ISO14001

Environmental Management System.

Directory

ANNUAL REPORT

|

13 9

DISCLAIMER:
This document has been prepared by NorthWest Healthcare Properties Management

Limited (the Manager) as manager of the Vital Healthcare Property Trust (the Trust).

This document provides general information only and is not intended as investment,

legal, tax, financial product or financial advice or recommendation to any person and

must not be relied on as such. You should obtain independent professional advice

prior to making any decision relating to your investment or financial needs.

All references to $ are to New Zealand dollars unless otherwise indicated.

This document may contain forward-looking statements. Forward-looking statements can include

words such as “expect”, “intend”, “plan”, “believe”, “continue” or similar words in connection

with discussions of future operating or financial performance or conditions. Any indications

of, or guidance or outlook on, future earnings or financial position or performance and future

distributions are also forward-looking statements. The forward-looking statements are based

on management’s and directors’ current expectations and assumptions regarding the Trust’s

business, assets and performance and other future conditions, circumstances and results. As with

any projection or forecast, forward-looking statements are inherently susceptible to uncertainty

and to any changes in circumstances. The Trust’s actual results may vary materially from those

expressed or implied in the forward-looking statements. The Manager, the Trust, and its or their

directors, employees and/or shareholders have no liability whatsoever to any person for any

loss arising from this document or any information supplied in connection with it. The Manager

and the Trust are under no obligation to update this document or the information contained

in it after it has been released. Past performance is no indication of future performance.

The information in this document is of general background and does not purport to

be complete. It should be read in conjunction with Vital’s market announcements

lodged with NZX, which are available at www.nzx.com/companies/VHP.

---

FY22 Annual
Results Presentation

11 AUGUST 2022

All amounts are in NZD unless otherwise shown
Contents

Overview of Vital 3

FY22 highlights 4

Financial results and capital management

1

2

Portfolio and acquisitions

17

5 largest assets and asset groupings 22

Developments 28

Future focus

33

Appendices 38

Acquisitions and de

velopments detail

3

9

Additional por

tfolio information

49

Additional financial information


5

6

Presenters

Aaron Hockly

Fund Manager

Richard Roos

Exec. Director, Portfolio

Michael Groth

Chief Financial Officer

Chris Adams

Exec. Director, Projects

VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 2

~$3.3bn17.6 years
VITAL IS THE ONLY SPECIALIST HEALTHCARE LANDLORD LISTED ON THE NZX

Overview of Vital

1

~$2.4bn

~$0.9bn

31 PROPERTIES (AUS)

16 PROPERTIES (NZ)

47

1

PROPERTIES

(AUS & NZ)

W

ALE

WESTERN

AUSTRALIA

NORTHERN

TERRITORY

SOUTH


AUSTRALIA

NEW

SOUTH

WALES

TASMANIA

VICTORIA

QUEENSLAND

4

3

6

6

12

T he owner of a ~$3.3 billion healthcare

property portfolio in New Zealand

(28% of assets) and Australia (72%);

T he only NZX-listed specialist

healthcare landlord (NZX ticker: VHP);

Externally managed by a subsidiary

of Toronto-listed, global healthcare

real estate owner and manager,

NorthWest Healthcare Properties REIT

(TSX ticker: NWH);

Underpinned by rental income that

tracks inflation with ~80% of lease

income indexed to CPI in some way;

and

T argeting 2–3% AFFO and DPU

growth per annum over the medium

term, whilst retaining a conservative

pay-out ratio.

VITAL HEALTHCARE PROPERTY

TRUST (VITAL) IS:

1

Number of properties include Kawarau Park Health Precinct, Queenstown, but excludes strategic assets.

All other figures exclude Kawarau Park Health Precinct, Queenstown

As at 30 June 2022

14

2

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

3

FY22
highlights

Key events over FY22
2021

JULY 2021

P ractical completion of Wakefield

Hospital, Wellington Stage 1 for

a total cost of ~$50.8m

AUGUST 2021

FY22 AFFO and distribution

guidance announced of 11.8cpu

and 9.5cpu respectively

Acquisition of Hutt Valley Health

Hub, Wellington for $46.5m

announced

OCTOBER 2021

A$315m debt refinance to extend

debt capacity by A$65m and

extend debt tenor

Acquisition of Tennyson Centre,

Adelaide for A$92.75m

$115m placement primarily to

existing institutional holders at

$2.90 per unit

Commencement of $91.5m

Wakefield Hospital Stage 2 with

demolition of existing building

Terms agreed for $74m of

new and extended brownfield

developments across five of

Evolution Healthcare’s facilities in

New Zealand

NOVEMBER 2021

$27.8m raised via a Unit Purchase

Plan from existing retail holders at

$2.85 per unit

Completion of Stage 1 of Playford

Health Hub, Adelaide for ~A$20m

Commencement of $6.3m Royston

Stage 2, $31.7m Grace Hospital

and $6.3m Bowen Hospital

developments

MoU signed with Calvary Health

Care to operate a ~A$93m

hospital (Stage 3 of Playford

Health Hub)

VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 5

Key events over FY22 (cont'd)
2022

FEBRUARY 2022

Acquisition of land for expansion

of The Hills Clinic in Sydney for

~A$50m (includes land cost and

estimated construction costs)

Announcement of acquisition of

multi-stage development site in

South West Sydney for A$76.6m

(includes acquisition costs, Stage

1 construction costs and tenant

incentive)

Upgrade to annualised AFFO and

distribution guidance to at least

11.9cpu and 9.75cpu, respectively

3.2% and 8.5% above FY21

Practical completion achieved for

Royston DSU with a project value

of $9.5m

APRIL 2022

Appointment of Angela Bull

as an Independent Director

Acquisition of 68 St Asaph St,

Christchurch for $50.7m

Acquisition of Kawarau Park

Health Precinct, Queenstown

for ~$95m (settled July 2022)

Acquisition and expansion of

Endoscopy Auckland announced

for $43.8m (acquisition cost plus

estimated development spend)

Announcement of expansion of

Ormiston Hospital, Auckland

for ~$40m (includes land

already owned by Vital)

MAY 2022

$200m in new equity raised

through an entitlement

offer at $2.95 per unit

A cquisition of a vacant aged

care facility in Mt Eliza, Victoria

for ~$A12m (includes transaction

costs) for redevelopment

Ormiston Hospital $40m

expansion commenced

JUNE 2022

Retirement of Andrew Evans

as an Independent Director

after 15 years on the board

Acquisition of 80 Ascot

Ave, Remuera for $16m

Agreement to undertake a

~A$98m development of a new

health facility in Hobart, Tasmania

MARCH 2022

P ractical completion of A$97m

Epworth Eastern East Wing Tower

A$39.3m Playford Health

Hub Stage 2 commenced with

demolition of existing building

A$350 debt refinance completed,

increasing facility limits by A$150m

and weighted average term to

maturity by 1.1 years to 4.4 years

VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 6

FY22 highlights – capital and Unit Holder returns
TRANSACTIONS UNDERTAKEN TO GROW FUTURE EARNINGS AND SUPPORT FUTURE PORTFOLIO GROWTH

$379mA$665m

$397m

18.0%

15.3%

8.5%

equity raised

1

debt refinanced

property transactions

increase in earnings;

3.3% per unit

$382m

2

acquisitions and $15m disposals

increase in NTA per unit

increase in

distributions per unit

1

Excludes issue costs and comprises equity raising (x2), DRP (x4) and incentive units issued to the Manager

2

Excluding transaction costs but including Kawarau Park Health Precinct, Queenstown which settled in July 2022

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

7

FY22 highlights – increased development focus
ENHANCED PORTFOLIO METRICS IN ALIGNMENT WITH STRATEGY

10 developments$100m

$148m

$169m

$196m

underway, $215m spend

remaining with a further ~$1.8bn

1


being actively considered

of development and

capital expenditure

works undertaken

2


of developments moved from

“potential” to “committed”

fund-through developments

3

of strategic land held for

future development

1

Development timing and therefore spend expected to be over a staged and lengthy period (at least 10 years)

2

Includes $86m of developments, ~$12m of value-add capex and ~$2m maintenance and tenant incentive capex

3

Developments where Vital is funding through the development rather than acting as developer

VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 8

MATERIAL ACHIEVEMENT OF ALL FY22 TARGETS; FULL DETAILS AVAILABLE IN VITAL'S FY22 SUSTAINABILITY REPORT
FY22 highlights – sustainability

Continue to improve diversity on the

Board and in Management

F ocus on mentoring and career

progression

Encourage greater community involvement

Continue existing professional

development

Establish baseline environmental reporting

Meet distribution guidance

and AFFO target

Maintain prudent AFFO pay-out ratio

Continue charitable and community

support programme

Extend and diversify debt

P articipate in third-party assessments

through GRESB and CDP

Improve CDP score

Deploy sustainability initiatives with

key stakeholders including tenants

Continue to progress investigation of

additional solar installations

PeoplePracticePlaces

NWH released its first Sustainability Report for its

global operations including Vital. View the report at:

www.nwhreit.com/mailers/sustainability/nwh-sustainability-report.pdf

During FY22, Vital and NorthWest joined the New Zealand Green Building Council and the Green Building Council of Australia

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

9

Short, medium and longer term progression
1

PORTFOLIO ENHANCEMENTS SUPPORT TARGET OF GROWING AFFO AND DISTRIBUTIONS BY 2–3%

2

PER UNIT PER ANNUM

Portfolio enhanced through acquisitions, development and disposals to: (1) increase diversity of assets and tenants,

(2) reduce age of building and (3) maintain long WALE. This helps to reduce income risk for Vital’s Unit Holders.

1

All date references are to 30 June of that year unless otherwise stated

2

Average building age = the later of the date of construction or the last significant capital works

3

Includes $214.9m of committed development spend remaining and ~$1.8bn of developments being considered. Development timing and therefore spend expected to be over

4

Committed and potential development pipeline

489%

growth (FY12-FY22)

Market leading WALE

TOTAL PROPERTY VALUEWALE

17.6 years

2022

11.9 years

2 012

~ $0.57bn

(AUS: 71%,

NZ: 29%)


2 012

~$1.93bn

(AUS: 76%,

NZ: 24%)


2 019

~$3.34bn

(AUS: 72%,

NZ: 28%)


2022

2 019

18.1years

Younger buildings reduce

maintenance capex requirements

AVERAGE BUILDING AGE

11.1 years

20222 012

Data not

available

156%

increase (FY12- FY22)

NET PROPERTY INCOME (ANNUAL)

$123m

FY22

$48m

F Y 12

Enhance earnings and valuation

growth and support portfolio

development

DEVELOPMENT PIPELINE

$2.1bn

4

2022

$279m

2 019

~$60m

2 012

19 %

2022

4.58%

2022

49%

2 019

5.61%

2 019

40%

2 012

9.30%

2 012

Concentration

risk reduced

Diversity of assets reduces

risk and enhances earnings

LARGEST SINGLE TENANT EXPOSURESECTOR SPLIT

2022

Hospital 80%,

Ambulatory Care

16%,

Aged Care 4%

2 012

Hospital 88%,

Ambulatory Care

12%,

Aged Care 0%

Reduction demonstrates: (1)

quality of assets and tenants;

and (2) value added by leasing

and development undertaken

WEIGHTED AVERAGE CAP RATE

2 019

Hospital 83%,

Ambulatory Care

14%,

Aged Care 3%

13.5 years

2 019

$98m

F Y 19

VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 10

Balance sheet strengthened through raising $379m (before costs) of new equity and extending
debt whilst supporting portfolio growth as a means to grow AFFO and distributions

BALANCE SHEET STRENGTHENED

241%

growth (FY12-FY22)

NTA PER UNIT

Short, medium and longer term progression

1

$3.34

2022

$2.31

2 019

$0.98

2 012

30.0%

2022

35.3%

2 019

42.3%

2 012

BALANCE SHEET GEARING

No debt expiring

until October 2023

3.9 years

20222 019

2.2 years

2 012

3.8 years

AVERAGE DEBT MATURITY

Significantly

expanded

11 . 9 2 c

FY22

9.625

FY22

9.9c

F Y 19

8 . 75

F Y 19

8.0c

1

F Y 12

7. 7

F Y 12

AFFO PER UNIT (CPU)DISTRIBUTIONS PER UNIT (CPU)

49%

growth (FY12-FY22)

25%

growth (FY12-FY22)

1

Net Distributable Income per unit (AFFO not reported)

VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 11

Financial results and
capital management


Financial performance

PROPERTY EARNINGS GROWTH HAS FACILITATED AFFO GROWTH


FY22


F Y 21

($)

CHANGE

(%)

CHANGE

Net property income123,018 109,663 13,355 12.2

Expenses ex. finance(37,518)(30,915)(6,603)(21.4)

Net finance expenses(28,983)(27,684)(1,299)(4.7)

Operating profit before tax and other income56,51751,0645,45310.7

Property revaluations and other income305,758267,40338,35514.3

Profit before income tax362,275 318,467 43,808 13.8

Adjusted funds from operations (AFFO)67, 8 24 57,457 10,367 18.0

Adjusted funds from operations (cpu)11 . 9 2 11 . 5 4 0.38 3.3

Distributions per unit (cpu) 9.63 8.88 0.75 8.5

Average NZD/AUD exchange rate in the period0.93770.9306

Contribution from structured

rent reviews, acquisitions and

development rents

$244m of revaluation gains

during FY22

All values shown as $000s

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

13

Net property income
NPI GROWTH (EXCL FX) INCREASED FROM ACQUISITIONS, DEVELOPMENTS AND RENT REVIEWS

NET PROPERTY INCOME BRIDGE

($M)

Acquisitions – income from late FY21

Development income – rentalisation

of capital expenditure and holding

income from strategic site acquisitions

Disposals – income adjustment from

strategic disposal of three regional

hospitals in FY21 for ~A$100m and

sale of Gold Coast Surgical Centre for

~A$13m in FY22 (before selling costs)

Maintenance capex – remains modest

due to long term leases, minimal

upcoming expiries, young building

age and ability to capitalise or rentalise

upgrades as part of developments

1

Acquisitions of Grace Hospital, Epworth Camberwell, Tennyson Centre, Nelson Rd Box Hill and Hutt Valley Health Hub

2

Incremental development income contributed from Wakefield, Royston, South Eastern and Playford Health Hub - Retail and Carpark

3

Disposals of regional Healthe Care assets (Mayo, North West and Dubbo) in FY21 and Gold Coast Surgery Centre in FY22

4

Amortisation, Non-recurring R&M and abatements

~80% of Vital's leases (by income) are indexed to CPI in some way

109.7

9.9

3.7

4 .1

(0.7)

(3.0)

(0.7)

12 3 . 0

90

95

100

105

11 0

11 5

12 0

12 5

13 0

FY21Acquisitions

1

Development

Income

2

Rent Reviews

& Leasing Activity

Disposals

3

Amortisations

& Other

4

Foreign

Exchange

FY22

+12.2% growth (incl FX) / +12.8% (excl FX)

FY22 property income growth of +2.8%

(like-for-like, same currency basis)

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

14

Balance sheet
STRENGTHENED BY SIGNIFICANT REVALUATION GAINS, NEW EQUITY AND DEBT EXTENSION


FY22


F Y 21

($)

CHANGE

(%)

CHANGE

Investment properties3,339,169 2,634,588 704,581 26.7

Other assets60,6652 7, 9 7 232,693 11 6 . 9


Bank debt1,018,777 932,377 86,400 9.3

Other liabilities215 ,18 0226,733(11,553)(5.1)

Debt to gross assets

1

30.035.0(14.41)

Unitholder funds2,165,876 1,503,451 662,425 44.1

Units on issue (000s)649,155519 , 75 3129,402 24.9

Net tangible assets ($/unit)3.34 2.890.44 15.3

All values shown as $000s

Period end NZD/AUD exchange rate0.90370.9309

$379m (before costs) of new

equity raised via placement,

UPP, rights offer and four DRP's

Increase due to:

Development and capital works

expenditure of $100m

2

Acquisitions totalling $299m

(including transaction costs)

Revaluation gains of $244m

Disposals of $(13m) (book value

at sale date)

FX impact of $75m

1

Calculated in accordance with Vital's Trust Deed

2

Includes $86m of developments, ~$12m of value-add capex and ~$2m maintenance and tenant incentive capex

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

15

Debt duration
INCREASED WEIGHTED AVERAGE DEBT DURATION AND AVAILABLE HEADROOM FOR UTILISATION

Increased the weighted

average debt duration from

2.5 years to 3.9 years with no

expiries until October 2023

1

Trust Deed debt ratio is based on total borrowings to gross asset value of the Trust

2

Bank LVR is based on total indebtedness to secured property value as determined by external valuers

DEBT DURATION PROFILE – 30 JUNE 2022 (A$)

Headroom available under

existing facility to support

future growth primarily via

the development pipeline

0

50

100

150

200

250

300

350

Dec-23 Jun-24 Dec-24 Jun-25 Dec-25 Jun-26 Dec-26 Jun-27 Dec-27 Jun-28 Dec-28 Jun-29

VALUE ($M)

BANK FACILITIES30 JUNE 202230 JUNE 2021

Debt to gross assets (Trust Deed)

1

30.0%35.0%

Bank loan to value ratio - actual

2

32.1%38.0%

Bank loan to value ratio - covenant55.0%55.0%

Weighted average duration to expiry3.9 yrs2.5 yrs

Undrawn facility limit (A$)$302m$144m

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

16

Portfolio and
acquisitions

Portfolio update
~$3.3BN INVESTED IN 47 CORE HEALTHCARE PROPERTIES WITH OVER 2,800 BEDS AND OVER 135 SEPARATE TENANTS

CPI aligned leases support income growth

WA

NT

SA

NSW

TAS

VIC

QLD

NZ

$287m (excluding transaction costs) of acquisitions

undertaken; all of which have development upside

which is being pursued. Details of acquisitions

not previously announced are on pages 20-

21 of this presentation. Details of acquisitions

announced during FY22 are on pages 40-47 of

this presentation.

Portfolio composition enhanced through first South

Island acquisitions and growth in target markets of

NSW and NZ.

12.2% growth in net property income; 2.8% for

same properties on a like-for-like and constant

currency basis

GEOGRAPHIC DIVERSIFICATION

(BY VALUE

1

)

Income

4%

7%

12 %

26%

23%

26%

2%

1

Excludes post 30 June 2022 acquisition of Kawarau Park Health Precinct, Queenstown

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

18

Portfolio update (cont'd)
19 %

16 %

22%

15 %9%

4%

3%

3%

3%

2%

4%

Healthe Care Surgical 16%

Norfolk Southern Cross Limited 4%

Evolution Health

care

9%

Epwor

th 15%

Hall & Prior

4%

Bolton Clarke 3%

Sportsmed 3%

Mercy Ascot


3%

R

amsay

2%

Oth

er 22%

Aurora Healthcare 19%

Largest single tenant exposure

reduced largely through

acquisitions and disposals from

~50% two years ago to <20%

Vital has a diverse portfolio

and income stream by

location and tenant

Seeking to continuously

enhance diversity of income

Diversification

TENANT DIVERSIFICATION

% OF RENT

occupancy for the portfolio

98.8%

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

19

Recent acquisitions
A development approval was lodged in March 2022 for

18,347 square metres of GFA for both public and private

health services to support the growing catchment.

The public health services offered include general medical

and a broad range of surgical services including obstetrics,

paediatrics and psychiatry. The hospital is located in South

Brisbane and services a population of >340,000 within one

of Queensland’s fastest growing areas.

Meadowbrook

Queensland

Logan Hospital is undergoing

a A$540 million expansion to

deliver 688 beds by 2023.

VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 20

Recent acquisitions (cont'd)
Tasman Medical Centre

Hobart, TAS

In July 2022, Vital agreed terms with

Nexus Hospitals to fund through the

development of a new, purpose-built

8,747 square metre day hospital and

ambulatory care facility in Hobart,

Tasmania. The facility will be known as

"Tasman Medical Centre".

Total costs are expected to be ~A$98m

including A$9.5m of land which

Vital acquired in early July 2022.

Construction is expected to complete

by the end of 2024. Vital will receive

a ~4.5% yield during construction and

from practical completion. Tasman

Medical Centre is 100% pre-leased

from practical completion to a mixture

of Nexus (60% of rent) and a mix of

healthcare and ancillary tenants.

The WALE is expected to be 13.3 years

from practical completion with annual

rent reviews a mixture of CPI with a

floor of 2.5% and a cap of 5% and

fixed rent reviews (typically 2.5%). This

fund-through is Vital's sole investment in

Tasmania after previously selling a small

facility in Burnie, Tasmania in late 2020.

In May 2022, Vital acquired a former 60-bed aged care

facility ~7kms from Frankston for ~A$12m (including transaction

costs). A process is underway to redevelop this facility.

Mt Eliza

Mornington

Peninsula, VIC

New development fund-through

planned; Vital's first asset in

Hobart and its only exposure to

Tasmania.

In late June, Vital acquired 3,415

square metres of vacant land adjoining

Ascot Hospital in Remuera, Auckland

for $16m.

Planning work is underway to expand

Vital's footprint comprising two existing

buildings plus a car park in this leading

healthcare precinct.

80 Ascot Ave

Auckland, NZ

VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 21

5 largest assets
and asset groupings

5,330sqm of development land
available for further expansion

Epworth Eastern Precinct, Melbourne, VIC

A$482m

VALUE

ASSETS

Epworth Eastern Hospital campus, 17-23

Nelson Rd (development land), Ekera

Medical Centre and 120 Thames St

PATIENT BEDSLAND AREANLA

270~15,000sqm~35,000sqm

PROXIMITY TO

PUBLIC HOSPITAL

% OF VITAL'S

PORTFOLIO

YEAR ACQUIRED

BY VITAL

50m16.0%1999

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

23

Lingard Private Hospital Precinct, Newcastle, NSW
Recent expansion completed and further

expansion being considered

A$256m

VALUE

ASSETS

Lingard Private Hospital, Lingard

Day Centre and 27 Hopkins

Street (development land)

LAND AREANLA

~15,000sqm11,500sqm

PROXIMITY TO

PUBLIC HOSPITAL

% OF VITAL'S

PORTFOLIO

YEAR ACQUIRED

BY VITAL

3.6km8.5%2 010

PATIENT BEDS

14 0

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

24

Ascot Hospital Precinct, Auckland, NZ
~3,400sqm of development

land available for expansion

$209m

VALUE

ASSETS

Ascot Hospital, Ascot Central,

80 Ascot Ave (development land)

and Ascot Carpark

LAND AREANLA

~40,000sqm~16,000sqm

PROXIMITY TO

PUBLIC HOSPITAL

% OF VITAL'S

PORTFOLIO

YEAR ACQUIRED

BY VITAL

5.6km6.3%19 9 7

PATIENT BEDS

88

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

25

Belmont Private Hospital, Brisbane, QLD
A$22.6m expansion underway

A$146m

VALUEASSETS

Belmont Private Hospital

LAND AREANLA

~43,000sqm~8,700sqm

PROXIMITY TO

PUBLIC HOSPITAL

% OF VITAL'S

PORTFOLIO

YEAR ACQUIRED

BY VITAL

11.0km4.8%2 010

PATIENT BEDS

15 0

VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 26

Wakefield Hospital, Wellington, NZ
$130m

VALUE

Wakefield Hospital

ASSETS

14,500sqm of NLA anticipated on

completion of Stage 2 of redevelopment

LAND AREANLA

~20,000sqm14,500sqm

PROXIMITY TO

PUBLIC HOSPITAL

% OF VITAL'S

PORTFOLIO

YEAR ACQUIRED

BY VITAL

850m3.9%2 017

PATIENT BEDS

68

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

27

Developments

Development strategy and value-add
TARGETING 10–15% OF THE PORTFOLIO (BY VALUE) TO BE UNDER DEVELOPMENT

NorthWest has a market leading development team

with an unmatched depth of experience in the sector

Earnings and

capital growth

Enhancing the

portfolio

Meeting the needs

of our operator

partners

1

Development timing and therefore spend expected to be over a staged and lengthy period (at least 10 years)

2

Developments where Vital is funding through the development rather than acting as developer

Developments are key for:

FOCUS

PIPELINE

Development land has been

acquired in key locations in

New Zealand and Australia;

planning is being progressed

$293m of committed

developments, representing

~9% of total portfolio value;

$215m of spend remaining

~$1.8bn

1

of potential

development opportunities

identified (subject to business

cases, due diligence and

approvals)

In addition, $169m of fund-

through

2

developments have

been committed to

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

29

Having identified the opportunity within the Box Hill
Health and Education Precinct to co-locate a private

hospital with the existing public hospital, Epworth

Eastern Private Hospital completed in 2005, consisting

of 208 beds, eight operating theatres, associated

radiology, pathology and consulting suites.

Subsequent expansion of the Epworth Eastern

Tower was announced in 2018 responding

to the precinct's growth requirements.

The Epworth Eastern Tower project consists of

14-storey building including five operating theatres

and 63 beds. Construction was successfully

completed throughout COVID-19 lockdowns with

practical completion reached in March 2022.

The project had a total cost of A$97 million

bringing the total value of the Epworth

Eastern campus to over A$400 million.

Epworth have taken a head lease over all floors

to level 10 with the remaining levels 11-14 to

be leased to individual consulting surgeons.

Development case study - Epworth Eastern Precinct

NORTHWEST HAS A LONGSTANDING PARTNERSHIP WITH EPWORTH HEALTHCARE, HELPING VITAL DEVELOP THIS PRECINCT OVER 20 YEARS

Future growth has been provisioned for

via the acquisition of an adjacent land

parcel with potential for a 40,000sqm

mixed use development. Master

planning for this site has commenced.

total cost

fully let blended yield

$97m

~5.8%

completion

March 2022

WALE

20.5 years

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

30

As part of the acquisition Vital and the
hospital operator (a joint venture between

Evolution Healthcare and Southern Cross)

have been undertaking design and

planning to extend the existing facility.

As part of the acquisition, Vital committed

to funding masterplanned works at Grace

Hospital over five years from settlement of

the transaction. Stage 1 of the masterplan

works was to complete the fit-out two cold

shell theatres, taking the total number of

operational theatres to 11 and to improve

admission areas and patient flows.

This initial stage has been completed

and will officially open in July 2022.

The development spend is forecast

to increase the value of Grace

Hospital by over 25%.

expected completion

Late 2023

project value

$31.7m

yield

5.3%

spend to date

$5.5m

Development case study - Grace Hospital

IN LATE 2020 VITAL ANNOUNCED THAT IT HAD ACQUIRED GRACE HOSPITAL

VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 31

Work underway to convert ~$196m of strategic land holdings into income producing properties (including the above).
Update on new and proposed developments

Stage 1 Medical Office Building

Development Application lodged

in April 2022 and Stage 2 Mental

Health Development Application

lodged in June 2022.

Early works have commenced on site

to expand Ormiston Hospital. Leasing

pre-commitment sits at approximately

70% with strong enquiry.

Development Application lodged in

July 2022. Detailed Design phase

commenced with procurement strategy

to be determined in late 2022.

Coomera

BRISBANE, QLD

Ormiston

SOUTH AUCKLAND, NZ

Woolloongabba

SOUTH BRISBANE, QLD

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

32

Future
focus

Ehara tāku toa I te toa takitahi,

engari he toa takitini.

My strength is not as an individual,

but as a collective.

Whakataukī

Māori proverb

TENANT ENGAGEMENT
AND INTERACTION

Workshop with our key tenants

encouraging active engagement in our

sustainability efforts

STRATEGIC TENANT ALLIANCES

To support establishing a baseline,

tracking and transparently reporting

against Scope 3 GHG emissions

F urther prioritise and develop ESG

alliance with Epworth Healthcare and

Evolution Healthcare and implement

similar ESG alliances with other key

operators

OPTIMISING SPACES FOR

PATIENT WELLNESS

Continue to undertake air quality

testing with 100% of our managed and

controlled properties to be assessed

against wellness dimensions

Sustainability initiatives

GREEN STAR PERFORMANCE

Explore opportunities for full Green Star

certification on a number of the landlord-

controlled assets within the portfolio

NET-ZERO EMISSIONS

All new projects must be net zero-emissions

ready and enable a transition to 100%

renewable energy powered buildings, with

zero onsite fossil fuels

Over the next 18 months we will set a

short-term emissions and 100% renewable

energy target, and explore opportunities

to phase out fossil fuels from our existing

portfolio

EMBODIED EMISSIONS AND

LIFE CYCLE ASSESSMENTS

R educing upfront carbon emissions is a key

requirement for all new building projects

and redevelopments

HEALTH AND WELLBEING

Sustainable procurement, healthy

designs and building materials will be

incorporated on all projects, including

increased daylight, improved fresh air

provisions and sustainable materials

CLIMATE RESILIENCE

All projects must be climate resilient with

climate change risks identified

SEISMIC RESILIENCE

C ommitted to carrying out seismic

strengthening of 68 Saint Asaph St to

achieve a 100% IL3 rating, which is

designed for a 1/1000 year event

Healthy planet

Thriving partners

VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 34

Sustainability initiatives (Cont'd)
KEYSTONE TRUST

T hree year Key Scholarship Partner

programme through an annual

scholarship, mentoring and support

to a student from the University of

Auckland

CHARITABLE GIVING AND

COMMUNITY INVOLVEMENT

P artner with our tenants and local

communities through charitable giving

of time and resources

LEARNING AND DEVELOPMENT

C ontinue personalised learning and

development initiatives for all permanent

and contract staff

CAREER PROGRESSION

Identify and further support enhanced

development and growth opportunities

for staff

TCFD FRAMEWORK

Vital is required to provide Climate-related disclosures under Financial Sector (Climate-related

Disclosures and Other Matters) Amendment Act 2021. We have engaged Deloitte to provide

gap analysis activities based on current exposure drafts of the standards to assist us in our

development of a roadmap for compliance that is informed by market experts and understood

by our Board and executive team.

GREEN LEASES

We have committed to embed a green lease clause within all new leases

INDIGENOUS WORKGROUP

AND RAP INITIATIVE

Deliver on-line training for all our

staff in A/NZ to ensure a baseline

understanding of indigenous matters

across Māori, Aboriginal and

Torres Strait Islander cultures and

the development of a Reconciliation

Action Plan (RAP)

Inclusive company

Enablers

Strong communities

VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 35

Sustainability remains a key focus for Vital and NorthWest
Significant development pipeline


$293m committed


$215m remaining cost to complete


~$1.8bn

1

potential pipeline

opportunities identified

In addition, $169m of fund-through

2


developments have been committed to.

Development is now a key focus

for short-medium term growth

Outlook and guidance

CONTINUED DELIVERY AND FOCUS ON EARNINGS GROWTH

FY23 distribution guidance of 9.75 cpu;

1.3% above FY22 to provide a projected

5 year CAGR of 2.2% per annum to 30

June 2023

Conservative ~80% pay-out ratio

expected to be retained

Health care assets (businesses

and real property) remain in high

demand evidenced by recent and

proposed acquisitions

Investors attracted to the stable

and growing returns offered by this

key sector

1

Development timing and therefore spend expected to be over a staged and lengthy period (at least 10 years)

2

Developments where Vital is funding through the development rather than acting as developer

VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 36

Why invest in Vital
VITAL IS THE ONLY SPECIALIST NZX-LISTED OWNER OF HEALTHCARE PROPERTY

Private healthcare is typically

a non-discretionary or high

priority discretionary spend

Less impacted by economic

or business cycles than other

property sectors

Ageing demographics and

growing population in both

Australia and New Zealand

Rising life expectancy

Improvements in science,

technology and healthcare

increase service offerings

Landlord to some of New

Zealand and Australia’s leading

private healthcare operators

~$3.3bn portfolio

98.8% occupancy

WALE: 17.6 years

Average building age

1

:

11.1 years

Targeting 2–3% AFFO

and DPU growth with a

conservative pay-out ratio

92% of leases increase

by CPI or fixed %

Embedded earnings

growth enhanced

by acquisitions and

developments

$215m

2

of remaining spend

on existing developments

and ~$1.8bn

3

of identified,

potential pipeline to be

partially funded by asset

recycling and existing debt

facilities

Weighted average project

yield of 5.8%; provide value

creation and earnings growth

DEFENSIVE SECTORHIGH DEMANDHIGH QUALITY

PORTFOLIO

EARNINGS GROWTHDEVELOPMENT UPSIDE

1

Average building age = the later of the date of construction or last significant capital works

2

Excludes fund-through developments

3

Development timing and therefore spend expected to be over a staged and lengthy period (at least 10 years)

Vital seeks to deliver stable and growing total Unit Holder returns, including an attractive risk-adjusted

income distribution, sourced from healthcare property

VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 37


Appendices


Acquisitions and

developments detail

General Notes: All non fund-through development costs excluding land
Committed developments – Australia and New Zealand

DEVELOPMENTS ENHANCE EARNINGS GROWTH AND IMPROVE ASSET QUALITY

ALL VALUES SHOWN IN $MDESCRIPTION OF WORKSDEVELOPMENT

COST

SPEND

TO DATE

COST TO

COMPLETE

FORECAST

NET RETURN

FORECAST

COMPLETION DATE

STATUS

Abbotsford Private Hospital (WA)47 beds, parking, therapy rooms and adminA$18.6A$14.0A$4.66.1%Late-22Structure complete. Internal fitout well advanced.

Belmont Private Hospital (QLD)48 new inpatient beds, 13 private practice consulting suites

and 70 new car parks

A$22.6A$10.4A$12.25.8%Late-22Main structure complete with roofing works underway. Services

installation commenced on lower floors.

Playford Health Hub Stage 2 (SA)Specialist Medical Centre - Radiology, Oncology,

Radiotherapy & Consulting

A$39.3A$5.3A$34.07.3%Early-24Demolition of existing shops completed. Main works contractor

appointed, works to commence onsite end of July.

Total Australian Developments A$A$80.5 A$29.7 A$50.8 6.6%

Wakefield Hospital Stage 2

(Wellington)

Second stage of hospital rebuild delivering 8 operating

theatres, 42 beds, new Day Surgery Unit and additional

expansion capacity

NZ$91.5NZ$29.1NZ$62.45.6%Late-24Stage 2 commenced Oct-21. Demolition and benching of the site

completed. Piling for foundations well advanced. Targeting completion

Late-24.

Boulcott Hospital (Wellington)Two new theatres, PACU expansion and conversion of

double rooms to singles

NZ$7.7NZ$0.0NZ$7.76.2%TBC

1

New ownership in place. Updated business case being awaited.

Procurement options being considered with ECI likely.

Ormiston Hospital Stage 1

(Auckland)

Stage 1 - 3 level expansion of existing hospitalNZ$37.9NZ$5.1NZ$32.85 .1 %Mid-24Early works commenced May-22 with long lead time

items purchased within budget allowance. Forecast

completion date remains at May 2024.

Grace Hospital Stage 1

(Tauranga)

Fitout of two theatres, new endoscopy room, additional 10

beds and redevelopment of existing clinical areas

NZ$31.7NZ$5.5NZ$26.25.3%Late-23Theatre fitout works completed along with alterations to the day surgery

unit. Main works design under review.

Royston Hospital Stage 2

(Hastings)

Fitout of two theatres and reconfiguration of pre and post

operative clinical areas

NZ$6.3NZ$2.4NZ$3.95.3%Late-22Minor demolition complete. Design work progressing.

Bowen Hospital OT5 (Wellington)Fitout of one theatre, new sterile stores and expansion of

consulting suites

NZ$6.3NZ$3.0NZ$3.35.3%Late-22Theatre fitout works complete. Balance of work to ward rooms and

seismic gap commenced.

Endoscopy Auckland (Auckland)4 dedicated endoscopy procedure rooms, 15 car parks,

reception/waiting areas

NZ$22.6NZ$0.3NZ$22.35 .1 %Late-23Resource consent extension underway. ECI procurement likely.

Total New Zealand DevelopmentsNZ$204.0NZ$45.4NZ$158.65.4%

Total Developments in NZ$NZ$293.2NZ$78.3NZ$214.95.8%

Campbelltown Stage 1New cancer centreA$54.4A$6.1A$48.34.3%

3

Early-24Construction commenced in July-22.

Tasman Medical CentreSpecialist Ambulatory Care/Private HospitalA$98.6A$9.5A$89.1~4.5%Late-24Terms agreed.

Total Australian Fund-through developmentsA$153.0A$15.6A$137.14.4%

Total Fund-through developments in $NZD

2

NZ$169.3NZ$17.2NZ$152.1

1

Subject to receipt of final business case

2

Developments where Vital is funding through the

development rather than acting as developer

3

Stabilised yield based on Genesis Care rent in Yr3

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

40

Acquisition of Hutt Valley Health Hub, Wellington, NZ
VITAL ACQUIRED A PREMIUM CO-LOCATED AMBULATORY CARE FACILITY TO COMPLEMENT EXISTING INVESTMENTS

~4.0%

Feb 2022

Sustainable features

$46.5m

~3,300sqm

~3,200sqm

~14.2 years

7 tenants

Key precinct

WALE

focused on primary care

and outpatient services

Co-located with Hutt Hospital and

Boulcott Hospital (also owned by Vital)

initial yield

settlement

Sustainable features include CLT timber construction

and seismic dampers incorporated into design.

acquisition price

net lettable area

Future expansion land

available for development

1

ACQUISITION SUMMARY

FUTURE DEVELOPMENT SUMMARY

1

Includes existing adjoining holding and development land expected to be settled shortlyVITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 41

Acquisition of The Tennyson Centre, Adelaide, SA
VITAL ACQUIRED ONE OF ADELAIDE’S LEADING “CANCER CENTRES OF EXCELLENCE”

4.8%~A$93m

1

12,700sqm

Oct 2021

1,900sqmA$2.75m

6,568sqm

3.5%–4%

Quality tenantsSeveral key leases

net lettable area

fixed annual rent reviews

Icon Cancer, GenesisCare, Nexus

Day Hospitals, Dr Jones & Partners

renewed since acquisition

Initial yieldacquisition price

site area

settlement

site areaacquisition price

ACQUISITION SUMMARY

DEVELOPMENT LAND SUMMARY

The Tennyson

Centre

Development

Land

1

Includes development acquisition cost listed below

VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 42

BLINK TO FORMAT
Acquisition of land to expand The Hills Clinic, Sydney, NSW

VITAL ACQUIRED A STRATEGIC LAND HOLDING ADJOINING EXISTING PREMIUM ASSET FOR FACILITY EXPANSION

Feb 2022A$50m

4,340sqm

~5%

25 years

100%

settlementacquisition and estimated

development costs

site area

yield on cost

in line with existing lease

pre-committed to

Aurora Healthcare

ACQUISITION SUMMARY

The Hills

Clinic

~4,340sqm

MEMORIAL AVENUE

MCCAUSLAND PLACE

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

43

Acquisition of multi-stage development site in South West Sydney
VITAL ACQUIRED A PRE-COMMITTED GENESIS CARE CANCER CENTRE AND MULTI STAGE DEVELOPMENT SITE IN SYDNEY GROWTH CATCHMENT

~4.0%

2

Feb 2022A$52m

1

3%

40,000

sqm

UP TO

23,000sqmA$24.6m

2,713sqm

15 year

net lettable areaWALE

initial yield

for stage 1

settlementacquisition price &

development costs

annual rent reviews

additional GFA

site areaacquisition price

STAGE 1 – FUND-THROUGH DEVELOPMENT OVERVIEW

STAGES 2 & 3 – ADDITIONAL DEVELOPMENT SUMMARY

1

Excludes adjoining development land but includes fund-through construction costs for Stage 1

2

After deducting ground rent costs and allowing for benefit of stamp duty savings via fund-through structure

Camden Rd

Hurley St

Cancer Cancer

CentreCentre

Mental Mental

HealthHealth

Health Health

FacilityFacility

VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 44

Arvida Retirement and
Aged Care Facility

(under construction)

Queenstown

Airport

The precinct strategically adjoins

NZX-listed Arvida's retirement

village and aged care facility

(under construction).

Childcare

Retail 2

Retail 1

Medical Centre

/ Pharmacy

Southern Cross

Hospital

Radiology

Centre of Medical

Excellence

Arvida Group

Country Club

Buildings to be on separate

titles which supports a higher

valuation than if combined

Kawarau Park

Health Precinct

The hospital is the only private hospital

in Queenstown and Central Otago and

the precinct benefits from Queenstown's

favourable demographics.

Acquisition of Kawarau Park Health Precinct, Queenstown

A newly developed health precinct

comprising six tenanted buildings

including Queenstown's only

private hospital operated in a joint

Venture between Southern Cross

Healthcare and Central Lakes Trust.

The hospital includes three operating

theatres and 13 inpatient rooms.

Other tenants include nationwide

providers such as NZX-listed Green

Cross Health and Pacific Radiology

(subsidiary of NZX-listed Infratil),

along with several surgical consulting

rooms, childcare and supporting

retail and commercial uses.

TENANTS

The precinct is situated on over 2.3ha of

land and has additional development

potential of at least 2,000sqm of land.

DEVELOPMENT POTENTIAL

FAVOURABLE DEMOGRAPHICS

1

Settlement occurred in late July 2022

2

Excludes development land of ~$4m

WALE underpinned by

hospital lease of 12 years

8.7 years

of leases (by income) increase by the

greater of market and CPI (uncapped)

~40%

fully let blended yield

~4.5%

2

purchase price

$95m

1

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

45

The facility sits on a large land
holding of ~15,000sqm and has

an existing planning height limit of

17m (4 levels compared with the

current single level building).

There is potential for future

redevelopment, including ~1,600sqm

of additional land that currently earns

income from parking but provides

an opportunity to enhance the

acquisition noting that this corner is

closest to Christchurch Hospital.

Acquisition price of $50.7m

(excludes transaction costs and

fit-out loan to CDHB which is

repayable over 10 years).

~30% of the facility is currently

available for lease and is subject to

a 24-month vendor rental underwrite.

The acquisition settled on 1 April 2022.

Acquisition of 68 Saint Asaph St, Christchurch

Existing tenants include a Canterbury

District Health Board (CDHB) maternity

care facility

1

and Syft Technologies

(~50% of the Syft tenancy is life

sciences laboratory space with the

balance used for offices).

TENANTS

DEVELOPMENT POTENTIAL

ACQUISITION

Metro sports facility

(in construction)

5.1%

April 2022

settlement

estimated NOI

2

yield excluding

fees and development land but

including a ~$7m fit-out loan

repayable over 10 years.

8.5 years

WALE (by income)

1

Lease commences 1 August 2022

2

Net Operating Income

Hospital and related

68 St Asaph St

CDHB multi deck

staff carpark

CDHB head office

Manawa Building

Public outpatient

clinic

Public hospital

energy centre

/boiler house

(in construction)

and existing labs

Public Hospital

VITAL HEALTHCARE PROPERTY TRUST | ANNUAL RESULTS 2022 | 46

Acquisition and expansion of Endoscopy AucklandAcquisition and expansion of Endoscopy Auckland
The property is leased to Evolution Healthcare

for 20 years with the hospital business owned

jointly by Healthcare Holdings and Evolution

Healthcare (respectively, New Zealand’s second

and third largest private hospital operators).

Vital has acquired land and

buildings at 148 Gillies Avenue and

22–24 Kipling Avenue, Epsom.

1

Currently, the properties comprise an

endoscopy facility and residential

units on ~4,000sqm of land.

PROPERTY

TENANTS

AGREED DEVELOPMENT

~4.75%

initial yield

~$21.6m

development costs

~5.1%

net yield on

development cost

$22.2m

1

purchase price

Gillies Property

Kipling Property

(site now predominantly

cleared for development)

1

Settlement for the majority of the land and buildings occurred in June 2022 with the balance awaiting Overseas Investment Office approval

Mercy Ascot

Hospital

Auckland Surgical

Centre (Southern Cross)

Gillies Hospital

(Southern Cross)

Brightside Hospital

(Southern Cross)

Ascot Hospital

(Vital Asset)

Endoscopy Auckland

Newmarket

Epsom

Mount Eden

Remuera

Terms have been agreed to

utilise the vacant land at 22

Kipling Ave and develop a new

day surgery and endoscopy

facility, with the existing facility

expanding surgery capacity.

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

47

Artist’s impression showing existing building on left and proposed extension set back on the right.
AGREED DEVELOPMENT

Expansion of Ormiston Hospital, Auckland

The property is leased to Ormiston

Surgical Endoscopy Limited which is

~50% owned by Southern Cross, New

Zealand’s largest private hospital operator.

On completion, the new facility will

be leased for 20 years with the lease

of the existing facility also extended to

20 years (an ~18.5 year extension).

Terms have been agreed to develop

a new ~4,500sqm, 3 level building

linked to the existing ~5,000sqm, 3

level building by an air bridge.

Vital has agreed terms for a

~$40m expansion of its existing

asset, Ormiston Hospital.

PROPERTY

TENANTS

~5.5%

net yield on

development cost

~$40m

development costs

1

Artist’s impressions

1

Includes allocation of land (already owned by Vital) and unrentalised development fees and remains subject to final pricing

Savory appointed as

lead contractor

Construction

commenced mid-2022

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

48

Additional portfolio
information

WESTERN
AUSTRALIA

NORTHERN

TERRITORY

SOUTH


AUSTRALIA

NEW

SOUTH

WALES

TASMANIA

VICTORIA

QUEENSLAND

4

3

6

6

12

Investment properties

1

~$3.3BN PORTFOLIO OF HEALTHCARE REAL ESTATE COMPRISING 47 INVESTMENT PROPERTIES AND 2,800+ BEDS

Vital also owns strategic land holdings for future development valued at ~$196m

AS AT 30 JUNE 2022

Western Australia (4)

Abbotsford Private Hospital

Hamersley Aged Care

Marian Centre

Rockingham Aged Care

South Australia (3)

Sportsmed Hospital, Clinic, Consulting

and Office

The Tennyson Centre

Playford Health Hub – Retail and Carpark

Queensland (6)

Baycrest Aged Care

Belmont Private Hospital

Eden Rehabilitation

Palm Beach Currumbin Clinic

Tantula Rise Aged Care

The Southport Private Hospital

New South Wales (12)

Clover Lea Aged Care

Darlington Aged Care

Fairfield Aged Care

Grafton Aged Care

Hirondelle Private Hospital

Hurstville Private Hospital

Lingard Day Centre

Lingard Private Hospital

Maitland Private Hospital

Mons Road Medical Clinic

The Hills Clinic

Toronto Private Hospital

Victoria (6)

Ekera Medical Centre

Epworth Eastern

Hospital & Medical Centre

120 Thames Street

Epworth Camberwell

Epworth Rehabilitation Hospital

South Eastern Private Hospital

Auckland (6)

Apollo Health and Wellness Centre

Ascot Central

Ascot Carparks

Ascot Hospital & Clinics

Ormiston Hospital

Endoscopy Auckland

Wellington (4)

Boulcott Hospital

Bowen Hospital

Wakefield Hospital

Hutt Valley Health Hub

Northland (1)

Kensington Hospital

Bay of Plenty (1)

Grace Hospital

Christchurch (1)

Saint Asaph Street

Hawke's Bay (2)

Napier Health Centre

Royston Hospital

Queenstown (1)

Kawarau Park Health

2

14

1

Number of properties include Kawarau Park Health Precinct, Queenstown, but excludes strategic assets. All other figures exclude Kawarau Park Health Precinct, QueenstownVITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

50

PRIVATE HOSPITALS – AUSTRALIA
17 hospitals (acute and specialty –

mental health, rehabilitation)

F our hospital operators

80% of AUS portfolio value;

79% of AUS rent

WALE: 19.1 years

6 assets, multiple tenants

1 4% of AUS portfolio value;

12% of AUS rent

WALE: 7.0 years

8 facilities (all in AUS)

2 operators

6% of AUS portfolio value;

9% of AUS rent

WALE: 9.9 years

AMBULATORY CARE – AUSTRALIA

AGED CARE – AUSTRALIA

~$2.4bn Australian portfolio overview

GEOGRAPHICALLY DISPERSED AUSTRALIAN PORTFOLIO CONTINUES TO PERFORM WELL

45%

35%

14 %

6%

H

O

S

P

I

T

A

L


8

0

%

O

T

H

E

R


2

0

%

AMBULATORY

CARE

SPECIALTY

HOSPITAL

AGED CARE

ACUTE

HOSPITAL

17.1 years

WALE

SUBSECTOR DIVERSITY (BY VALUE)

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

51

~$0.9bn New Zealand portfolio overview
KEY NEW ZEALAND MARKET PERFORMING STRONGLY

PRIVATE HOSPITALS – NEW ZEALAND

9 hospitals (all acute)

6 hospital operators

75% of NZ portfolio value;

75% of NZ rent

WALE: 21.6 years

6 assets, multiple tenants

25% of NZ portfolio value;

25% of NZ rent

WALE: 9.9 years

AMBULATORY CARE – NEW ZEALAND

18.7 years

WALE

75 %

25%

H

O

S

P

I

T

A

L


7

5

%

O

T

H

E

R


2

5

%

AMBULATORY

CARE

ACUTE

HOSPITAL

SUBSECTOR DIVERSITY (BY VALUE)

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

52

Lease expiry profile
LOW RISK EXPIRY PROFILE SUPPORTS SUSTAINABLE, PREDICTABLE AND DEFENSIVE CASH FLOWS

Lease expiries in FY23 primarily reflect smaller tenancies at multi-tenant properties

10-year average annual lease expiry of only 1.7% (as % of total portfolio income)

Jun-23

0%

2.5%

5.0%

7.5%

10%

Jun-24Jun-25Jun-26Jun-27Jun-28Jun-29Jun-30Jun-31Jun-32

Total expiry

Largest single rent expiring10 Year Average

1.7%

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

53

Rent reviews
HIGH PERCENTAGE OF TOTAL RENT IS REVIEWED ANNUALLY WITH STRUCTURED

1

REVIEW MECHANISMS

Rent reviews have

been completed for

110 leases in FY22

Structured reviews

represent 92%

1

of

leases by income

as at 30 June 2022

Significant uplift via

structured rent reviews

across Portfolio

1

Includes fixed percentage and CPI reviews

Rent reviews – FY22

(“LIKE-FOR-LIKE” EXCLUDES DEVELOPMENTS, ACQUISITIONS AND DISPOSALS)


#

Jun-21 Rent p.a.

(NZD)

Jun-22 Rent p.a.

(NZD)

Increase

(NZD)

Annualised Growth

(Stable currency)

AustraliaAUS5484,752,63387,830,9793,078,3463.6%

New ZealandNZ5632,466,16433, 733, 75 91,267,5953.9%

Total11 0117,218,797121,564,7384,345,9423.7%


#

Jun-21 Rent p.a.

(NZD)

Jun-22 Rent p.a.

(NZD)

Increase

(NZD)

Annualised Growth

(Stable currency)

CPICPI78103,256,277106,892,7793,636,5023.5%

FixedFixed2311, 742 , 27812,237,226494,9494.2%

MarketMarket81,254,7571,349,96695,2107.6%

TurnoverTurnover1965,4851,084,766119,28112.4%

Total11 0117,218,797121,564,7384,345,9423.7%

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

54

Core portfolio metrics
5 YEAR TRENDS HIGHLIGHT PORTFOLIO STRENGTH AND UNDERPIN LONG-TERM PERFORMANCE

OCCUPANCY

AVERAGE 10 YR LEASE EXPIRY

1

WALE

TOTAL INCOME SUBJECT TO

STRUCTURED RENT REVIEWS

~99%

occupancy

Long-term track record of maintaining

High degree of confidence that

future expiries will be renewed

or replaced with new tenants in

advance of expiry

1

Reflects the average % of total portfolio

income that expires over the next 10 years

95%

96%

97%

98%

99%

100%

2018

99.3

99.499.4

99.2

98.8

2019202020212022

15

16

17

18

19

2018

18.2

18.118.1

18.7

17.6

2019202020212022

0%

1%

2%

3%

4%

5%

6%

1.8

1.7

1.3

1.6

1.7

20182019202020212022

PERCENTAGE OF INCOME

0%

20%

40%

60%

80%

100%

85.8

90.0

94.0

95.0

92.3

20182019202020212022

PERCENTAGE OF INCOME

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

55

Additional financial
information

Adjusted funds from operations (AFFO)
CONSERVATIVE PAY-OUT RATIO

FY22F Y 21($) CHANGE(%) CHANGE

Operating profit before tax and other income

1

56,517 51,064 5,453 10.7

Add/(deduct):

Current tax expense(8,280) (7,858) (422) (5.4)

Incentive fee 15 , 914 12,402 3 , 512 28.3

Current tax on translation of foreign currency funding transactions 98 227 (129) (56.8)

Amortisation of borrowing costs 1, 270 878 392 44.6

Amortisation of leasing costs & tenant inducements 2 , 778 2,421 357 14 . 7

Strategic transaction expenses 283 - 283 -

IFRS 16 operating lease accounting(163) (144) (19) (13.2)

Funds from operations (FFO)

1

68,417 58,990 9,427 16.0

Add/(deduct): -

Actual capex & leasing from continuing operations(593) (1,533) 940 61 . 3

Adjusted funds from operations (AFFO) 67, 8 24 57,457 10,367 18.0

AFFO (cpu)11 . 9 2 c11.54c0.38c 3.3

Distribution per unit (cpu)9.63c8.88c0.75c 8.5

AFFO pay-out ratio81 %77%--

1

All values shown in NZ$000s

Units on issue (weighted average, 000s)569,104497,892

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

57

Interest rate hedging profile
COST OF DEBT WELL HEDGED, MANAGING RISK

1

Drawn debt (excludes line fees on undrawn facility)

HEDGING MATURITY PROFILE ($A)

NOTE: Fixed rates exclude line fees and margin

0.00%

0.50%

1.00%

1.50%

2.00%

2.50%

3.00%

0

50

100

150

200

250

300

350

400

450

Jun-22

Dec-22

Jun-23

Dec-23

Jun-24

Dec-24

Jun-25

Dec-25

Jun-26

Dec-26

Jun-27

Dec-27

Jun-28

Dec-28

Jun-29

VALUE ($M)

Maturity dateAverage interest rate

RATES30 JUNE

2022

30 JUNE

2021

Weighted average cost of debt

1

3. 73 %3.32%

"Weighted average fixed rate

(excl line and margin)"

2.89%2.94%

Weighted average fixed rate duration4.7 yrs5.5 yrs

% of drawn debt fixed45%49%

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

58

Net tangible assets (NTA)
NTA PER UNIT BRIDGE

REVALUATION GAINS SUPPORTED STRONG NTA GROWTH PER UNIT

Revaluation gain of $244m;

9.3% increase from June 2021

~77% of gain from Australian

portfolio and ~23% from

New Zealand

Revaluation gains include

~$100m from rental increases,

leasing activity and ~$10m of

development margins

$2.40

$2.50

$2.60

$2.70

$2.80

$2.90

$3.00

$ 3 .10

$3.20

$3.30

$3.40

$2.89

$3.34

$0.32

$0.06

$0.07

($0.02)

$0.02

FY2022property revaluationscurrency translationretained earningsnew units issuedinterest rate swapsFY2021

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

59

Movement in investment property
WELL-LEASED HEALTHCARE ASSETS CONTINUE TO EXPERIENCE CAP RATE COMPRESSION

INVESTMENT PROPERTY BRIDGE (FY22)

KEY POINTS

(NZ MILLIONS)

Continued activation of strong development

pipeline, contributing ~$100m to portfolio

over FY22

1 00% of Vital's Income Producing Properties

independently valued over FY22

R evaluation gains include ~$100m from

rental increases and leasing activity, ~$10m

of development margins and 30 basis points

cap rate compression since 30 June 2021

Maintained geographic balance

between Australia and New Zealand of

approximately two-thirds and one-third

respectively

1

$287m (excluding transaction costs) of acquisitions, including $94m for The Tennyson Centre, $52m for Saint Asaph St (Christchurch), $45m for Hutt

Valley Health Hub, $20m for Endoscopy Auckland and the balance for strategic / development sites. All asset values shown in NZ$, pre costs

2

Includes development expenditure and capitalised interest costs

3

Book value at sale date

4

Period end NZD/AUD exchange rate moved from 0.9309 at 30 June 2021 to 0.9037 at 30 June 2022

$0

$500

$1,000

$1,500

$2,000

$2,500

$3,000

$3,500

2,635

$1,934m

$701m

$2,391m

$948m

298

100

244

(13)

753,339

30-Jun-22Acquisitions

1

Capital

additions

2

Property

revaluations

Disposals

3

Foreign

exchange

4

30-Jun-21

AUS Assets

NZ Assets

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

60

Comparative returns
LONG-TERM OUTPERFORMANCE BY VITAL VS BENCHMARK ON A TOTAL RETURN

1

BASIS

TOTAL RETURN

1

TO 30 JUNE 20221YR

(%)

5YR (P.A.)

(%)

10YR (P.A.)

(%)

SINCE 2004

(P.A.)

2

(%)

Vital-10.27. 213 . 212 . 7

S&P/NZX All Real Estate Index-13.66.49.08 .1

S&P/NZX 50 Index-14.17. 412.37. 7

Vital’s performance vs NZX REIT3.50.94.24.6

Vital’s performance vs NZX 503.9-0.20.95.0

Outperformance against both the S&P/NZX All Real Estate Index

and S&P/NZX 50 Index since December 2004

L ong-term outperformance highlights the defensive nature of

healthcare real estate compared to other real estate classes

7 .9% outperformance versus NZX REIT benchmark over last 24

months and 5.2% outperformance versus NZX 50

Source: Forsyth Barr

1

Total returns measured by change in unit price plus post-tax distributions to 30 June 2022

2

S&P/NZX All Real Estate Index and S&P/NZX 50 Index data from 31 December 2004, being

the inception date of the NZX All Real Estate Index

VHP VS S&P NZX REAL ESTATE INDEX

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

61

Glossary
AFFO

Adjusted Funds From Operations is an alternate measure used for assessing distributable income. Essentially adjusts net profit

after tax for all non-cash items (i.e. NDI) then makes adjustments for items such as maintenance capex and lease incentives paid.

Cap Rate

Capitalisation Rate. Generally calculated as net operating income / current market value of investment property.

CPI

Consumer Price Index. An index that measures the change in the cost of a ‘basket’ of basic goods and services, showing how

the cost-of-living changes over time. The most widely accepted indicator of inflation.

FX

An abbreviation for ‘foreign exchange’ used where there is a transaction in a currency other than the local currency.

GFA

Gross floor area

NPI

Net Property Income.

NTA

Net Tangible Assets. The total assets of the Trust less total liabilities. NTA is normally divided by the number of units on issue and

expressed as an annual amount per unit.

WALE

Weighted Average Lease term to Expiry. The weighted average lease term remaining to expire across a portfolio, sometimes

also referred to as WALT.

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

62

Disclaimer
This document has been prepared by NorthWest Healthcare Properties Management Limited (the Manager) as manager of the Vital

Healthcare Property Trust (the Trust). This document provides general information only and is not intended as investment, legal, tax, financial

product or financial advice or recommendation to any person and must not be relied on as such. You should obtain independent professional

advice prior to making any decision relating to your investment or financial needs.

All references to $ are to New Zealand dollars unless otherwise indicated.

This document may contain forward-looking statements. Forward-looking statements can include words such as “expect”, “intend”, “plan”,

“believe”, “continue” or similar words in connection with discussions of future operating or financial performance or conditions. Any

indications of, or guidance or outlook on, future earnings or financial position or performance and future distributions are also forward-

looking statements. The forward-looking statements are based on management's and directors’ current expectations and assumptions

regarding the Trust’s business, assets and performance and other future conditions, circumstances and results. As with any projection or

forecast, forward-looking statements are inherently susceptible to uncertainty and to any changes in circumstances. The Trust’s actual results

may vary materially from those expressed or implied in the forward-looking statements. The Manager, the Trust, and its or their directors,

employees and/or shareholders have no liability whatsoever to any person for any loss arising from this document or any information

supplied in connection with it. The Manager and the Trust are under no obligation to update this document or the information contained in it

after it has been released. Past performance is no indication of future performance.

The information in this document is of general background and does not purport to be complete. It should be read in conjunction with Vital’s

market announcements lodged with NZX, which are available at www.nzx.com/companies/VHP.

11 August 2022

VITAL HEALTHCARE PROPERTY TRUST

|

ANNUAL RESULTS 2022

|

63

www.vhpt.co.nz
Thank you

Artist's impression of development of GenesisCare, Campbelltown

---

VITAL HEALTHCARE PROPERTY TRUST vhpt.co.nz
Managed by NorthWest Healthcare

Properties Management Limited

Page 1 of 1


MARKET RELEASE

11 August 2022

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.